Infection dynamics and effective control strategies of tuberculosis in badgers and cattle in Ireland by Aznar Asensio, J.I.

  
 
 
 
 
 
 
Infection dynamics and effective 
control strategies of tuberculosis in 
badgers and cattle in Ireland 
 
 
 
 
 
 
 
 
 
 
 
 
 
J Inmaculada Aznar Asensio 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thesis committee 
 
Promotor 
Prof. Dr M.C.M. de Jong 
Professor of Quantitative Veterinary Epidemiology 
Wageningen University & Research 
 
Co-promotor 
Dr K. Frankena 
Associate professor, Quantitative Veterinary Epidemiology Group 
Wageningen University & Research 
 
Other members 
Prof. Dr M. Nielen, Utrecht University, The Netherlands  
Dr A.P. Koets, Wageningen Bioveterinary Research, Lelystad, The Netherlands 
Prof. Dr G.F. Wiegertjes, Wageningen University & Research 
Dr W.F. de Boer, Wageningen University & Research 
 
 
This research was conducted under the auspices of the Graduate School of Wageningen 
Institute of Animal Sciences (WIAS).  
  
 
 
 
 
 
Infection dynamics and effective control 
strategies of tuberculosis in badgers and 
cattle in Ireland 
 
 
 
 
J Inmaculada Aznar Asensio 
 
 
 
 
 
 
 
 
 
Thesis 
 
submitted in fulfillment of the requirements for the degree of doctor  
at Wageningen University 
by the authority of the Rector Magnificus, 
Prof. Dr A.P.J. Mol, 
in the presence of the 
Thesis Committee appointed by the Academic Board 
to be defended in public 
on Friday 9 February 2018 
at 1.30 p.m. in the Aula. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aznar, I. 
Infection dynamics and effective control strategies of tuberculosis in badgers and cattle in 
Ireland, 
167 pages. 
 
PhD thesis, Wageningen University, Wageningen, the Netherlands (2018) 
With references, with summary in English 
 
ISBN: 978-94-6343-726-4 
DOI: https://doi.org/10.18174/430133
  
 
 
 
 
 
 
 



 4 
 
  
 
 
5 
 
Background information 
 
Mycobacterium bovis (M. bovis) infection in cattle in Ireland 
 
Mycobacterium bovis, the causative agent for tuberculosis in cattle, is a member of the 
Mycobacterium tuberculosis complex. This group is comprised of closely related 
bacterial species that cause tuberculosis in humans and other mammals (Wirth et al., 
2008). Wildlife species acting as reservoir hosts for cattle include: brushtail possum, 
European badger, African buffalo, wild boar and white-tailed deer (Palmer, 2013). 
Bovine tuberculosis has a significant impact on farmer livelihood due to movement 
control and trading restrictions of affected herds, apart from the zoonotic aspect. In 
Ireland, an estimated 80% of the cattle herds were infected in 1954, when a 
control/eradication programme for M. bovis infection in cattle started. This 
programme initially consisted in the use of the Single Intradermal Comparative 
Tuberculin Test (SICTT) to test and remove infected cattle. Since this programme 
commenced, animal incidence decreased from 17% to 0.5% in 1965 (Watchorn, 
1965; More and Good, 2006). The large success of this programme over a relatively 
short period of time led to a declaration of Officially Tuberculosis Free (OTF) status 
in accordance with Directive 64/432/EEC. Over the years and based on the findings 
of national and international scientific research, the Irish bTB control programme 
has been constantly under review, and additional control measures being 
progressively added. Apart from the intensive tuberculin testing of all cattle in the 
country on a yearly basis, many other measures such as random sample testing of 
herds, routine veterinary post-mortem surveillance at the slaughterhouse, contiguous 
testing, depopulation of problematic herds, etc. were adopted (More, 2005). Despite 
a strong focus on measures to reduce cattle to cattle transmission, prevalence of the 
disease has remained relatively stable since the initial decrease in animal incidence 
(More et al., 2006) as shown in Figure 1. 
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Figure 1. The annual number of reactors to the bovine tuberculin test in Ireland, from 1959 
to 2015 (Updated figure from More, 2009). 
 
Badgers as a main reservoir for bTB 
 
The inability to eradicate the disease by focusing on strategies that aimed at reducing 
cattle to cattle transmission suggested the presence of one or more reservoirs of the 
pathogen outside the cattle population. M. bovis was first isolated from a badger 
(Meles meles) in Ireland in 1974 (Noonan et al., 1975), following work carried out 
in the UK where badgers were also suspected as a reservoir for M. bovis (Krebs, 
1997). Since then, a large amount of literature looking at different epidemiological 
aspects was dedicated to investigating the role of badgers in bTB maintenance (More 
and Good, 2006). In Costello et al. (1999), restriction fragment length polymorphism 
(RFLP) and spoligotyping analysis were used to strain type M. bovis isolates from 
domestic and wild species, showing a similar range and geographic distribution of 
strains from cattle, badgers, and deer. Several studies have highlighted the 
susceptibility of badgers to M. bovis infections, as well as a wide distribution of the 
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infection in the badger population (Gormley and Costello, 2003; Corner et al, 2005). 
Two large field studies (the East Offaly and the four area projects) were conducted, 
seeking to clarify the role of badgers in the epidemiology of M. bovis infection in 
cattle. Following the proactive removal of badgers in some of the study area, these 
studies demonstrated a significant reduction in cattle incidence in comparison to 
control areas where no badger removals were carried out (Eves, 1999; Griffin et al., 
2005; Olea-Popelka et al., 2009). These studies provided evidence of the role of 
badgers as a disease-maintenance-host (in areas of known cattle infection). It was 
then assumed that the main constraint to the eradication programme was the presence 
of a largely infected badger population. 
 
In Ireland, badger culling commenced in 2000 as a strategy to reduce the incidence 
of the infection in badgers with the aim to achieve eradication in cattle. Since the 
introduction of culling, the incidence of bTB in cattle that had been stalled for the 
previous 30 years, commenced to slowly decline (small figure within Figure 1). 
Although a number of other strategies to tighten controls in cattle were also 
introduced during this time, based on the results obtained from field studies, it was 
believed that it was primarily badger culling that lead to this decline. The current 
national policy in response to a cattle herd bTB breakdown is to attempt to determine 
the most likely cause of the breakdown; if no specific cause can be identified, an 
investigation is carried out to establish whether or not badgers are responsible for 
transmission of infection. If badgers are the most plausible source of infection, then 
badgers from setts within a 500 meter radius from the infected farm are removed. A 
total of approximately 6,000 badgers are being culled per year as part of the DAFM 
wildlife bTB strategy. However, badgers are a protected species and as such, they 
have to be preserved to comply with the Bern Convention (Convention on the 
Conservation of European Wildlife and Natural Habitats, 1979). As badger culling 
cannot be sustained over time, research has gradually moved towards investigating 
a feasible long-term solution. Bacille Calmette-Guérin (BCG) vaccination in badgers 
was an eradication strategy on which all stakeholders (policy makers, farmers, 
ecologists, economists, and society) could agree. 
 
BCG badger vaccination 
 
A 10-year project to study the possibility of using BCG vaccine in badgers to assist 
in the control and eradication of bTB in cattle commenced in Ireland in 2001 funded 
by the Department of Agriculture, Food and the Marine (DAFM). A number of 
experimental challenge trials were initially conducted with captive badgers (Corner 
et al., 2007; Lesellier et al., 2009). In all of these studies, vaccination via either 
subcutaneous, mucosal, oral or intramuscular routes showed a reduction of disease 
progression (Corner et al., 2008; Lesellier et al., 2009, 2011; Murphy et al., 2014). 
The findings from these trials were promising, and helped to refocus the scientific 
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debate towards the need to assess estimates of BCG vaccine efficacy and its 
effectiveness in terms of reducing M. bovis transmission in natural populations of 
badgers.  
 
Thesis Objectives 
 
Vaccine Efficacy estimation 
 
The first objective of this thesis was to design a field trial enabling quantification of 
the efficacy of BCG vaccination on M. bovis transmission in badgers under field 
conditions. BCG had previously been tested in badgers in a controlled environment; 
however, it is not possible to directly extrapolate these results to vaccine efficacy 
under field conditions. To that purpose, the Kilkenny badger vaccine field trial was 
designed (Aznar et al., 2011). Although laboratory trials had shown a reduction of 
disease progression in captive badgers, all badgers challenged with M. bovis became 
infected. A field trial was therefore a way of establishing whether or not protection 
against infection could be attained under natural conditions, where the infective dose 
that badgers are exposed to is likely much lower than that used in experimental trials 
(Corner et al., 2010; Lesellier et al., 2011; Aznar et al., 2011). Protection against 
infection can be the result of both a reduction in the susceptibility of the receiver 
and/or a reduction in the infectiousness of the donor. Reduction in susceptibility 
corresponds first of all to a direct effect of vaccination or vaccine efficacy for 
susceptibility (VES). Note, however that a reduction in susceptibility also has an 
indirect effect, as it reduces the transmission of bTb. Likewise, the trial in wild 
badgers could help to determine if the observed reduction in disease progression 
under laboratory conditions was linked to a reduction in infectiousness and therefore 
in the probability of secondary transmission. This type of protection is referred to as 
vaccine efficacy for infectiousness (VEI). In this thesis we aimed to estimate both 
VES and VEI. 
 
Estimation of the basic reproduction ratio (R0) and R(p) 
 
The second and most important objective in this thesis was to assess how much 
reduction in M. bovis transmission in badgers, and subsequently in the cattle-badger 
system, could be achieved by introducing BCG badger vaccination. To measure the 
impact of vaccination in transmission, first it was essential to have an estimate of the 
current level of transmission as expressed by R0. R0 is a mathematical parameter that 
refers to the number of cases one typically infectious individual generates, on 
average, over the course of its infectious period in a fully susceptible population. R0 
is a very important parameter, summarizing the behaviour of an infection in a 
population in just one single value (Kermack et al., 1927; Diekmann et al, 1990, 
2010; Fulford et al., 2002). This parameter is very simple to interpret when used as 
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a threshold. If for the cattle and badger system in Ireland R0 under the current control 
strategies is < 1, bTB will die out in the long run, if R0 > 1 bTB eradication with 
current control measures would not be achieved.  
 
Once the R0 for the system is estimated under current control measures, the efficacy 
of added strategies such as badger vaccination could be assessed based on how much 
they are capable of reducing R0, ideally to below 1. As R0 is a combination of the 
susceptibility of the receiver and the infectivity of the donor, knowing the effects of 
vaccination in both susceptibility and infectivity was essential to estimate the 
efficiency of vaccination. The R0 for the M. bovis cattle-badger system had never 
been estimated in Ireland. In this thesis, an estimate of the R0 for the system is 
presented as well as how this parameter changes depending on vaccination coverage 
(R(p)). Also, by estimating the Next Generation Matrix (NGM) for the system, we 
aimed to assess the contributions of each of the species transmission to the system 
R0 and the reduction of this parameter and the partial reproduction ratios achieved 
by BCG vaccination.  
 
Chapters and challenges 
 
Chapter 2: Trial design to estimate the effect of vaccination on tuberculosis incidence 
in badgers. 
 
The design of the Kilkenny badger vaccine field trial, as well as the methodology to 
analyse data generated from it, are presented in the second chapter of this thesis. The 
challenges in designing a trial capable of estimating both the direct and the indirect 
effect of vaccination have been highlighted in the literature (Halloran et al., 1997, 
1999; Longini et al., 1998). In essence, while a double blinded randomized vaccine 
placebo controlled trial is still the design of choice to estimate VES, it does not allow 
estimations of VEI unless information on actual contacts between infected and 
susceptible individuals is available. Longini et al. (1998) resolved this issue 
presenting a trial design and analysis that permitted estimations of both vaccine 
efficacies without the need of contact data. This design required at least two 
populations to be vaccinated with different vaccination coverage. Following on this 
approach, the Kilkenny vaccine trial consisted of three badger populations 
vaccinated with: 0, 50 and 100% vaccine coverage. This trial differed from other 
human trials in the fact that the required vaccination coverages were achieved over 
time rather than instantaneously, and this is something that was taken into account 
in our design and analysis. 
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Chapter 3: Estimating the power of a Mycobacterium bovis vaccine trial in Irish 
badgers 
 
When designing a (vaccine) trial, it is of great importance to ensure that the design 
will enable, to a specified level, often set to 80%, an effect to be found (if the effect 
really exists). In other words, it is critical that the statistical power of the study is 
sufficient (Riggs and Koopman, 2004, 2005). In many studies, power calculations 
are done a priori in order to determine the minimum/optimal sample size. In the 
Kilkenny trial, sample size was somehow pre-determined by logistical issues, as it 
was not possible to enlarge the trial area. Nonetheless, it was important that other 
factors that could affect power were examined. In the third chapter of the thesis, we 
carried out a study of factors that could affect our ability to detect a positive effect 
of vaccination if present, including: sample size (recapture percentage), initial 
prevalence, sensitivity and specificity of the diagnostic test used, transmission rate 
between unvaccinated badgers, and assumed VES and VEI.  
 
Chapter 4: Optimising and evaluating the characteristics of a multiple antigen ELISA 
for detection of M. bovis infection in a badger vaccine field trial 
 
The results from Chapter 3 showed that the factor with the greatest potential to 
compromise our ability to detect a positive effect of the BCG vaccine was the 
specificity of the diagnostic test used to determine infection in badgers. A diagnostic 
test with a nearly perfect specificity (>99.8%) was necessary to achieve a study 
power of at least 60%. As a diagnostic test with such a large specificity was not 
commercially available, the Enfer test to be used in the Kilkenny vaccine trial was 
optimized and evaluated. 
 
Chapter 5: Quantification of Mycobacterium bovis transmission in a badger vaccine 
field trial 
 
Using the optimized Enfer test, VES and VEI were calculated from the trial carried 
out in Kilkenny (2009-2013) and results are presented in Chapter 5. The impact of 
vaccination on transmission between badgers was evaluated assuming badgers are 
the only host for M. bovis. Nonetheless, ultimately, it was the effect of badger 
vaccination on transmission in the cattle-badger system that was of interest.  
 
Chapter 6: Characterizing transmission in a Mycobacterium bovis multi-host system 
 
If an infectious agent is transmitted between two (or more) different host species, R0 
calculations become more complex. These systems can be modelled using the Next 
Generation Matrix (NGM) (Diekmann et al., 1990, 2010; Fulford et al., 2002) and 
R0 can be determined mathematically as the dominant eigenvalue of this NGM. The 
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challenge in estimating R0 in this way arises from the need to parameterise these 
models with data carrying large uncertainty. In Chapter 6, a solution to this problem 
is presented: the  transition matrices for cattle herds and badgers at the endemic (M) 
and disease free (NGM) equilibrium were estimated by solving M.e=e and 
calculating the NGM from M. These equations did not require data on the 
transmission parameters between species, i.e from badgers to cattle and vice versa, 
in this way avoiding the introduction of large uncertainty. 
 
Chapter 7: General Discussion 
 
Finally, the results of this thesis are placed and analysed in a broader context so they 
can best inform policy in this area. The challenges of introducing badger vaccination 
in the bTB strategy are discussed. Suggestions on the road map to eradication are 
made and further research is suggested. 
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Abstract  
 
The principal wildlife reservoir of Mycobacterium bovis in Ireland is the European 
badger. Studies in the Republic of Ireland (RoI) have shown that badgers culled in 
association with cattle herd tuberculosis breakdowns (focal culling) have a higher 
prevalence of infection than the badger population at large. This observation is one 
rationale for the medium term national strategy of focal badger culling. A 
vaccination strategy for the control of bovine tuberculosis (bTB) in badgers is a 
preferred long-term option. The Bacillus Calmette-Guérin (BCG) vaccine has been 
shown to decrease disease severity in captive badgers under controlled conditions. 
As the vaccine has been tested in a controlled environment with precise information 
on infection pressure, it cannot be assumed a priori that the effects of vaccination 
are similar in the wild, where other environmental and/or ecological factors prevail. 
For this reason we have designed a vaccine field trial to assess the impact of 
vaccination on the incidence of TB infection in a wild badger population. 
 
The selected study area for the vaccine trial (approximately 755 square kilometers) 
is divided into three zones each of which has similar characteristics in terms of size, 
number of main badger setts, cattle herds, cattle and land classification type. Three 
vaccination levels (100%, 50% and 0%) will be allocated to the three zones in a way 
that a gradient of vaccination coverage North to South is achieved. The middle zone 
(Zone B) will be vaccinated at a 50% coverage but Zone A and C will be randomly 
allocated with 100% or 0% vaccination coverage. Vaccination within Zone B will 
be done randomly at individual badger level.  
 
The objective of this paper is to describe the design of a field TB vaccination trial 
for badgers, the epidemiological methods that were used to design the trial and the 
subsequent data analysis. The analysis will enable us to quantify the magnitude of 
the observed vaccination effect on M. bovis transmission in badgers under field 
conditions and to improve our knowledge of the biological effects of vaccination on 
susceptibility and infectiousness. 
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1. Introduction  
 
Ireland initiated an eradication program for bovine tuberculosis (bTB) as early as 
1950 (More and Good, 2006). The adopted test-and-slaughter policy achieved a 97% 
reduction in cattle tuberculosis prevalence, from 17% to 0.5% prevalence in the 
initial ten years (Watchorn, 1965). Since then, bTB prevalence has remained 
relatively unchanged despite the introduction of a range of measures aimed at 
reducing cattle to cattle transmission (Griffin and Dolan, 1995).  
 
In the 1970s in England, badgers were first suspected as a reservoir for 
Mycobacterium bovis (Krebs, 1997). The first infected badger was discovered in 
Ireland in 1974 (Noonan et al., 1975). Since then numerous papers have been 
published that confirm badgers as the main wildlife M. bovis reservoir in Ireland and 
England (Barrow and Gallagher, 1981; Cheeseman et al., 1981; Fagan, 1993; 
Gallagher et al., 1998). A recent study carried out in Ireland detected a prevalence 
of 36.3% in badgers trapped as part of Department of Agriculture, Fisheries and Food 
(DAFF) culling operations; the prevalence reported here was much higher than in 
previous studies where less comprehensive bacteriological culture methods had been 
used (Murphy et al., 2010). 
 
The precise role of badgers in the dynamics of bTB is not clear. Several studies in 
Ireland have linked badger removal with a subsequent reduction in bTB incidence 
(Eves, 1999; Griffin et al., 2005; More and Good, 2006; Olea-Popelka et al., 2009). 
However, in a field trial carried out in Britain, the reduction in cattle TB incidence 
in culled areas was only modest and an increase in TB incidence, albeit transient 
(Jenkins et al., 2008), was observed in non culled neighboring areas (Woodroffe et 
al., 2007). Pope et al. (2007) concluded that the increased prevalence observed in 
neighboring areas was associated with medium and long-distance badger dispersal 
and emphasized the importance of taking into account the potential negative effects 
associated with badger dispersal when using culling as a disease control strategy. 
Although there are discrepancies between different studies about the efficiency of 
badger culling in the control of bTB, they all provide evidence that badgers play an 
important role in the maintenance of it. Therefore, addressing infection in badgers is 
considered vital when trying to control bovine tuberculosis in the aforementioned 
countries. In the short- to medium-term in Ireland, focused badger culling is being 
conducted as part of a broader national TB control programme, to limit TB 
maintenance in areas where TB incidence in cattle is high. However, badgers are a 
protective species in the Republic of Ireland (ROI) under the 1976 Wildlife Act. 
Consequently, alternative strategies to badger culling are being sought in the long 
term for the control of bovine tuberculosis. 
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In 2001, a 10-year work program was designed in Ireland to study the possibility of 
using Bacillus Calmette-Guérin (BCG) vaccine in badgers to assist in the control and 
eradication of TB in cattle. The program consisted of a sequence of experimental 
studies carried out initially with captive badgers (Corner et al., 2007; Lesellier et al., 
2009). Although vaccines can be tested in a controlled environment for evidence of 
both protection and decreased transmission, it cannot be assumed a priori that the 
effects of vaccination are similar in the wild where other factors may play a role. For 
this reason, a vaccine field trial to assess the impact of vaccination on the incidence 
of tuberculosis in a wild badger population has been designed as part of the 10-year 
project. 
 
The objective of this paper is to describe a field trial design, the epidemiological 
methods that were used to design the trial and the subsequent data analysis. The 
analysis will enable us to quantify the magnitude of the observed vaccination effect 
on transmission under field conditions and to improve our knowledge of the 
biological effects of the vaccination on susceptibility and infectiousness of badgers. 
 
2. Theoretical basis: a review  
 
2.1 Initial considerations in designing a vaccine trial 
 
Specifying clear question(s) of interest is essential when designing a trial to evaluate 
the effects of vaccination. Different vaccination programs have different aims; the 
question of interest could vary, for example from how good vaccination is in 
protecting the individual against infection to what reduction in infectiousness can be 
achieved. The effect of interest will determine the study unit, parameters of effect, 
as well as the level of information required (Halloran et al., 1997). The main question 
of interest in our study is to determine the efficiency of badger vaccination in 
reducing M. bovis transmission. Specifically we are interested in the value of the 
reproduction ratio (R) at different levels of vaccination (p); ie R(p). We will clarify 
how to estimate R(p) subsequently. 
 
Vaccines that reduce transmission in a population can have a beneficial effect in 
vaccinated as well as in unvaccinated individuals. Most studies of vaccine efficacy 
emphasize the direct benefit of vaccination (often called ‘protective ability’) to 
vaccinated individuals. Following Halloran et al. (1999), we denote this as VES or 
vaccine efficacy for susceptibility. In addition, there often are indirect benefits for 
both vaccinated and unvaccinated individuals which Halloran et al. denoted as 
vaccine efficacy for infectiousness (VEI). These measures will be estimated in this 
trial; however, for subsequent modelling purposes we will emphasize R(p)  
 
 20 
 
2.2 Parameters of effect 
 
In order to estimate R(p), we define four transmission parameters:  
 transmission from a vaccinated to a vaccinated badger (βVV);  
 transmission from a vaccinated to an unvaccinated badger (βVU);  
 transmission from an unvaccinated to a vaccinated (βUV), and  
 transmission from an unvaccinated to an unvaccinated badger (βUU).  
 
The average number of secondary cases caused by one typically infected individual in 
a fully susceptible population (Diekmann and Heesterbeek 2000) is called the basic 
reproduction ratio (R0). Reproduction ratios of host populations in which 
interventions are taking place are often represented by R to distinguish them from 
R0. The reproduction ratio as a function of the proportion of vaccinated badgers R(p) 
can be determined from the transmission rates described above and the time that 
infected badgers remain infectious (T). Transmission rates are a combination of the 
infectiousness of the donor and the susceptibility of recipient individuals, and since 
vaccination with BCG has the potential to affect both of these, R(p) will be an 
important parameter for understanding the impact of badger vaccination in disease 
transmission and population dynamics of M. bovis. Ultimately, the R(p) obtained 
from the badger vaccine trial will be used in further modelling aimed at assessing 
badger vaccination as a strategy to control/eradicate M. bovis infection in cattle.  
 
As noted above, vaccine efficacy/effectiveness has been traditionally defined as 1 
minus some measure of relative risk (RR) of the incidence of disease in the 
vaccinated group compared to the incidence in the non-vaccinated group (Halloran 
et al., 1999). In the past, the main objective of human vaccine studies was to measure 
individual protection against infection or disease (VES). Perhaps less appreciated, 
but not less important, is the ability of a vaccine to reduce the duration or severity of 
the infectiousness of those vaccinates that become infected (VEI) (Longini et al, 
1998). In recent experiments, M. bovis was recovered from both vaccinated and non-
vaccinated badgers after being challenged with the mycobacterium; however, a 
reduction in the size, number and distribution of gross and histological lesions in 
vaccinated badgers compared to non-vaccinated badgers was demonstrated (Corner 
et al., 2008). Vaccination did not confer individual protection against infection in the 
mentioned study, but this has to be cautiously interpreted as vaccine protection could 
be dependent on the infection dose. It is not known what the infectious dose is in 
natural infections. In field vaccine trials in possum in New Zealand, using 
conjunctival and intranasal vaccination (Corner et al., 2002) and more recently 
vaccination by oral delivery (Tompkins et al., 2009), significant protection against 
natural exposure was seen in the vaccinated group compared to the control groups. 
Protection was much higher than predicted from previous studies where possums 
had been experimentally challenged (Corner et al., 2001; Buddle et al., 2006). 
 
 
21 
 
Estimation of R(p), VES and VEI will give us a more detailed understanding of the 
ways BCG vaccine works in a wild badger population.  
 
3. Epidemiological contribution to the design of the vaccine trial  
3.1 Study site 
 
Prior to deciding on our study site for the badger vaccine trial, several 
epidemiological and logistic factors were considered:  
 Culling history. Because of the badger culling pollicy in Ireland, it was 
important to have confidence that the area selected for the trial had been 
protected from culling for some time before the commencement of the trial. 
Badger culling in that area could have had a negative effect not just in the total 
number of individuals captured but also on the initial prevalence of TB among 
badgers.  
 Knowledge of sett location. Knowledge of the area in terms of sett location was 
considered an advantage and helped in dividing the study area into three similar 
zones (see below). 
 Community and technical support. Good support from the local farming 
community as well as from from both the District Veterinary Offices (DVOs) 
and Regional Veterinary Laboratories (RVLs) was vital. 
Based on these criteria, the area selected for the vaccine trial is located in County 
Kilkenny (Fig. 1).  
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Fig. 1. Study site selected for the vaccine trial is highlighted in red. 
 
The size of the area is approximately 755 square kilometers. This area had been part 
of one of the reference areas in the Four Area Project (FAP) (Griffin et al., 2005) 
and will have been protected from culling for at least two years before the start of 
the vaccine trial. A prevalence of infection of 30% is expected based on historical 
data from neighbouring areas. 
 
3.2 Trial design 
 
A vaccine trial to exclusively determine VES can be designed by vaccinating one or 
several populations with the same vaccination coverage, with coverage being strictly 
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inferior to 100% (40%, 50%, 60%, etc.) so that a number of infections within the 
vaccinated group can occur. Because we aimed to estimate both VES and VEI, then 
two populations vaccinated with different vaccination coverage are required 
(Longini et al., 1998). In this paper it is explained how the vaccination fractions for 
these two populations have to be selected to maximise the differences on indirect 
effects between the two populations. This can be achieved with one population 
vaccinated at 0% and the other vaccinated at the highest percentage that allows a 
minimum number of infections to happen (critical vaccination fraction). Likewise to 
estimate the four betas (transmission rates), different levels of coverage are needed 
(DeJong et al., 1996). 
 
Our objectives could have therefore been attained with two populations, one 
vaccinated at 0% and the other at 100% vaccination coverage (badger trapping rates 
will never be 100% effective; also the dynamics of the badger population ensures a 
certain number of susceptible badgers every year and therefore a certain number of 
infections). We chose though to include a third population vaccinated at 50% to 
optimise the design in two ways: firstly by making sure that there will be enough 
new infections even if the 100% vaccination would lead to R<1 and secondly by 
allowing us to estimate the area effect (in the case of only two populations, the 
parameters would be estimated from different populations and it would not be 
possible to disentangle the area effect). 
 
The trial area is divided into three zones with similar characteristics in terms of size, 
number of main badger setts, cattle herds, cattle and land classification (Fig. 2). In 
these zones, vaccination coverage will be 100, 50 and 0%, with the gradient of 
coverage (either 100% to 0% from north to south, or vice-versa) being allocated 
randomly at the start of the trial. Badger data were acquired through rigorous 
surveying of the entire study area. Previous surveying had been performed in 
sections of the study area as part of the FAP reference area and through the activities 
of the DAFF’s licensed badger culling policy on setts adjacent to herd bTB 
breakdowns. Setts previously recorded were revisited during the recent survey and 
assessed for signs of activity. All bovine data were derived from the Animal Health 
Computer System (AHCS) and farm outlines were taken from the Land Parcel 
Identification System (LPIS). Land use classifications were defined using the 
CORINE dataset (Coordination of Information on the Environment, 2000). Using 
ArcMap 9.2 (ESRI, Redlands, CA, USA) with geo-rectified colour 
orthophotography and vectorized 1:50,000 data (Ordnance Survey Ireland, Dublin, 
Ireland), natural boundaries, where possible, were selected to define the perimeter 
and internal boundaries of the study area. The aim was to achieve similar infection 
pressure from cattle and badgers in the three zones.  
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Fig. 2. Map showing study area divided into three zones A, B and C (grey, pink and yellow, 
respectively) where vaccination coverage will be 100, 50 and 0%. The gradient of coverage 
(100% to 0% from north to south, or vice-versa) will be allocated randomly at the start of the 
trial. Main badger setts are represented with red dots, and green dots represent other sett 
types. 
 
Badgers will be captured, treated with a vaccine or a placebo depending on the 
randomly allocated treatment and then released. In zone B (with 50% vaccine 
coverage), each badger at first capture will be randomly allocated to either vaccine 
or placebo. In each zone throughout the study period, the treatment will be 
administered every year to avoid possible waning of vaccine effects. Live M. bovis 
BCG strain Danish will be used. It will be prepared in a lipid formulation for oral 
delivery, containing 108 colony forming units/ml. A lipid-only placebo with identical 
visual characteristics, texture and viscosity to the vaccine, and in identical syringes, 
will also be used (Aldwell et al., 2003a,b). Vaccine and placebo control samples will 
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be coded at the laboratory where they are prepared, and neither field staff nor data 
analysts will be aware of the vaccine status of individual animals.  
 
The trial will employ a capture-tag-release regime with both cages and stopped wire 
restraints being used. Badgers in the trial will be ‘hand vaccinated’; that is, each 
animal will be individually orally dosed with the vaccine. Each badger will be 
permanently identified with a tattoo and passive transponder (microchip) when first 
captured. At each capture, badgers will be examined and a blood sample collected. 
Humoral immune responses (serologic titres) will be used to determine the badger’s 
infection status and to detect a change in infection status; that is, to detect both pre-
existing infection in badgers as they are recruited to the study and the occurrence of 
new infections on recapture. Key data, including sex, estimated age (cub, juvenile, 
yearling, adult and old adult), body weight, presence of injuries and the GPS location 
of the cage trap or restraint, will be recorded at each badger capture. All data 
collected in the field will be recorded onto handheld computers. The trial will last 
four years and there will be two ‘catching’ sweeps of the entire area each year. At 
the end of the trial, badgers in the three zones will be depopulated and a detailed post 
mortem examination will be conducted on all badgers, involving an examination for 
gross pathology and the collection of samples for histopathology and bacteriology. 
The severity of infection will be assessed from the number, distribution and the 
severity of gross lesions, the number and distribution of histological lesions, and the 
number and distribution of culture positive tissues and the bacterial load in those 
tissues. 
 
Badger removal will be undertaken within the trial area when three or more standard 
reactors are disclosed in a herd only if active badger setts are found in the farm and 
all other sources of infection (residual, purchase and farm to farm spread) have been 
ruled out by an epidemiological investigation. If culling of badgers is deemed 
necessary for control of tuberculosis in cattle herds, the culling will be carried out 
by field staff of the project when they next trap in the designated area.  
 
4. Analysis of the vaccine trial data 
 
4.1 General description 
 
The outcome from the vaccine trial will be in the form of a Bernoulli experiment: as 
badgers are trapped and a blood sample taken, we will gather information on whether 
these badgers have become or are infected (assigned value 1) or not (assigned value 
0) during the time at risk (time between two subsequent trappings). Infection in this 
case will be defined by serologic results i.e. by sero-positivity. Records on individual 
badgers will be taken at each successful capture (not necessarily at each trapping 
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exercise) such as location of the badger at the time of the trapping (zone A, B or C) 
and its vaccination status. Other demographic data will be also recorded. 
 
From the observations at each subsequent capture of each individual badger, the 
following variables will be extracted: 
 
 Time interval (Δt) between the two captures  
 Disease status of the badger at the beginning and at the end of the time interval 
 Vaccination status of the badger 
 Zone where the animal was observed at the beginning and end of the time 
interval (A, B or C) 
 Average prevalence of infection in the zone where the badger was caught during 
Δt (PrevA, PrevB, PrevC) 
 Average fraction of infected badgers that are vaccinated during Δt in the zone 
where the badger was caught (FVA, FVB, FVC) 
 
The rate at which vaccinated/non-vaccinated badgers acquire infection from 
vaccinated and non-vaccinated badgers (βVV, βVU, βUV, βUU) can be estimated based 
on the observed probability of becoming infected for each of these individuals. The 
estimated βs will be used to calculate VES, VEI and the reproduction ratio as a 
function of the vaccination coverage (R(p)). 
 
4.2 Estimation of the transmission parameters 
 
The rate at which vaccinated/non-vaccinated badgers acquire infection from 
vaccinated and non-vaccinated badgers (βVV, βVU, βUV, βUU) can be estimated based 
on the observed probability of becoming infected for each of these individuals. For 
the purposes of explanation, we shall at first ignore the vaccination state of the 
badgers. A stochastic susceptible-infectious (SI) model can be used then to describe 
the transmission of M. bovis in the trial where transmission can occur if an infectious 
and a susceptible individual make contact. The number of infectious contacts (NIC, 
contacts with an infectious individual) encountered by each randomly chosen 
susceptible individual in a period of time Δt can be expressed as: 
 
  
Where β is the transmission parameter, Δt= time interval, I= number of infected 
individuals*, N= total number of individuals, I/N= prevalence of infected badgers* 
* For our purpose infected badgers are deemed to be infectious. 
From the above it can be derived that the number of ‘successful’ infectious contacts 
(infectious contacts that result in transmission events) encountered by this randomly 
tNINIC  )/(
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chosen individual in a period of time Δt follows a Bernoulli distribution with 
probability:  
 
 
 
The expected number of new infections (E(C)) among all susceptible badgers at the 
end of the time interval between two captures can then be modelled using a binomial 
distribution where S is the number of susceptible badgers at the beginning of the 
time interval and the probability that each of these badgers will become infected 
during that time interval is defined by , 
 
 
 
Based on serologic results we will be able to determine the number of new cases 
among the susceptible badgers (C). By using a generalized linear model (GLM) with 
a complementary-log-log link function, a binomial error function, with binomial 
total S and offset , the transmission parameter β can be estimated. 
 
Following the introduction of the vaccination protocol, there will be heterogeneity 
in the vaccination status of badgers; we will have four different β values with two 
sub indexes, of the type βvu. The first sub index will refer to the vaccination state of 
the infectious badger and the second sub index to the vaccination state of the 
susceptible animal (to which the first has made contact). Clearly, we know the 
vaccination status of the receiving susceptible badger and thus we can calculate β.u 
and β.v separately. However to account for donor (infectious) badger, we use the 
differences in the fraction of infected badgers that are vaccinated in the different 
zones. 
 
Let’s assume that a badger that was originally trapped in zone A at time ‘t’ is trapped 
again in zone A at time ‘t+1’ and that this badger had been vaccinated. Vaccination 
coverage in zone A is targeted to be 100%, but since not all badgers will be trapped 
in each trapping exercise it will take 2-3 trapping rounds to approach this goal. Our 
hypothetical badger will then have infection pressure coming from both vaccinated 
and non-vaccinated infected badgers. The number of infectious contacts encountered 
by this randomly selected badger in that period of time is defined by: 
 
 
 
NtIep /1  
NtIe /1  
)1()( / NtIeSCE  
)*)/ln(( tNI 
tNININIC UUVVVV  )/*/( 
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If we assume that there is a multiplicative effect on NIC as the fraction of infected 
vaccinated badgers increases, after doing some algebraic manipulations (De Jong et 
al., 1996): 
 
 
 
or: 
 
 
 
where FVA is the fraction of infected badgers that are vaccinated in zone A and PrevA 
is the average prevalence of infection in zone A during Δt. If we set βUV = K0 and 
(βVV -βUV) = K1 then we can write: 
 
 
 
Since we will know the observed infection status of the specific badger (CV) at the 
end of the time interval (Δt), we can fit a GLM with Log (PrevA Δt) as an offset and 
calculate K0 and K1. We can subsequently calculate βUV  and βVV as: 
 
βUV = Exp[K0] 
βVV = Exp[K0+K1] 
 
If we apply the same logic to model the expected infectious status of an unvaccinated 
badger (CU) that was trapped in zone A at time t and at time t+1, we could estimate 
βUU and βVU as: 
 
 
 
where βUU=Exp[k0] and βVU=Exp[k0+k1] 
 
This way we can estimate the four betas based on incidence data from all three zones. 
In zone C, there will be no (or very few) vaccinated badgers, so FVC will be zero and 
that zone does not contribute to the estimation of k1 and thus that area does not give 
information for βVU. 
Vaccine efficacy for susceptibility can be calculated then as: 
 
tevAPreNIC VAUVVAVV FF   )1(*
tevAPreNIC VAUVVVUV F)(   
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We can also calculate vaccine efficacy for infectiousness as: 
 
 
 
Finally we can estimate R(p) where p is the proportion of vaccinated as: 
 
 
 
where T is the duration of the infectious period of a typical infected individual (for 
relative comparisons of R(p) knowledge of T is not essential).  
 
For decision making, if p=0 and βUUT <1, then no vaccination is needed; if p=1 and 
βVVT>1, vaccination will not stop spread of the disease. Otherwise, the vaccination 
fraction necessary in order to achieve R(p)<1 can be calculated. 
 
5. Concluding remarks 
 
The aim of this paper was to present the theory applied to the design of a badger 
vaccine trial, as well as the epidemiological methodology and statistical analysis that 
will help to interpret the results obtained.  
 
The vaccine trial area was divided into three zones A, B and C, such that differences 
in infection pressure in the three zones at the beginning of the trial will be minimized. 
However, there is an inherent assumption that the contact patterns between badgers 
will be similar in the three zones. We believe that this is a reasonable assumption as 
the size of the total area is sufficiently small, and the landscape and distribution of 
setts is very similar in the three zones. Further, changes with respect to infection 
pressure in the three zones will occur as the vaccine starts working. Our model is 
designed to adjust for these changes. For simplicity, we have only presented the 
analysis relevant to badgers repeated trapped in the same zone. However, the final 
model can be modified to accommodate other scenarios where badgers move from 
one zone to another. 
 
Where possible, natural boundaries are used to define the perimeter of the study area. 
The internal boundaries between the three zones include streams, rivers and roads. 
The external boundaries, while not bio-secure, should be substantial enough to 
)/(1 UUUVSVE 
)/(1 UUVUIVE 
TpppppppR VUUVVVUUVVUU  )]**)1(**4)**)1((*)1[(*2
1)( 2 
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delineate badger territories. This would reduce the extent of typical badger 
movement into and out of the study area. 
 
Defining specific questions of interest in the early stages of the vaccine trial was 
considered crucial. Estimation of the reproduction ratio (R(p)) calculated as a 
function of the vaccination coverage (p) will give us invaluable information on the 
impact of vaccination in disease transmission and dynamics of M. bovis infection in 
badgers. The importance of considering the potential indirect effects associated with 
the vaccination program in badgers has been highlighted in the paper; furthermore, 
it has been shown how to estimate R(p), VES and VEI by using different vaccination 
coverages in the study area. 
 
Although the vaccine trial will not determine whether bTB can be eradicated in cattle 
and badgers through a strategy of badger vaccination, the parameters obtained in the 
vaccine trial will be used in a mathematical model of bTB transmission (currently 
under development) in order to assess different control and eradication options for 
bTB in cattle in the Republic of Ireland.  
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Abstract 
 
The aim of this study was to estimate the power, using simulation techniques, of a 
group randomized vaccine field trial designed to assess the effect of vaccination on 
Mycobacterium bovis transmission in badgers. The effects of sample size (recapture 
percentage), initial prevalence, sensitivity and specificity of the diagnostic test, 
transmission rate between unvaccinated badgers, Vaccine Efficacy for Susceptibility 
(VES) and Vaccine Efficacy for Infectiousness (VEI), on study power were 
determined.  
 
Sample size had a small effect on power. Study power increased with increasing 
transmission rate between non-vaccinated badgers. Changes in VES had a higher 
impact on power than changes in VEI. However, the largest effect on study power 
was associated with changes in the specificity of the diagnostic test, within the range 
of input values that were used for all other modelled parameters. Specificity values 
below 99.4% yielded a study power below 50% even when sensitivity was 100% 
and, VEI and VES were both equal to 80%. The effect of changes in sensitivity on 
study power was much lower. 
 
The results from our study are in line with previous studies, as study power was 
dependent not only on sample size but on many other variables. In this study, 
additional variables were studied i.e. test sensitivity and specificity. In the current 
vaccine trial, power was highly dependent on the specificity of the diagnostic test. 
Therefore, it is critical that the diagnostic test used in the badger vaccine trial is 
optimized to maximise test specificity. 
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1. Introduction 
 
Badgers (Meles meles) are an important reservoir of Mycobacterium bovis for cattle 
in Ireland and the United Kingdom and as a result, eradication of bovine tuberculosis 
(bTB) will be highly unlikely without measures to prevent transmission between 
cattle and badgers and vice versa (More, 2009). In a recent Irish study, 36% of 
badgers were found to be infected with bTB (Murphy et al., 2010), with prevalence 
known to vary in areas of high (43.2%, Corner et al., 2012) and low (14.9%, Murphy 
et al., 2011) bTB prevalence in cattle. Focused badger culling is currently being used 
as a short-to-medium term strategy to limit transmission in areas of high bTB 
prevalence in cattle, with the expectation that culling will be replaced by badger 
vaccination once an effective bTB vaccine becomes available (Sheridan, 2011). In 
2001, Ireland initiated a 10-year work programme investigating the use of Bacillus 
Calmette-Guerin (BCG) vaccine in badgers as a medium-long term strategy to assist 
with national bTB control and eradication (Corner et al., 2007; Lesellier et al., 2009). 
Based on a series of initial studies in captive badgers, BCG vaccination in badgers 
was associated with a reduction in both the number and size of gross histological 
lesions (Corner et al., 2007, 2008a,b, 2010). These pen-based studies were recently 
extended to the field, with the design and implementation of a field trial in Ireland 
to evaluate vaccine efficacy in wild badger populations (Aznar et al., 2011). 
 
In traditional vaccine field trials, individuals are randomly allocated (individual 
randomization) to either a vaccine or a placebo treatment and the relative risk of 
acquiring infection is determined by comparing infection rates in vaccinated and 
non-vaccinated individuals. This design is appropriate for non-communicable 
diseases because the probability that an individual will become infected depends 
only on their susceptibility. Individual randomized trials allow the estimation of 
vaccine effects that reduce the susceptibility of an individual to infection or Vaccine 
Efficacy for Susceptibility (VES), also known as the direct effect of vaccination 
(Halloran et al., 1999). When dealing with infectious diseases, however, the 
likelihood that an individual will become infected depends not only on its 
susceptibility but also on the infectivity of surrounding individuals. The reduction in 
infectivity achieved by vaccination is known as Vaccine Efficacy for Infectiousness 
(VEI), and is the result of the indirect effects of the vaccination on vaccinated and 
non-vaccinated individuals, of which herd immunity is the most important. With 
infectious diseases, group randomized trials are the design of choice, allowing 
estimates of both the reduction in susceptibility (VES) and infectiveness (VEI) (Riggs 
and Koopman, 2005). In a field trial to evaluate BCG vaccine efficacy in badgers, 
Aznar et al. (2011) outlined the use of group randomization to provide estimates of 
both VES and VEI based on incidence data from three badger populations vaccinated 
with BCG at different levels of vaccination coverage: 100%, 50% and 0%. In such a 
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trial, estimates of VEI may be particularly important, given the reported reduction in 
gross histological lesions (and, potentially, reduced infectiousness) in vaccinated 
badgers (Hayes et al., 2000; Corner et al., 2008a). This trial design is similar to that 
outlined by Longini et al. (1998), who propose methodology, using unconditional 
parameters, to jointly estimate VES and VEI from a trial conducted in only two 
populations. This approach, as used by Longini et al. (1998) and Aznar et al. (2011), 
has been defined by Hayes et al. (2000) as a hybrid of group and individually 
randomised trials. 
 
As outlined by Charvat et al. (2009), power calculations based on the comparison of 
two independent binomials can largely overestimate study power if indirect effects 
are not taken into account. In recognition of this concern, there have been recent 
changes in both the design and analysis of vaccine trials to for estimate sample size 
and power in these studies. In particular, computer simulation techniques are now 
frequently used to address study power issues (Walters, 2004; Barth-Jones et al., 
2004). 
 
In group randomized trials, where direct and indirect vaccine effects are each 
important, power depends on a range of factors. Riggs and Koopman (2004, 2005) 
examined some of these factors, including unit (group) size, contact rate, external 
force of infection and infection duration.  
 
In this paper, we estimate the power, using simulation techniques, of a group 
randomized vaccine field trial designed to assess the effect of vaccination on M. 
bovis transmission in badgers. In this work, study power was defined as the 
proportion of simulations in which the null hypothesis (that the transmission 
parameter between vaccinated (βVV) and non-vaccinated badgers (βUU) was equal) 
was rejected at a 0.05 level of significance. Further, we assess the effects on study 
power of sample size (recapture percentage), initial prevalence, the sensitivity and 
specificity of the diagnostic test, transmission rate between badgers prior to the start 
of the trial, and VES and VEI. 
 
 2. Material and Methods 
 
2.1. Vaccine trial design  
 
The vaccine trial area, covering approximately 750 km2 in county Kilkenny, was 
divided into three zones (A, B and C) north to south, each with similar characteristics 
in terms of size, number of main badger setts, cattle herds, cattle and land 
classification type. Three vaccination levels, 100%, 50% and 0%, were allocated to 
zones A, B and C to achieve a north-south gradient in vaccination coverage. The 
middle zone (zone B) was vaccinated using a capture-tag-release protocol, to achieve 
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and maintain 50% vaccination coverage throughout the trial period. In this zone, 
randomisation was conducted at the level of the animal (Aznar et al., 2011). Zones 
A and C were randomly allocated to a 100% and 0% vaccination coverage. 
 
The vaccination trial commenced in September 2009 and ran for four years. During 
each of the first 3 years, there were two trapping exercises over the entire trial area. 
At their first trapping, each badger was allocated to a vaccine/placebo treatment. A 
blood sample was taken at each capture during the trial period; however, treatment 
was repeated no more than once each year. During year 4, two trappings exercises 
were also conducted. At their first capture in year 4, a blood sample was collected, 
and each badger was either vaccinated or euthanized for detailed post mortem 
investigation. Data from the second trapping carried out in year 4 was not included 
in the analysis. Therefore, each badger could be captured, at most, on 7 separate 
occasions. 
 
2.2. The model 
 
The outcome from the vaccine trial will be of the form of a Bernoulli experiment. 
Data were collected about each badger at each trapping, including the infection status 
of each animal at the initial and each subsequent trapping. 
 
Further to Aznar et al. (2011), the expected number of vaccinated E(CV) and non-
vaccinated (E(CU) badgers in each of the study zones that became infected with M. 
bovis between consecutive trappings can be estimated as: 
)1()( Pr)*( 10 tevZFvzKKVV eSCE
  and 
)1()( Pr)*( 10 tevZFvzkkUU eSCE
 , respectively. 
where K0 = βUV, K1 = (βVV – βUV) , k0 = βUU and k1 = (βVU - βUU). 
SV and SU are the number of susceptible vaccinated and non-vaccinated badgers 
observed at the previous trapping exercise, FVZ is the fraction of infected badgers 
that are vaccinated and PrevZ is the average prevalence of infection in the zone 
selected (A, B or C). ∆t is the time between two consecutive trappings. 
 
As the number of new infections will be inferred from available serology, by fitting 
a GLM with log(PrevZ*∆t) as an offset, Aznar et al. (2011) showed how to calculate 
K0, K1, k0 and k1. The four transmission parameters can then be calculated as:  
βUV =Exp[K0], βVV=Exp[K0+K1], βUU=Exp[k0] and βVU=Exp[k0+k1]. 
To estimate study power, only βVV and βUU are needed. 
 
2.3. The simulation process 
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2.3.1. Input data  
 
In order to estimate βVV and βUU, each of the following were added as input data in 
the simulation process: 
 the prevalence (PrevZ) prior to the commencement of the study and at every 
time interval (∆t),  
 the fraction of infected badgers that were vaccinated at the end of every time 
interval (FVZ denoted as fi in SAS program, see supplementary file) in each of 
the study zone, and the fraction of susceptible badgers that were vaccinated at 
the end of every time interval (FSZ denoted as fs in SAS program) in each study 
zone. Both fractions FVZ and FSZ had the same values, 
 the total number of badgers trapped in each study zone at each trapping exercise 
(Total_n), 
 the recapture percentage; of the badgers caught during the current trapping 
exercise, this was the percentage that had been caught at least once during a 
previous trapping exercise (Trapperc),  
 the transmission parameter among non-vaccinated badgers at the beginning of 
the study (βUU), 
 the Vaccine Efficacy for Susceptibility (VES) and Vaccine Efficacy for 
Infectiousness (VEI), and 
 the sensitivity (Se) and specificity (Sp) of the serological test. 
 
2.3.2. Simulation flow 
 
A dataset of 36 entries (6 subsequent trappings x 3 study zones x 2 vaccination status) 
was created (see the supplementary file for information about the data). Each entry 
included trapping number (2-7), study zone (A to C, coded as 1-3), the vaccination 
status (0=non vaccinated: 1=vaccinated), fi, fs, PrevZ and Total_n. 
 
We assumed that none of the badgers trapped were vaccinated in zone A and that all 
badgers trapped were vaccinated in zone C. For each subsequent trapping (i.e. all but 
the first trapping) and for each study zone, the number of new infections within 
vaccinated and non-vaccinated badgers (variables E(CV) and E(CU) respectively) 
were simulated using the cumulative binomial distribution with parameters (s, p), 
where s is the total number of susceptible badgers caught in each of the trial zones 
at the beginning of each time interval Δt, and p is the probability that each of these 
badgers will become infected during that time interval.  
The parameter s was calculated separately for vaccinated (SV) and non-vaccinated 
badgers (SU) as: 
(SV)= Total_n * Trapperc* FVZ * (1-PrevZ) 
and 
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(SU)= Total_n * Trapperc* (1-FVZ) * (1-PrevZ) 
and the probability of becoming infected was calculated as: 
tevZe VZFKKep 

 Pr
)10(1  
The initial transmission parameter βUU, needed to estimate p was set within the SAS 
program (see the supplementary file). The values of βUV (transmission parameter 
from a non-vaccinated to a vaccinated badger) and βVU (transmission parameter from 
a vaccinated to a non-vaccinated badger) were determined based on the assumed 
reduction in βUU given by the values of VES and VEI. So, for instance, if we assume 
VEs=80%, and a βUU=0.1, then there will be a reduction of 80% in the transmission 
parameter βUV with respect to βUU, so βUV=0.02. The initial transmission parameter 
within vaccinated badgers (βVV) was calculated as: 
βVV = βUV * βVU 
 
The number of new infections E(CV) and E(CU) was then refined depending on the 
Sp and Se of the diagnostic test, taking into account the number of false positives 
and false negatives.  
 
By fitting a GLM (binomial distribution, complementary loglog link function) with 
log (PrevZ*∆t) as an offset, βUU and βVV were estimated and study power determined 
by means of a paired t-test. 
 
2.3.3. Output 
 
The dataset was read into SAS (SAS 9.1, SAS Institute Inc., Cary, NC, USA) and a 
simulation process was set up by means of a macro. We performed 1,000 simulations 
for each set of conditions (see section 2.3.4). Study power was defined as the 
proportion of simulations in which the null hypothesis (βVV = βUU) was rejected at 
the 0.05 level of significance.  
 
A three dimensional graph showing the power of the study for all combinations of 
sensitivity (Se) between 10 and 100%, and specificity (Sp) between 98 and 100% at 
increments of 5% and 0.2%, respectively, was built using Mathematica® 6.0 
(Wolfram Research, Champaign, IL, USA). We assumed an initial transmission 
between non-vaccinated badgers of βUU=0.1 and a vaccine effect on susceptibility 
(VES) and infectivity (VEI) of 80%. To create the graph, we fitted a generalized 
linear model (GLM) with different links of the binomial family (Stata® version 10; 
Stata Corp, College Station, TX, USA) to obtain the function that fitted our data best. 
The link with the lowest AIC was selected.  
 
2.3.4. Sensitivity analysis 
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Table 1. Details of input parameters for a simulation model to estimate power of a vaccine trial in badgers 
Notation Parameter Central value Range Source 
βUU Initial transmission parameter 
between non vaccinated badgers 
0.1 0.025-0.4 Hardstaff et al. (2013) 
FSZ (FVZ) Fraction of susceptible (infected) 
badgers that were vaccinated at 
the end of every time interval in 
each study zone 
-a -a Expert opinion 
Prev Initial prevalence 30% 15%, 50  Murphy et al. (2011) 
Se Sensitivity of the diagnostic test 30% 10%-100% Unpublished data 
Sp Specificity of the diagnostic test 99.99% 10%-100% Unpublished data 
Total_n Total number of badgers trapped 
in each trapping exercise in each 
study zone 
A=120 
B=60 
C=120 
Fixed Unpublished data, from vaccine trial 
Trapperc Recapture percentage 50% 10-100% Byrne et al. (2012) 
VEI Vaccine Efficacy for 
Infectiousness 
40% -80% Fixed Hardstaff et al. (2013) 
VES Vaccine Efficacy for 
Susceptibility 
40%-80% Fixed Hardstaff et al. (2013) 
a See the supplementary file for information about the data (FSZ and FVZ are denoted as fs and fi in the macro, respectively) 
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In the sensitivity analysis, the central value and range for each parameter was chosen 
as follows: 
 With Se and Sp of the diagnostic test, all possible values (that is, from 10% to 
100%) were considered, at increments of 5%. 
 For all other parameters, the selection of values was determined following a 
review of relevant literature or, if not available, expert opinion. If knowledge 
was lacking, a conservative approach was taken, when considering the central 
value and the likely ranges. 
To elaborate (see Table 1): 
 Sample size is defined in our study as the total number of badgers that were 
recaptured (Total_n * Trapperc). In the simulation exercise, the total number 
of badgers trapped (Total_n) was 300, including 120, 60 and 120 in zones A, 
B and C, respectively. These numbers were based on the figures obtained 
during the first trapping exercise (120, 64 and 115 badgers in zones A, B and 
C, respectively; unpublished data). The percentage of badgers re-trapped was 
set at 50% based on expert opinion, and recapture values ranging from 10 to 
100% were also evaluated. 
 The initial prevalence for the three trial zones was set at 30% based on an 
average from Murphy et al. (2011), and values of 15 and 50% were also 
evaluated. 
 The initial transmission parameter βUU was set to 0.1, being an approximate 
average of the inter- and intra-group transmission parameters described by 
Hardstaff et al. (2012). In the sensitivity analysis, values of 0.4, 0.2, 0.1, 0.05 
and 0.025 were also evaluated.  
 
3. Results 
 
3.1 Effect of sensitivity and specificity of the diagnostic test on study power 
 
The study power for varying Se and Sp values of the diagnostic test is shown in Fig. 
1. A decrease in Sp had a much larger impact on power than a decrease in Se. The 
power of the study decreased sharply to 15% or lower when the Sp is equal or lower 
than 98.0%, independent of Se. The effect of Se on study power was much less; 
given a Sp of 98.8, study power remained above 50% even when Se was 40%. In 
these calculations, VES and VEI were each assumed to equal 80%, however, similar 
results were obtained when VES and VEI were assumed to be 40%. 
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Fig. 1. Three dimensional plot showing the power of the badger vaccine trial as a function of 
the sensitivity and specificity of the diagnostic test. βUU was set at 0.1, re-trapping percentage 
was set at 50%, and VEI and VES at 80%. 
 
3.2. Effect of variations in sample size on study power 
 
Assuming a Se of 30%, a Sp of 99.99% and a transmission parameter for non-
vaccinated badgers βUU=0.1, the study power was determined for two scenarios: VES 
and VEI both equal to 40% and 80%, respectively, when the percentage of total 
badgers re-trapped varied from 10% to 100%. Study power increased from 40% to 
85% as recapture percentage increased from 10% to 40%, but did not increase further 
as recapture percentage increased from 40 to 100%. When VES and VEI were each 
set to 40%, study power increased from 40% to 77% as sample size increased from 
10% to 60%, with little further change as sample size increased above 60%. 
 
3.3. Effect of variations in the initial transmission rate on study power 
 
The impact on study power of changes in transmission rate between badgers prior to 
the start of the vaccine trial (βUU) was assessed. In all previous calculations, a 
transmission value of 0.1 had been used. Assuming Se=30%, Sp=99.99%, and VES 
and VEI=80%, study power increased from 84% to 90% as βUU increased from 0.1 
to 0.4, and decreased to 48% when βUU was 0.025. Under equivalent conditions but 
assuming a VES and VEI of 40%, power varied from 49% to 76% as βUU increased 
from 0.025 to 0.1 and then remained stable. Study power was on average 77% and 
68% when assuming an 80% and 40% reduction in VES and VEI, respectively. In 
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both cases, the power decreased with a reduction in the transmission rate between 
non-vaccinated badgers.  
 
3.4. Effect of variations in VEI and VES on study power 
 
To illustrate whether changes in VES had a higher, lower or equal impact on power 
than changes in VEI, the simulation process was run for the same range of βUU values 
as previously, but keeping either VEI or VES at 80% while decreasing the opposite 
vaccine effect to 40%. Using a Se=30% and Sp=99.99%, the average study power 
when VEI and VES were 80% and 40%, respectively, was 69%, compared to an 
average of 77% when VEI and VES were 40% and 80%, respectively. By comparing 
these two averages with the average obtained when both vaccine effects are set to 
80% (average power=77%), we found that a decrease in VES has a higher impact on 
study power than a decrease in VEI.  
 
3.5. Effect of variations in initial prevalence on study power 
 
The study power was assessed assuming an initial prevalence of 15% and 45%. 
When the initial prevalence was 45%, and both VES and VEI were set to 80%, the 
study power obtained was 88%. The power decreased to 77% when both vaccine 
efficacies were set to 40%. When the initial prevalence assumed was 15% and 
vaccine efficacies were set to 80% the power obtained was 78% and this power 
decreased to 68% when vaccine efficacies were 40%. 
 
4. Discussion 
 
Scientific evidence obtained from vaccine field trials has played an important role in 
public health, helping governments to plan successful vaccination programs. 
Estimating statistical power in a vaccine trial is of great importance. If done a priori 
(before the trial starts), the optimal sample size to be used in the trial can be 
estimated. The optimal sample size can give assurance that there is sufficient 
statistical power to detect a pre-determined vaccine effect if it does indeed exist, 
whilst avoiding any unnecessary waste of resources. In the current badger vaccine 
trial, however, the sample size was determined based on logistical issues, without 
potential for further expansion of the vaccine trial area. Nonetheless, power 
calculations were still relevant as other parameters affecting power, such as Se and 
Sp of the diagnostic test, could potentially be adjusted to optimize study power.  
 
A simulation approach was used to estimate the power of the trial where the 
following assumptions were made: 
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 The contact function is frequency rather than density-dependent. Riggs and 
Koopman (2004, 2005) demonstrate that sample size has a much higher impact 
on study power in density-dependent as compared to frequency-dependent 
models. This is in agreement with the results obtained in our simulations. 
Power remained relatively constant, varying from 90% to 93% when sample 
size increased from 120 to 300 badgers (assuming a VES and VEI equal to 
80%). De Jong et al. (1995) explained how, for most animal diseases, a 
frequency-dependent contact rate function fits the data better than a density-
dependent function. Therefore, our assumption seems reasonable. 
 The prevalence of bTB in badgers in the trial area was assumed to be 30%. A 
recent study carried out in Ireland, where comprehensive bacteriological 
culture methods had been used, detected a prevalence of 36.3% in badgers 
(Murphy et al., 2010). As highlighted previously, bTB prevalence in Ireland is 
known to vary in areas of high (Corner et al., 2012) and low (Murphy et al., 
2011) bTB prevalence in cattle. 
 The expected number of badgers being trapped in each trapping exercise was 
set to 120, 60 and 120 for zones A, B and C, respectively. Although the three 
zones in the vaccine trial area were selected to have a similar number of main 
badger setts, the first trapping carried out during the trial revealed a lower 
number of badgers in Zone B compared to zones A and C. 
 Data on the fraction of susceptible (fs) and infected (fi) vaccinated badgers 
were based on expert opinion. A sensitivity analysis was carried out to see the 
effect on study power of changes to fs and fi. In scenarios where changes to fs 
and fi were simulated, no meaningful changes were observed in study power. 
 Recapture percentage was set to 50%. This number was determined at the start 
of this study based on expert opinion from previous trapping exercises carried 
out in nearby areas. Subsequently, and while this study was being conducted, 
Byrne et al. (2012) confirmed that recapture percentage during this trial was 
around 50%. 
 
The most striking result obtained during the simulations was the large effect of 
diagnostic test specificity on study power, within the range of input values that were 
used for all other modelled parameters. The minimum test specificity required to 
achieve a power above 60% was 99.8%. We were expecting low specificity values 
to have a substantial effect on power due to the large number of false positive badgers 
in a low prevalence population, however, the effect was larger than expected. This 
is because the vaccine effect is quickly masked by even a small proportion of false 
positives, randomly occurring in the many negative samples from both vaccinated 
and unvaccinated animals. The effect of sensitivity on power was much smaller. 
Assuming both VES and VEI are equal to 80% and given a specificity of 99.8%, 
study power remained above 50% even when test sensitivity was 40%. The effect of 
sample size on study power was very small. This is because a small number of false 
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negatives would be expected in a population were disease incidence is low, even 
when test sensitivity is poor. In other words, the expected number of false negatives 
will be a fraction of what is already a very low number. This is regardless of whether 
the low sensitivity is due to the low sensitivity of the diagnostic test itself or because 
of smaller sample size. Collectively, these results have substantial implications in 
terms of the optimization of the diagnostic test to be used in the vaccine trial, 
showing that although specificity needs to be very high, there is some degree of 
flexibility in terms of the sensitivity of the diagnostic test.  
 
When the initial transmission between unvaccinated badgers was set to 0.025, study 
power obtained was around 50% (48%-51%), depending on other parameters. This 
power would not be considered optimal for detecting a difference between the two 
transmission parameters βUU and βVV, noting that we are seeking a study power of at 
least 60%. Data on the transmission parameter between non-vaccinated badgers is 
scarce. The transmission values presented in Hardstaff et al. (2012), and referenced 
in this manuscript, were estimated based on studies using proximity data loggers. 
Logically, these are very likely an overestimation of such values, but as 
acknowledged by these authors, there is no data available to quantify the extent of 
this overestimation. 
 
Decreasing VES and VEI each had a negative effect on power with changes in VES 
having a larger impact on power than changes in VEI. For a βUU=0.1, a reduction in 
VEI of 50% (from 80% to 40%) had little effect on study power (84% versus 85%, 
respectively), while the same reduction in VES led to a reduction in power, from 84% 
to 76%. This difference in reduction in power can be understood from the fact that a 
reduction in susceptibility has a direct and full effect on the vaccinated badger. The 
same reduction in infectivity only has the same impact when all the infected animals 
that the recipient badger encounters are vaccinated. However, this was not achieved 
in this trial, due to the design used, and therefore the effect is diluted. Although the 
reduction in power due to reduction in VEs is not considered high, the effect of a low 
VES on the power is nonetheless something to consider because of the uncertainty 
around the biological mechanisms of the BCG vaccine in badgers. Using BCG 
vaccine by the subcutaneous or mucosal routes in badgers, Corner et al. (2008a) 
demonstrated a reduction in histological lesions in vaccinated badgers compared to 
non-vaccinated badgers but did not show individual protection against infection. 
This lack of protection must be interpreted with caution as the challenging doses 
used during the experiments might not be representative of the natural infection dose. 
However, if the results obtained in the study are indicative of the real VES, study 
power could be somewhat compromised. 
 
In summary, the results from our study are in line with Riggs and Koopman (2004, 
2005) in that study power in group randomized trials depends not only on sample 
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size but on many other parameters. In the current vaccine trial, power was highly 
dependent on the specificity of the diagnostic test and this is always to be expected 
when the expected incidence without vaccination is already low. For the badger 
vaccine trial this implies that the diagnostic test to be used has to be optimized to 
maximise test specificity.  
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Estimating the power of a Mycobacterium bovis vaccine trial in Irish badgers 
Supplementary material 
 
Appendix A 
*SAS (9.2) program to evaluate study power of a badger vaccine trial; 
*For running under SAS 9.1, 'LBetaEstimate' should be replaced by 'estimate'; 
*Published in Preventive Veterinary Medicine: volume, issue, pages; 
 
options nocenter; 
libname trial 'd:\power_sas'; 
 
*Reading basic data; 
data fixed0;  
input period area vaccinated fs fi prev total_n; 
cards; 
 
2 1 0 0 0 0.3 120 
3 1 0 0 0 0.3 120 
4 1 0 0 0 0.3 120 
5 1 0 0 0 0.3 120 
6 1 0 0 0 0.3 120 
7 1 0 0 0 0.3 120 
2 2 0 0.3 0.3 0.3 60 
3 2 0 0.3 0.3 0.3 60 
4 2 0 0.3 0.3 0.3 60 
5 2 0 0.4 0.4 0.3 60 
6 2 0 0.4 0.4 0.3 60 
7 2 0 0.4 0.4 0.2 60 
2 3 0 0.6 0.6 0.2 120 
3 3 0 0.6 0.6 0.2 120 
4 3 0 0.6 0.6 0.1 120 
5 3 0 0.7 0.7 0.1 120 
6 3 0 0.8 0.8 0.1 120 
7 3 0 0.8 0.8 0.05 120 
2 1 1 0 0 0.3 120 
3 1 1 0 0 0.3 120 
4 1 1 0 0 0.3 120 
5 1 1 0 0 0.3 120 
6 1 1 0 0 0.3 120 
7 1 1 0 0 0.3 120 
2 2 1 0.3 0.3 0.3 60 
3 2 1 0.3 0.3 0.3 60 
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4 2 1 0.3 0.3 0.3 60 
5 2 1 0.4 0.4 0.3 60 
6 2 1 0.4 0.4 0.3 60 
7 2 1 0.4 0.4 0.2 60 
2 3 1 0.6 0.6 0.2 120 
3 3 1 0.6 0.6 0.2 120 
4 3 1 0.6 0.6 0.1 120 
5 3 1 0.7 0.7 0.1 120 
6 3 1 0.8 0.8 0.1 120 
7 3 1 0.8 0.8 0.05 120 
; 
data fixed; set fixed0;  
*Set sample size as retrapping percentage; 
trapperc=100; total_n=int(total_n*trapperc/100); 
run; 
 
*Run (or block) next 2 lines to suppress (or not) screen output; 
proc printto log='d:\power_sas\log.txt' new;run; 
proc printto print='d:\power_sas\out.txt' new;run; 
 
*Call macro doloop; 
%doloop; quit; 
 
*Back to screen output; 
proc printto;run; 
 
*MACRO DESCRIPTIONS ARE BELOW; 
 
*Macro DOLOOP evaluates power at varying values of SE and SP; 
%macro doloop; 
*First clean directory from existing files in case macro doloop is re-run; 
%delfile(trial.collect6); 
%delfile(trial.collectC); 
 
*Set range of SE and SP, multiplied with 10,000 in order to allow small steps; 
%do SE=3000 %to 4000 %by 100; 
%do SP=9800 %to 9900 %by 2; 
 
*Call macro simulate (within macro doloop); 
%simulate 
 
data trial.collect2;set trial.collect; 
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*Keep the records with exponentiated coefficients; 
if label in ("Exp(vacc=0)","Exp(vacc=1)"); 
run; 
*Put coeffs and stderrs of each dataset at one line; 
data trial.collect3; set trial.collect2;k1=round(_N_/2);kse=&SE; ksp=&SP; 
run; 
proc transpose data=trial.collect3 out=trial.collect4a prefix=est_;var LBetaEstimate 
; by k1 kse ksp ;run; 
proc transpose data=trial.collect3 out=trial.collect4b prefix=stderr_;var stderr;by 
k1 kse ksp;run; 
proc transpose data=trial.collect3 out=trial.collect4c prefix=qc0_;var qc0;by k1 kse 
ksp;run; 
proc transpose data=trial.collect3 out=trial.collect4d prefix=qc1_;var qc1;by k1 kse 
ksp;run; 
data trial.collect5;  
merge trial.collect4a trial.collect4b trial.collect4c trial.collect4d;  
by k1 kse ksp; 
 
*Performing paired T-test using estimates and standard errors; 
n1=21;n2=14; 
C1=(stderr_1**2)/n1;C2=(stderr_2**2)/n2; 
tvalue=(est_1-est_2)/sqrt(C1+C2); 
df=(C1+C2)**2/(C1**2/(n1-1)+c2**2/(n2-1)); 
if tvalue >0 then p=1-CDF('T',tvalue,df);else p=1; 
if tvalue=. then p=.; 
if p<0.05 then test=1;else test=0; 
if tvalue=. then test=.; 
*Variable test indicates whether p is smaller than 0.05; 
keep k1 kse ksp est_1 est_2 stderr_1 stderr_2 tvalue df p test qc0_1 qc1_2 ;  
run; 
 
*The power is calculated and the average fraction C/NCS for the vaccinates and 
the non-vaccinates for each combination of SE and SP; 
*Results are stored in file trial.collect6;  
proc means data=trial.collect5 n mean noprint ; var test; output out=powerfile 
mean=power n=count;by kse ksp;run; 
proc means data=trial.collectC n mean noprint; var fraction; output 
out=fractionfile0 mean=mfrac_notvacc;by kse ksp;where vaccinated=0;run; 
proc means data=trial.collectC n mean noprint; var fraction; output 
out=fractionfile1 mean=mfrac_vacc; by kse ksp;where vaccinated=1;run; 
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data combine; merge powerfile fractionfile0 fractionfile1; by kse ksp; drop _type_ 
_freq_; run; 
proc append base=trial.collect6 data=combine;run; 
%end;%end; 
%mend doloop; 
 
*Macro simulate creates and analyses datasets; 
%macro simulate; 
%delfile(trial.collect); 
%delfile(trial.collectC); 
 
*Set number of simulations, run time heavily depends on this; 
%do j=1 %to 1000;  
 
*data trial.fixed&j;  
data fixed2; *Contains the created dataset; 
set fixed; *Reads the initial dataset; 
 
*Set initial transmission parameters; 
uu=0.1; vu=0.05;uv=0.05;vv=vu*uv; OFFSET=log(prev); 
 
*NCS=number caught susceptible; 
if vaccinated eq 0 then do;NCS0=(1-fs)*total_n*(1-prev);NCS=round(NCS0);end; 
if vaccinated ne 0 then do;NCS0=total_n*(1-prev)*fs;NCS=round(NCS0);end; 
 
*prob=probability of being infected when vaccinated or not; 
if vaccinated eq 0 then prob=1-exp(-1*(uu*(1-fi)+vu*fi)*prev); 
if vaccinated ne 0 then prob=1-exp(-1*(uv*(1-fi)+vv*fi)*prev); 
 
*Number infected (C); 
*Prepare for macro critbinom, alpha is drawn from a Uniform distribution; 
alpha=ranuni(0); trials=NCS; p_success=prob; 
*Call macro critbinom to obtain the critical value based on alpha, NCS and prob; 
%critbinom(p_success=prob) 
 
C=NCS-(critval); 
k=&j; 
 
*Number test positives depend on NCS, C, SE and SP; 
*Call macro critbinom to obtain the critical value based on alpha, C and p1; 
alpha=ranuni(0); trials=C; p1=&SE/10000;; 
%critbinom(p_success=p1) 
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*True positives; 
TP=C-(critval); 
k=&j; 
 
*Call macro critbinom to obtain the critical value based on alpha, C and p2; 
alpha=ranuni(0); trials=NCS-C; p2=(10000-&SP)/10000; 
%critbinom(p_success=p2) 
 
*False positives; 
FP=(NCS-C)-(critval); 
k=&j; 
kSE=&SE; 
kSP=&SP; 
 
*Total number tested positive; 
observed = TP+FP; 
run; 
 
*Fraction of cases/trial is calculated and stored in collectC; 
data keepC;set FIXED2; if NCS gt 0 then fraction=C/NCS; keep k kse ksp 
vaccinated NCS C critval TP FP observed fraction;run; 
proc append base=trial.collectC data=keepC; run; 
 
*Next the created dataset is analysed and output saved, separately for the 
vaccinated and unvaccinated records; 
*Proc genmod is used because it has the cll link function available; 
 
%delfile(run0); 
 
ods output estimates=run0 (keep=k label LBetaEstimate stderr); 
*proc genmod data=trial.fixed&j; 
proc genmod data=fixed2; where ncs gt 0 and vaccinated=0; 
model observed/ncs=fi/dist=binomial link=cll offset=offset; 
by k kse ksp;*k is just a count variable; 
estimate 'vacc=0' intercept 1 fi 0 /e exp; 
ODS select estimates; 
run; 
 
%append0(run0); 
 
%delfile(run1); 
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ods output estimates=run1 (keep=k label LBetaEstimate stderr); 
*proc genmod data=trial.fixed&j; 
proc genmod data=fixed2;where ncs gt 0 and vaccinated=1; 
model observed/ncs=fi/dist=binomial link=cll offset=offset; 
by k kse ksp; 
estimate 'vacc=1' intercept 1 fi 1/e exp; 
ODS select estimates; 
run; 
 
%append1(run1); 
 
%end; 
 
*Show screen output after one simulation of 1000 iterations; 
proc printto;run; 
%put &se &sp; 
*Overwrite the output files to prevent they grow very large; 
proc printto log='d:\power_sas\log.txt' new;run; 
proc printto print='d:\power_sas\out.txt' new;run; 
 
%mend simulate; 
 
 
*SAS does not have the Excel CRITBINOMIAL (BIN.INV) function, but a macro 
can be derived from 
 http://www.listserv.uga.edu/cgi-bin/wa?A2=ind0212c&L=sas-l&P=27308; 
%macro critbinom(critval=critval, 
                 trials=trials, 
                 p_success=p_success, 
                 alpha=alpha 
     ); 
 
  /*********************************************************/ 
  /* Macro variables name datastep variables:              */ 
  /*                                                       */ 
  /*   CRITVAL:    Variable holding returned value         */ 
  /*   TRIALS:     Number of independent bernoulli trials  */ 
  /*   P_SUCCESS:  Success probability per bernoulli trial */ 
  /*   ALPHA:      Criterion value with 0<alpha<1          */ 
  /*********************************************************/ 
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  if nmiss(&trials, &p_success, &alpha)>0 then do; 
    put "Error: Invocation of CRITBINOM subroutine -"; 
    put "       Invalid specification of TRIALS, P_SUCCESS, or ALPHA"; 
  end; 
  else do; 
    &critval=int(&trials/2); 
    _max=&trials; 
    _min=0; 
    do until(_test1>&alpha & _test2<&alpha); 
      _test1 = cdf('BINOM', &trials-&critval, &p_success, &trials); 
      _test2 = cdf('BINOM', &trials-(&critval+1), &p_success, &trials); 
      if _test1<&alpha then do; 
        _max=&critval; 
        &critval=int((&critval-_min)/2)+_min; 
      end; 
      else if _test2>&alpha then do; 
        _min=&critval; 
        &critval=_max - int((_max-&critval)/2); 
      end; 
    end; 
  end; 
  drop _min _max _test1 _test2; 
%mend; 
 
*Macro DELFILE deletes specified files; 
%macro delfile (DS); 
  %if %sysfunc (exist (&DS)) %then %do; 
    proc sql noprint; drop table &DS; quit; 
  %end; 
%mend delfile; 
 
*Macro's APPEND0 EN APPEND1 accumulate genmod outcomes; 
*In case the original genmod halted because of non-convergence, results of an 
intercept only model are stored instead; 
%macro append0(R0); 
%if %sysfunc (exist (&R0)) %then %do; 
  data run0;set run0;qc0=0;qc1=.;run; 
      proc append base=trial.collect data=run0; run; 
  %end; 
%else %do;  
 ods output estimates=run0 (keep=k label LBetaEstimate stderr); 
 *proc genmod data=trial.fixed&j; 
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 proc genmod data=fixed2; where ncs gt 0 and vaccinated=0; 
 model observed/ncs= /dist=binomial link=cll offset=offset; 
 by k kse ksp;*k is just a count variable; 
 estimate 'vacc=0' intercept 1 /e exp; 
 ODS select estimates; 
 run; 
 data run0;set run0;qc0=1;qc1=.;run; 
 proc append base=trial.collect data=run0; run; 
%end; 
%mend append0; 
 
%macro append1(R1); 
%if %sysfunc (exist (&R1)) %then %do; 
 data run1;set run1;qc1=0;qc0=.;run; 
    proc append base=trial.collect data=run1; run; 
 %end; 
 %else %do;  
 ods output estimates=run1 (keep=k label LBetaEstimate stderr); 
 *proc genmod data=trial.fixed&j; 
 proc genmod data=fixed2; where ncs gt 0 and vaccinated=1; 
 model observed/ncs= /dist=binomial link=cll offset=offset; 
 by k kse ksp;*k is just a count variable; 
 estimate 'vacc=1' intercept 1 /e exp; 
 ODS select estimates; 
 run; 
 data run1;set run1;qc1=1;qc0=.;run; 
 proc append base=trial.collect data=run1; run; 
  %end; 
%mend append1; 
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Abstract  
 
A long-term research programme has been underway in Ireland to evaluate the 
usefulness of badger vaccination as part of the national bTB (bovine tuberculosis) 
control strategy. This culminated in a field trial which commenced in county 
Kilkenny in 2009 to determine the effects of badger vaccination on Mycobacterium 
bovis transmission in badgers under field conditions. In the present study, we sought 
to optimise the characteristics of a multiplex chemiluminescent assay for detection 
of M. bovis infection in live badgers. Our goal was to maximise specificity, and 
therefore statistical power, during evaluation of the badger vaccine trial data. In 
addition, we also aimed to explore the effects of vaccination on test characteristics. 
For the test optimisation, we ran a stepwise logistic regression with analytical 
weights on the converted Relative Light Units (RLU) obtained from testing blood 
samples from 215 badgers captured as part of culling operations by the national 
Department of Agriculture, Food and the Marine (DAFM). The optimised test was 
applied to two other datasets obtained from two captive badger studies (Study 1 and 
Study 2), and the sensitivity and specificity of the test was attained separately for 
vaccinated and non-vaccinated badgers. During optimisation, test sensitivity was 
maximised (30.77%), while retaining specificity at 99.99%. When the optimised test 
was then applied to the captive badger studies data, we observed that test 
characteristics did not vary greatly between vaccinated and non-vaccinated badgers. 
However, a different time lag between infection and a positive test result was 
observed in vaccinated and non-vaccinated badgers. We propose that the optimized 
multiplex immunoassay be used to analyse the vaccine trial data. In relation to the 
difference in the time lag observed for vaccinated and non-vaccinated badgers, we 
also present a strategy to enable the test to be used during trial evaluation. 
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Introduction  
 
Badgers play an important role in the epidemiology of bovine tuberculosis (bTB) in 
Ireland, by acting as a source of infection to cattle [1,2]. The prevalence of 
Mycobacterium bovis infection in badgers, based on animals captured as part of 
culling operations by the national Department of Agriculture, Food and the Marine 
(DAFM), was estimated recently at 36.3% [3], although this is known to vary 
substantially between areas where bTB in cattle is problematic [4] or absent [5]. 
Sustainable progress towards eradication of M. bovis infection in cattle might not be 
possible in the face of continued spillover of infection from badgers to cattle [2]. 
 
Several control options are available to limit transmission of infection from badgers 
to cattle, including reducing the frequency of contact between these species and 
decreasing the proportion of the badger population susceptible to infection, through 
vaccination [2]. In Ireland, focused badger culling is being used to reduce contact 
rates between badgers and cattle in areas of high bTB incidence in cattle. However, 
it is hoped that badger culling can be replaced by, or supplemented with, badger 
vaccination. A long-term Irish research programme is on-going to evaluate the 
usefulness of badger vaccination as part of the national bTB control strategy. A series 
of pen-based vaccination trials have been conducted, where badgers were vaccinated 
with Bacillus Calmette-Guerin (BCG) and subsequently challenged with M. bovis, 
and the impact of vaccination on pathology, bacteriology and progression of 
infection in badgers has previously been reported [6-9]. Subsequent to this work, a 
field trial commenced in county Kilkenny, in 2009, to determine the effects of badger 
vaccination on M. bovis transmission in badgers under field conditions [10]. The 
field trial design will enable comparison of bTB incidence between vaccinated and 
unvaccinated badgers in three areas of differing vaccine coverage (100, 50 and 0%).  
 
A number of challenges have been encountered during the design of the field trial in 
Co. Kilkenny, including: a) the need to fully understand the biology underpinning 
protection following BCG vaccination, both in individual badgers and within the 
broader badger population (including the likelihood of reduction of infectiousness 
and therefore transmission); b) the need to identify the infection status of each badger 
at each capture event (a capture/ recapture design has been employed), and c) the 
need for sufficient statistical power in the aforementioned design. There is now a 
better understanding of options to address the first and third of these challenges 
[10,11]. In this paper, we consider the second of these challenges, that is, the need 
for a test to identify the infection status of individual badgers at each capture event. 
It has been shown recently that this diagnostic test will need a specificity very close 
to 100% in order to obtain sufficient study power [11]. The authors estimated a 
minimum specificity of 99.8% to achieve a power above 60% in this trial. The need 
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for a high specificity reflects the fact that the cost of false positive test results is much 
higher than that of false negative results. 
 
A significant amount of work in relation to diagnostic methods for tuberculosis in 
live badgers has been conducted in Ireland and the United Kingdom [12-17]. Assays 
based on the measurement of cellular responses, such as gamma-interferon, have 
attracted considerable interest as they are expected to deliver a higher sensitivity in 
comparison to antibody-based assays [13, 15]. Furthermore, these cell response 
assays have the advantage of being able to detect earlier stages of infection [18]. 
However, one of the drawbacks of these assays is the large effect of pre-culture 
holding time and temperature on gamma-interferon responses [19,20]. Several other 
bTB assays have been developed. The Brock test is an indirect ELISA that measures 
M. bovis-specific antibody responses to a single antigen, MPB83 [21,22]. MPB83 is 
expressed by other members of M. tuberculosis complex, but is serodominant in 
M.bovis infection. Subsequent studies have shown that test sensitivity and specificity 
can be enhanced by using a mixture of antigens rather than a single antigen. Based 
on the use of a multi-antigen print immunoassay (MAPIA) and culture as the gold 
standard, the sensitivity was found to increase from 47.4% to 52.6% and the 
specificity from 89% to 95% [23]. In an attempt to simplify the procedure, thereby 
allowing badger testing to be performed in the field, a lateral flow immunoassay (the 
Brock TB Stat-Pak assay; Chembio Diagnostic Systems, Inc., Medford, NY) was 
developed [14, 16]. 
 
Here, we will look at the Enfer chemiluminescent multiplex ELISA system, 
originally developed for testing M. bovis in cattle [24,25]. The test was adapted for 
badgers and applied to 200 blood samples from badgers captured in Ireland in areas 
of high bovine tuberculosis prevalence [26], this study reported a sensitivity and 
specificity in badgers of 56.7% and 96.99%, respectively, when using a panel of M. 
bovis antigens. The availability of this test, the fact that this test can be performed in 
stored blood samples without losing sensitivity or specificity, and its quantitative 
nature, made this test the test of choice. Given this background, the current study had 
two objectives. First, we sought to statistically optimise a multiplex 
chemiluminescent assay for detection of M. bovis infection in live badgers to 
maximise specificity, and therefore statistical power, during evaluation of the badger 
vaccine trial in Ireland. Second, we aimed to explore the effects of vaccination on 
test characteristics and to review the implications for analysis of the data from the 
Kilkenny badger vaccine trial. 
 
Material and Methods 
 
The 215 blood samples used for test optimization were part of an archive. The 
badgers from which these samples had been taken, had been captured as part of the 
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DAFM culling operations carried out in the Republic of Ireland. The Department of 
Arts, Heritage and the Gaeltacht, specifically the National Parks and Wildlife 
Service, issues licences to the Department of Agriculture, Food and the Marine to 
undertake the capturing programme. The captive badger studies were carried out 
under license (No. B100/3187, Cruelty to Animals Act 1876) issued by the 
Department of Health and Children, and ethical approval was obtained from the 
UCD Animal Research Ethics Committee (AREC-P-04-28 and AREC-P-24-06). 
 
1. Test optimisation using naturally infected wild badgers 
 
1.1 Samples 
 
Serum samples from 215 badgers captured as part of the DAFM culling operations 
carried out in the Republic of Ireland were used for optimisation of the diagnostic 
test. Focused (reactive) badger removal is conducted under license in the vicinity of 
herds that have had a severe bTB breakdown where the cause cannot be attributed to 
non-wildlife sources. The serum samples had been collected for archiving purposes. 
A study by Murphy et al. (2010) [3] looked at these badgers for gross visible lesions 
of TB at post mortem and samples were collected from a range of tissues and pooled 
into groups for bacterial culture of M. bovis. An aseptic technique was used when 
preparing tissue samples to minimize contamination before culture. In the current 
study, culture results were used as the gold standard and a badger was considered 
infected when M. bovis was isolated from any of the samples taken.  
 
1.2 Multiplex immunoassay 
 
Antibody responses, expressed as relative light units (RLU), to a panel of antigens 
were measured using the Enfer chemiluminescent multiplex ELISA system (Enfer 
Scientific, Co. Kildare, Ireland). The antigen panel consisted of the following six 
recombinant proteins: MPB83, MPB70, Rv3616c fragment and full protein, ESAT-
6 and CFP10, as well as purified protein derivative from M. bovis (PPDb) and a 
peptide of MPB70. Tests were carried out by Enfer Scientific using 96-well 
microtitreplates. Recombinant antigens (Fusion Antibodies Ltd. (Belfast)) and 
peptides (Genosphere Biotechnologies (France)) were prepared as previously 
described by Whelan et al. (2008)[24]. 
 
The multiplex assay was carried according to Whelan et al. (2008) [24]. Serum 
samples were diluted 1:450 into sample dilution buffer and mixed. A 50µl sample 
dilution was added per well. The plates were incubated at room temperature with 
agitation for 90 minutes. The plates were washed once with Enfer Wash Buffer 
(Enfer Scientific) and aspirated. The detection antibody (CF2/HRPo Anti-Badger 
IgG-HRP conjugate, kindly provided by Mark Chambers, AHVLA, Weybridge, UK) 
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was prepared to a dilution of 1:75,000 in detection antibody dilution buffer. After 
addition of 50µl of the detection antibody to each test well, the plates were incubated 
at room temperature for 30 minutes with agitation. The plates were washed as above 
and 50µl of chemiluminescent substrate (50:50 substrate and diluent) was added per 
well. Signals were captured and data were extracted and analysed as previously 
described [24]. 
 
1.3 Data analyses 
 
The 8 antibody response RLU-signals were blank-corrected by subtracting a blank 
spot signal specific to each sample. Initially, all zero or negative test-result values 
were converted to 0.0001 to allow for logarithmic transformation; however, the 
logarithmic transformation did not improve ROC curves. The blank-corrected values 
with negative values converted to 0.0001 will be referred to as “converted RLU”. 
Descriptive statistics (mean, standard deviation, minimum, maximum and median) 
of the converted RLU to the 8 antigens were calculated separately for non infected 
(NI) and infected (I) badgers. ROC curves for each antigen were constructed, and 
the ROC curve showing the largest sensitivity, with specificity set at 99.99%, is 
presented in this manuscript.  
 
A stepwise logistic regression, with culture status as the dependent variable, the 
converted RLU to each of the 8 antigens as the independent variables, and using a 
significance level of 0.05, was carried out. Analytical weights were used to account 
for the cost of false positive test results being higher than that of negative test results. 
After exploring different cost ratios, a cost ratio of 100:1 (false positive: false 
negative) was selected. Cost ratios higher than 100:1 did not improve the ROC curve. 
From the logit obtained after using logistic regression, a cut off was chosen that 
allowed sensitivity to be maximised for specificity equal to 99.99%. A Hosmer-
Lemeshow test was used to assess the goodness of fit of the final model. For the best 
linear combination of antigens, a ROC curve was created. All analyses were 
performed using Stata version 12 (Stata Corp, College Station, TX, USA). 
 
2. Evaluation of test characteristics in vaccinated and non-vaccinated captive badgers 
 
2.1 Study 1 samples  
 
Serum samples were available from a laboratory vaccine trial (Study 1). This trial 
was conducted to compare the levels of protection between vaccinated and non-
vaccinated badgers, and between badgers vaccinated with different vaccines. Briefly, 
badgers were sourced from an area free of bTB and allowed to adapt to captivity for 
12 weeks prior to the start of the experiment. During adaptation, the badgers were 
screened for tuberculosis using a lymphocyte transformation assay (LTA). The 
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experiment consisted of three groups of badgers: animals vaccinated (108 CFU) with 
either BCG Danish 1331 (n=8 animals) or BCG Pasteur 1173P2 (n=7), and controls 
(n=8). All badgers were challenged by the endo-bronchial route with 6x103 CFU M. 
bovis. The badgers were euthanised 15 weeks post-challenge and subjected to a 
detailed post-mortem examination. Blood samples were taken twice a month prior 
to vaccination (6 samples per badger) and once a month subsequently (2 samples 
prior and 4 samples subsequent to challenge, per badger). 
 
2.2 Study 2 samples 
 
Serum samples were also available from a second captive badger study (Study 2). 
Data were available from a group of 9 badgers that were vaccinated (108 CFU, BCG 
Danish strain) and a group of 10 badgers that served as a control group. Badgers 
were challenged with 3 x 102 CFU of M. bovis by the endo-bronchial route, and 
followed for 51 weeks after challenge. Blood samples were taken every two weeks 
before badgers were vaccinated (3 samples per badger) and once a month subsequent 
to vaccination (3 samples before and 10 samples after challenge per badger) with a 
further sample taken before badgers were euthanized three months later.  
 
2.3 Multiplex immunoassay 
 
The assay was conducted as described previously. 
 
2.4 Data analysis 
 
For each of the captive studies, descriptive statistics of the antibody responses to 
each of the 8 antigens were calculated independently for each of the following badger 
categories: non-vaccinated - non-infected (Category 1), vaccinated - non-infected 
(Category 2), non-vaccinated - infected (Category 3) and vaccinated - infected 
(Category 4). In Study 1, the descriptive analysis was done taking into account only 
those badgers vaccinated with the Danish strain and then repeated using data from 
both groups of vaccinated badgers (Danish and Pasteur). 
 
The optimal antigen combination (described in section 2.1) was applied to the data 
from Study 1 and Study 2 resulting in estimated logits; by applying the selected cut-
off to the logits obtained, the sensitivity and specificity of the multiplex 
immunoassay test was estimated separately for each of the studies. In order to be 
consistent, only samples from badgers vaccinated with the Danish strain were used 
for estimating sensitivity and specificity in Study 1.The sensitivity and specificity 
was also estimated separately for vaccinated and non-vaccinated badgers in Study 2. 
Badgers in these datasets were considered infected one day after they had been 
challenged. For Study 2 data, the probability of testing positive was calculated from 
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the logit using the formula: prob= exp(logit)/(1+exp(logit)). The cut-off value was 
also converted into a probability using the same formula. Scatter plots of the 
probability of testing positive by time since the start of the trial and least squares 
means of these probabilities were created separately for the control and vaccinated 
groups in Study 2. In order to explore whether the logit was associated with time 
since infection, a generalized estimating equations model (GEE; to account for 
repeated measures within a badger) with a vaccination-time interaction term was 
conducted. The model used a Gaussian distribution with identity link and 
exchangeable correlation structure. Quadratic and logarithmic transformations of the 
independent variable “time since challenge” were carried out but did not yield lower 
values of QIC (quasilikelihood under the independence model criterion). The 
working correlation for the repeated effect was 0.288. A two-way graph was created 
using the predictions of the GEE model and time since infection by vaccination 
status. All statistics were carried out using Stata version 12 (Stata Corp, College 
Station, TX, USA). 
 
Results 
 
1. Test optimisation  
In total, 78 of the 215 samples (36.3%) were infected with M. bovis based on culture 
results. Descriptive statistics for converted RLU response to each of the 8 antigens 
by infection status are presented in Table 1. 
 
When using stepwise logistic regression with analytic weights, 7 of the 8 antigens 
were retained in the final model, but MPB70 peptide was not. The Hosmer-
Lemeshow test showed that the model fitted the data sufficiently well (p-value 0.29). 
Figure 1 depicts the ROC curve of the logit obtained for the combination of antigens. 
For a specificity of 99.99%, a logit cut-off of -2.67 was needed. At this cut-off, the 
sensitivity was 30.77%. Of the single antigens, MPB83 achieved the largest 
sensitivity, 24.36%, with the specificity set at 99.99% (Figure 1).  
 
2. Evaluation of test characteristics in vaccinated and non vaccinated badgers 
 
In Study 1, 258 samples were analysed, with 30% of the badgers being tested 11 
times and 70% of them 12 times. In Study 2, 297 samples were analysed (two 
samples could not be analysed for Rv3616c (fragment) due to insufficient serum, 
and were removed from the study), with a mean of 15.6 samples per badger (min=9, 
max=17). A table showing the descriptive statistics for each of the 8 antigens as 
converted RLU, by infection and vaccination status, is presented as a supplementary 
file (Supplementary Table S2). This file also presents data for Study 1 samples 
originating from badgers vaccinated with the Danish strain. 
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Table 1. M an, standard deviation, maximum and median values for converted RLU response to each of the 8 antigens, by infection status (based on culture). 
 
Antigen Mean   SD   Max   Median 
  NI I   NI I   NI I   NI I 
MPB70* 53.1 57.9  119.2 144.4  840.0 919.0  0.0 0.0 
MPB70 161.1 4611.2  808.7 10845.5  9057.5 53843.0  6.5 106.3 
MPB83 120.4 5081.5  365.3 11470.1  3160.0 53718.0  10.5 127.3 
Rv3616c** 132.7 3627.7  498.3 9748.9  4952.0 53780.5  16.0 85.0 
PPDb 124.7 3533.6  392.9 9205.1  2899.3 53749.3  15.5 74.6 
Rv3616c 379.7 7303.4  1545.8 9205.1  13494.5 59739.0  7.5 263.8 
ESAT-6 49.1 859.0  88.5 6866.2  494.5 60639.0  0.0 0.0 
CFP-10 237.0 1501.6   924.4 7112.3   8605.5 53182.5   23.0 20.5 
            
            
*MPB70 peptide, **Rv3616c fragment 
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Figure 1. ROC curves of the logit obtained using either the optimised combination of 
antigens (blue line) or MPB83 (red line). Each is based on converted RLU values, and the 
green line is included for reference. 
 
Using the optimal antigen combination, the mean sensitivity and specificity of the 
multiplex immunoassay test were respectively 22.99% (CI:14.64-33.25%) and 
78.95% (CI:72.07-84.80%) for Study 1, and 33.51% (CI:26.76-40.81%) and 83.04% 
(CI: 74.78-89.47%) for Study 2. The sensitivity and specificity were also calculated 
separately for vaccinated and non-vaccinated badgers from Study 2, obtaining 
sensitivity values for vaccinated badgers of 32.26% (CI:22.93-42.75%) and 
specificity of 88.89% (CI:70.84-97.65%); the equivalent values for non-vaccinated 
badgers were 34.78% (CI:25.15-45.43%) sensitivity and 81.18% (CI:71.24-88.84%) 
specificity. 
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Figure 2. Scatter plot and least square means of the probability of testing positive for the control (left 
graph) and vaccinated (right) groups in Study 2 by time since the start of the study. Vertical reference 
lines showing the day of vaccination and challenge, and a horizontal reference line of the cut-off are 
included. 
 
Figure 2 presents scatter plots and least square means of the probability of testing 
positive for the control and vaccinated groups in Study 2 by time since the start of 
the study. 
 
A two-way graph showing the GEE predictions by time since challenge is presented 
in Figure 3. In this Figure, the rate of increase of the logit is presented separately for 
vaccinated and non-vaccinated badgers. The GEE analysis showed a significant 
association of the dependent variable with all three independent variables: time since 
challenge, vaccination and their interaction term (p<0.005). When a robust GEE 
model was fitted, the interaction term was borderline significant (p=0.045). In the 
Figure, a line showing the selected cut off value is highlighted. A reference line 
showing the minimum number of days to test positive for infected non-vaccinated 
badgers is also presented. 
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Figure 3. GEE predictions by time since challenge for vaccinated and non-vaccinated 
badgers. Two reference lines are presented: a vertical line showing the minimum number of 
days to test positive for infected non-vaccinated badgers and a horizontal cut-off line. 
 
Discussion 
 
The main objective of this paper was to optimise a diagnostic test for M. bovis 
infection in live badgers, for use during the evaluation of vaccine efficacy in a large 
bTB vaccine field trial in Ireland. On most occasions when a test is being developed, 
it is desirable to optimise both the sensitivity and the specificity of the test; in such 
situations, a cost ratio for false positives and false negatives of 1:1 is selected. 
However, in a previous study focusing on the statistical power of this trial [11], it 
was demonstrated that the diagnostic test needed to be tailored to achieve a 
specificity close to 100% to achieve a reasonable statistical power (60-80%). As the 
incidence of M. bovis infection in the badger population decreases, there will be an 
increasing number of false positive results, randomly occurring in the mainly 
negative samples from both vaccinated and unvaccinated animals, with the potential 
to greatly bias estimates of vaccine efficacy. Hence, the need for specificity close to 
100%, thereby minimising the number of false positive results. Greiner et al. (2000) 
[27] have shown that analytic weights can be used to optimise cut-off values with 
regard to a specific cost ratio of false positive and false negative results. In order to 
reduce the number of false positive results, the upper left corner of the ROC curve 
(draw as sensitivity against 1-specificity) was optimised by selecting a cost ratio of 
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false positives to false negatives equal to 100:1. Other ratios were explored, noting 
that cost ratios higher than 100:1 did not improve the ROC curve, probably due to 
the relatively small number of samples available to test. Subsequently, a cut-off 
value of a logit equal to -2.67 was needed to achieve a specificity of 99.99%, 
resulting in a maximum sensitivity of 30.77%. This sensitivity, although quite low 
in comparison to generally available diagnostic tests, is sufficient to achieve a 
statistical power of the vaccine trial of over 80% [11]. In this trial, test sensitivity is 
of lesser importance on study power because, when the incidence of M. bovis 
infection in badgers is low, the expected proportion of false negatives will be a 
fraction of something that is already a very small proportion. 
 
In this study, culture was used to ascertain the disease status of individual badgers. 
Although it is unlikely that culture is a perfect ‘gold standard’, the methodology used 
in this study is based on an enhanced post mortem technique, currently the most 
sensitive available. In recent years, a progressive increase in estimated prevalence of 
M. bovis infection in badgers has been observed, both in Ireland and the UK, 
attributable to improved sensitivity of detection [3,4]. Crawshaw et al. (2008) [28] 
reported a 54% sensitivity of a standard post-mortem procedure compared to a more 
detailed enhanced post mortem technique. 
 
A second objective in this paper was to assess the effects of vaccination on test 
characteristics. The optimised test described above was applied to data from Study 
1 and 2. Badgers in Study 2 were followed for a much longer period of time 
subsequent to challenge than badgers in Study 1. Therefore data from Study 2, as 
opposed to Study 1, were used for further analysis. The sensitivities /specificities for 
non-vaccinated and vaccinated badgers in Study 2 were 34.78/77.97% and 
32.26/88.68%, respectively. The test characteristics for both vaccinated and non-
vaccinated badgers were very similar, as indicated by the overlap of the confidence 
intervals. Nonetheless, the specificity obtained for Study 2 was lower than that 
obtained when the test was optimised in naturally infected individuals (99.99%). 
When looking at the specific badger data presented in Figure 2, it was observed that 
a large proportion of the false positives samples within the control group badgers 
belonged to two badgers that repeatedly tested positive prior to challenge (6 and 4 
times per badger respectively, out of a total of 6 sampling times during this period). 
One possibility is that those two badgers were infected prior to the start of the 
experiment. However, blood samples from these animals were repeatedly screened 
before challenge by the more sensitive lymphocyte transformation assay using 
bovine and avian tuberculins, and were negative on all occasions (data not shown). 
The underlying cause of the false positive reactions in the two badgers is unknown 
though cross reactivity can potentially arise from concurrent infections with related 
pathogens or any microbe with shared epitopes, all of which potentially influence 
the specificity of this test. By removing samples from those two badgers, the 
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specificity of the test increased to 93.62% in non-vaccinated badgers and to 91.00% 
for all badgers (vaccinated and non-vaccinated combined). Contrary to the control 
group, the false positives samples observed in the vaccinated group belonged to 
different badgers. These badgers tested positive (prior to challenge) on no more than 
one occasion, out of an average of 6 tests per badger during this period.  
 
One of the concerns of serologically-based assays is that they detect infection later 
than assays based on the cell-mediated immune response, such as gamma-interferon. 
This is because the initial immune response is cell-mediated. A lag between infection 
and positive test results has been observed in the data obtained from Study 2 (Figures 
2 and 3); this lag varies between vaccinated and non-vaccinated animals. From a 
biological point of view, we would expect that non-vaccinated badgers will carry a 
larger antigen load and thus will mount a larger antibody response to M. bovis 
challenge than those that are vaccinated. Nonetheless, it is the vaccinated group that 
shows the earliest positive test when a cut-off=-2.67 is selected (Figure 3 shows 
samples of vaccinated badgers testing positive earlier than 100 days after challenge, 
while the equivalent for the non-vaccinated group was 215 days). We can think of 
two possible interpretations for the observed results, one is that vaccinated badgers 
will mount a serological response faster than non-vaccinated badgers following 
infection, the other option is that observed results are due to chance (due to the small 
number of badgers in each group). It is possible that some of the badgers that were 
randomly allocated to the vaccinated group were extremely susceptible to infection 
and for those badgers, vaccination did not work. 
 
Considering all of the above, what we propose in this study is that the multiplex 
immunoassay can be used to analyse the vaccine trial data, incorporating the optimal 
antigen combination identified from section 2.1 and a consistent cut-off of -2.67. To 
account for the differences observed in the lag between time of infection and a 
positive test, we recommend that only subsequent captures that occur more than “Y” 
days apart are used for the analysis, with “Y” being the minimum number of days 
necessary between infection and a subsequent positive test (215 days in this study). 
The number “Y” can be determined, after the vaccine trial dataset is gathered, as a 
trade-off between the increase in sensitivity and the possible reduction in power 
resulting from a decrease of our sample size. By taking this approach, it will be 
possible to minimise bias, specifically the incorrect classification of infected animals 
as non-infected. 
 
In summary, a multi-antigen test has been optimised for use during the evaluation of 
vaccine effectiveness in a badger bTB vaccine field trial in Ireland. During 
optimisation, test sensitivity was estimated, while specificity was set at 99.99%. 
Based on the operating characteristics of the diagnostic test, it has been demonstrated 
that the statistical power of the field trial could exceed 80% [11]. We have also 
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observed that test characteristics do not vary greatly between vaccinated and non-
vaccinated badgers. In relation to the time lag between infection and a positive test 
in vaccinated and non-vaccinated badgers, we have presented a strategy to enable 
the test to be used, and applied consistently, during trial evaluation. 
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Table S1. Mean, standard deviation, maximum and median values for converted RLU response to each of the 8 
 antigens, by infection and vaccination status (Categories 1 to 2) 
  Ag   Category 1   Category 2 
    Mean SD Max Median   Mean SD Max Median 
B
R
O
C
 6
 
MPB70*  72.6 114.8 693 10.0  44.0 62.2 174 0.0 
MPB70  73.6 107.6 681 26 0  44.9 82.9 287 0.0 
MPB83  83.9 103.5 443 43.0  50.1 63.1 197 11.0 
Rv3616c**  62.7 117.2 871 0.0  67.4 102.2 417 14.0 
PPDb  1131.3 3642.4 29260 164.0  269.8 463.9 1853 81.0 
Rv3616c  1308.2 4013.9 34017 5.5  2 7.7 867.1 4257 25.0 
ESAT-6  2436.4 7181.6 42291 130.0  399.4 855.3 3940 74.0 
CFP-10  606.4 3152.2 24542 65.0  2107.2 7192.3 28545 0.0 
            
B
R
O
C
 6
**
* 
MPB70*  6 ,1 97.6 389 3.5  54.  67.4 174 21.0 
MPB70  77.0 103.7 439 23.0  64.4 97.3 287 0.0 
MPB83  80.1 103.1 443 37.0  54.1 68.4 197 13.0 
Rv3616c**  62.1 123.0 871 0.0  82.1 118.6 417 18.0 
PPDb  1453.6 4148.4 29260 239.5  307.3 544.9 1853 95.0 
Rv3616c  1710.0 4557.1 34017 98.5  436.9 1100.9 4257 72.0 
ESAT-6  3187.9 8141.5 42291 198.0  506.2 1049.6 3940 81.0 
CFP-10  768.9 3619.7 24542 72.5  3478.4 9145.6 28545 0.0 
            
B
R
O
C
 7
 
MPB70*  76.2 134.3 666 6.5  141.5 300.4 1304 0.0 
MPB70  59.7 103.4 469 0.0  37.2 80.1 372 8.0 
MPB83  188 406.2 2796 41.0  54.7 88.7 260 0.0 
Rv3616c**  65.1 120.1 652 0.0  30.9 49.4 152 0.0 
PPDb  409.4 1575.7 13654 30.0  1051.5 2385.2 9440 69.0 
Rv3616c  914.2 2719.5 16438 25.5  330.0 775.8 2963 35.0 
ESAT-6  1226.6 4004.1 25337 61.5  181.4 343 1610 68.0 
CFP-10   322.9 911.9 6795 49.5   137.9 259.8 1048 20.0 
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Table S1. Mean, standard deviation, maximum and median values for converted RLU response to each of the 8 
antigens, by infection and vaccination status (Categories 3 to 4) 
 
  Ag   Category 3   Category 4 
     Mean SD Max Median   Mean SD Max Median 
B
R
O
C
 6
 
MPB70*  44.1 65.0 233 0.0  45.2 80.2 403 0.0 
MPB70  485.7 1054.6 4857 15.5  109.6 214.5 1105 0.0 
MPB83  876.2 3600.1 20427 80.5  68.9 80.4 360 46.0 
Rv3616c**  42.8 72.4 309 0.0  49.2 67.8 267 19.0 
PPDb  4813.8 11303.7 50765 249.5  586.8 1442.0 7524 82.0 
Rv3616c  12906.3 19955.2 61275 1224.5  1781.3 4954.1 2 815 48.0 
ESAT-6  7592.8 16547.4 56623 520.0  1882.6 6172.3 28703 142.0 
CFP-10  264.2 685.8 3430 18.0  2370.6 8096.9 37025 53.0 
            
B
R
O
C
 6
**
* 
MPB70*  44.1 65.0 233 0.0  60.7 92.9 403 14.0 
MPB70  485.7 1054.6 4857 15.5  149.6 257.2 1105 21.0 
MPB83  876.2 3600.1 20427 80.5  85.1 87.7 360 78.0 
Rv3616c**  42.8 72.4 309 0.0  56.4 69.5 267 37.5 
PPDb  4813.8 11303.8 50765 249.5  693.5 1540.8 7524 1 3.5 
Rv3616c  12906.3 19955.2 61275 1224.5  2989.8 6254.0 25815 136.5 
ESAT-6  7592.8 16547.4 56623 520.0  3134.5 7904.1 28703 187.5 
CFP-10  264.2 685.8 3430 18.0  4031.1 10362.7 37025 106.5 
            
B
R
O
C
 7
 
MPB70*  113.0 235.0 2020 35.0  277.5 1269.3 10333 51.0 
MPB70  4437.5 12579.1 55895 86.0  1865.5 6374.1 43801 69.0 
MPB83  7142.4 17381.9 61266 438.0  2764,4 9964.4 60815 80.0 
Rv3616c**  1334.2 3732.3 21051 87.0  339.8 2502.2 24182 10.0 
PPDb  4548.6 9459.8 55391 299.0  1948.8 5456.6 37152 194.0 
Rv3616c  15231.5 20246.1 62784 2668.0  1420.9 6825.3 61237 79.0 
ESAT-6  836.5 2368.3 11083 66.0  161.1 237.9 1888 104.0 
CFP-10   1680.6 5683.4 29668 82.0   117.0 292.4 2658 53.0 
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Abstract  
 
In the UK and Ireland, Bacille Calmette-Guérin (BCG) vaccination of badgers has 
been suggested as one of a number of strategies to control or even eradicate 
Mycobacterium bovis infection in badgers. In this manuscript, we present the results 
of a badger field trial conducted in Ireland and discuss how the novel trial design and 
analytical methods allowed the effects of vaccination on protection against infection 
and, more importantly, on transmission to be estimated. The trial area was divided 
into three zones North to South (A, B and C) where vaccination coverages of 0, 50 
and 100%, respectively, were applied. Badgers were trapped over a 4 year period. 
Badgers were assigned to either placebo or vaccine treatment, with treatment 
allocation occurring randomly in zone B. Blood samples were collected at each 
capture, and serology was performed in these samples using a chemiluminescent 
multiplex ELISA system (Enfer test). The analysis aimed to compare new infections 
occurring in non-infected non-vaccinated badgers to those in non-infected 
vaccinated ones, while accounting for the zone in which the badger was trapped and 
the infection pressure to which this individual badger was exposed. In total, 440 
records on subsequent trappings of individual non-infected badgers were available 
for analysis. Over the study period, 55 new infections occurred in non-vaccinated 
(out of 239 = 23.0%) and 40 in vaccinated (out of 201 = 19.9%) badgers. A 
Generalized Linear Model (GLM) with a cloglog link function was used for analysis. 
Statistical analysis showed that susceptibility to natural exposure with M. bovis was 
reduced in vaccinated compared to placebo treated badgers: vaccine efficacy for 
susceptibility, VES, was 59% (95% CI = 6.5%-82%). However, a complete lack of 
effect from BCG vaccination on the infectivity of vaccinated badgers was observed, 
i.e. vaccine efficacy for infectiousness (VEI) was 0%. Further, the basic reproduction 
ratio as a function of vaccination coverage (p) (i.e. R(p)) was estimated. Given that 
the prevalence of M. bovis infection in badgers in endemic areas in Ireland is 
approximately 18%, we estimated the reproduction ratio in the unvaccinated 
population as R(0) = 1.22. Because VES was now known, the reproduction ratio for 
a fully vaccinated population was estimated as R(1) = 0.50. These results imply that 
with vaccination coverage in badgers exceeding 30%, eradication of M. bovis in 
badgers in Ireland is feasible, provided that the current control measures also remain 
in place. 
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1. Introduction  
Bovine tuberculosis (bTB, caused by infection with Mycobacterium bovis) is a 
chronic inflammatory disease of bovidae (Bezos et al., 2014). A control/eradication 
programme for bTB in cattle started in Ireland in 1959 not only to address the 
economic losses associated with the infection (Caminiti et al., 2016), but also its 
zoonotic potential (Langer and LoBue, 2014). In the first ten years of the control 
programme, with a focus on measures to limit cattle to cattle transmission, the 
incidence of M. bovis infection in cattle was reduced from 17% to 0.5% (More and 
Good, 2006). Subsequently, progress has been slow, despite ongoing application of 
intense control strategies, which raised concerns about a role for one or more 
reservoirs of M. bovis maintaining transmission. Over the years, this hypothesis has 
been confirmed, including work highlighting high prevalence of infection in badgers 
(Meles meles) (Corner et al., 2005). Since then substantial research has been 
conducted to understand transmission of M. bovis between cattle and badgers, and 
of potential strategies capable of reducing this transmission. One such strategy is the 
use of BCG (Bacille Calmette-Guérin) badger vaccination (More and Good 2006). 
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Figure 1. Topographic map of the Irish badger vaccine field trial showing: number of farms 
and bovines, zone area and area of farmed grassland (sq km), and number of main and 
secondary badger setts per zone. From north to south, zones A, B and C indicate placebo 
(blue badger) and/or vaccine (yellow badger) allocation. Estimated M. bovis prevalence in 
badgers at the end of the first year is shown per zone (pie charts). Badger setts are represented 
as: all surveyed setts (grey dots), setts with at least one positive badger trapped in the first 
year (purple cross), setts with at least one negative badger trapped in the first year (light green 
cross). 
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Experimental challenge trials with M. bovis following BCG vaccination by 
subcutaneous, mucosal, oral or intramuscular routes (Corner et al., 2008; Lesellier 
et al., 2009, 2011; Murphy et al., 2014) have demonstrated a reduction in disease 
progression in captive badgers. It has been proposed that this observed reduction in 
the number of sites with gross pathology and of general gross pathological severity 
scores observed in these badgers, could translate to a reduction of badger infectivity, 
and thus to a reduction in transmission in the field (Chambers et al., 2011). Here, the 
expected reduction in transmission due to a lower infectivity of badgers equates to 
what is known as vaccine efficacy for infectivity (VEI). In the human field, it is not 
uncommon to find vaccines that, by helping to reduce pathology and clinical 
symptoms in vaccinated and subsequently infected individuals, achieve a reduction 
of the infectivity of these individuals and, as a consequence, a reduction in 
transmission in the general population. Vaccines against smallpox, varicella, rubella, 
measles, hepatitis B and whooping cough have been recognized as having an 
important VEI which contributes to the overall effect of these vaccines on the 
population (vaccinated and non-vaccinated), this overall effect being referred to as 
herd immunity (Fine et al., 1993; Halloran et al., 1999; Stephens et al., 2008). 
 
In addition, protection of badgers against M. bovis infection could also be achieved 
as a consequence of reduced susceptibility. A reduction in susceptibility against 
infection would have both a direct and an indirect effect in the general population, 
i.e. vaccinated individuals are less likely to become infected (direct effect) and 
therefore, non-infected badgers are less likely to become infected if surrounded by 
these less susceptible individuals (indirect effect). Although this type of protection 
was not observed in laboratory trials, a reduction in susceptibility could potentially 
be attained under natural conditions because the infective dose that badgers are 
exposed to in the field is likely to be much lower than that used in experimental trials 
(Corner et al., 2008; Lesellier et al., 2011). This type of protection is referred to as 
vaccine efficacy for susceptibility (VES). VES solely refers to the direct effect. 
Knowledge of both vaccine efficacies is important as overall transmission depends 
on both susceptibility and infectivity. However, methods to quantify transmission 
after vaccination have only been used in the last 20 years (Moerman et al., 1993; 
Stegeman et al., 1995; de Jong and Kimman, 1994). In 1994, de Jong and Kimman 
designed an experimental study that allowed quantification of the transmission 
observed in pigs vaccinated against pseudorabies virus. In subsequent experimental 
and field transmission studies, the effectiveness of vaccination was evaluated based 
on estimation of R(p) or the basic reproduction ratio as a function of the proportion 
of the population that is vaccinated (Moerman et al., 1993; Stegeman et al., 1995). 
R(p) is a crucial parameter to understand the impact of vaccination on population 
dynamics of M. bovis infection. If BCG vaccination is capable of reducing 
transmission between badgers, then estimates of the minimum vaccine coverage 
necessary to achieve eradication in badgers would be essential when designing an 
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eradication program, based on Diekmann et al. (1990). By examining R(p), the 
effects of combining vaccination with other control methods in the same or different 
species (e.g. the strategy of detection-and-removal of infected cattle from cattle 
herds) can be calculated. This is extremely important in the case of vaccination in 
badgers, as the ultimate goal is to help in the control or eradication of M. bovis 
infection in cattle. 
 
Aznar et al. (2011) presented a novel design of a badger vaccination trial and 
developed a methodology to estimate both VES and VEI as well as R(p) based on 
incidence data (i.e. new M. bovis infections). The trial design consisted of three 
badger populations vaccinated with different vaccination coverages as suggested by 
Longini et al. (1998), but taking into account that these vaccination coverages are 
achieved over time rather than instantaneously. Here, we present the results of this 
badger vaccine/placebo field trial. M. bovis transmission among badgers was 
quantified as well as the effects of vaccination on the susceptibility and infectivity 
of badgers. Based on these results, the impact of badger vaccination on the M. bovis 
eradication program in Ireland is reviewed.  
 
2. Material and methods 
2.1. Trial  
The badger vaccine field trial ran from 2009 until 2013. The trial area of 
approximately 750 square kilometres was divided into three zones north to south (A, 
B and C respectively) (see Figure 1). Using cages and stopped wire restraints, a 
capture–tag–release regime was established. Traps were fitted and left in the vicinity 
of every active sett for 10 days, with daily checks carried out by DAFM (Department 
of Agriculture, Food and the Marine) employees. After the 10 day period, traps were 
moved to different setts, taking approximately 23 weeks to cover the whole trial area 
(trappings occurring simultaneously in all three zones). Each 23 week period 
constituted a “sweep”. A total of 8 sweeps were carried out over the length of the 
trial (2 sweeps per year). The last two sweeps involving some badger removal to 
allow for post-mortem evaluations (in the study of Gormley et al. (2017), sweeps 7 
and 8 were combined and presented as sweep 7).  
 
At first capture, each badger was tattooed and microchipped, with blood samples 
being collected at first capture and every subsequent recapture (Gormley et al., 
2017). Vaccination with an oral BCG vaccine (Danish strain 1331, at a dose of 1 x 
108 cfu of BCG administered in the upper pharyngeal mucosa) suspended on a lipid 
formulation (Ancelet et al., 2012; Gormley et al., 2017) was applied randomly to 
50% of the badgers trapped in zone B and to all badgers trapped in zone C. All 
badgers in zone A and the remaining 50% of the badgers trapped in zone B received 
a placebo.  
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The Enfer chemiluminescent multiplex ELISA system (Whelan et al., 2008, 2010; 
Aznar et al., 2014) had been previously optimized to be used as the diagnostic test 
in this trial. The Enfer test optimization was conducted using data obtained from a 
population of 215 badgers trapped across 16 counties in Ireland (Murphy et al., 2010; 
Aznar et al., 2014). These badgers had been thoroughly examined and a large number 
of samples from tuberculous and non-tuberculous lesions were taken for culture 
(culture was used as the gold standard). Details about these badgers and culture 
methods are in Murphy et al. (2010). A study of factors affecting the statistical power 
of this design highlighted the importance of achieving close to 100% specificity in 
the diagnostic test used (Aznar et al., 2013). Therefore, the Enfer test was optimized 
to maximise sensitivity while retaining specificity at 99.99% in order to avoid loss 
of power that would arise from a number of false positive results randomly occurring 
in the mainly negative samples from both vaccinated and unvaccinated animals 
(Aznar et al., 2014). Test sensitivity did not play a major role in terms of study power, 
however, there was a need for consistent test performance among samples from all 
study animals throughout the trial period, including those vaccinated and not 
vaccinated. Many steps were taken to achieve this, including evaluating and 
comparing test results from vaccinated and non-vaccinated animals from 
experimental studies. Differences in terms of time to seroconversion were observed 
when the Enfer test was applied to vaccinated and non-vaccinated captive badger 
groups. As a result, a minimum time lag between two subsequent trappings of 215 
days for all pairs of trappings was recommended (Aznar et al., 2014). 
 
The trial was carried out under three licences issued by three different bodies: the 
Department of Health & Children (research licence, B100/3187), the Department of 
Agriculture, Food & the Marine (clinical trial licence, RL/08/06) and the Animal 
Research Ethics Committee of University College Dublin (ethics approval, AREC-
P-08-26).  
 
2.2 Datasets 
Two datasets were collected for analysis. The first consisted of data collected in the 
field (using handheld computers) by operators in charge of capturing and treating 
badgers in the trial area. This dataset contained information on 2,189 badger 
trappings (from the 1st of September 2009 to the 12th of July 2013). Data recorded 
on the handheld computers prior to the start of the trial and during the operator’s 
training period were discarded (133 trapping records). Information recorded at each 
of the trappings were: badger identification (ID) data (badger ID, microchip and 
tattoo numbers), badger’s sett ID, date of examination, presence of ectoparasites 
(ticks, fleas, lice) and injuries, demographic data (age, sex, weight), type of 
diagnostic samples taken (faecal swabs, blood samples, pharyngeal swabs, DNA 
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samples, others), vaccination data (date of vaccination, vaccine code), operator 
name, comments, trial zone (A, B or C), and sweep number (1-8). 
 
The second dataset, consisting of 1,800 records, contained diagnostic test 
information of blood samples taken each time a badger was trapped. Blood samples 
were tested using the Enfer multiple antigen ELISA system for detection of M. bovis 
antibodies (Enfer Scientific, Co. Kildare, Ireland). Antibody responses were 
expressed as relative light units (RLU) to a panel of 8 antigens: MPB83, MPB70, 
Rv3616c fragment and full protein, ESAT-6 and CFP10, as well as purified protein 
derivative from M. bovis (PPDb) and a peptide of MPB70. The optimization process 
is described in detail by Aznar et al. (2014). Blood samples were analysed twice with 
the Enfer test: first after the end of each sweep, and a second time after the vaccine 
trial had ended. When both sets of results were compared, low repeatability for two 
antigens (MPB70 and Rv3616c fragment) was observed. These two antigens were 
removed prior to the final test optimization. The optimization was carried out using 
the second set of test results and after removing the two mentioned antigens. For 
that, a stepwise logistic regression with analytical weights (to optimize specificity 
versus sensitivity) on the converted RLU obtained for the six remaining antigens was 
carried out (Aznar et al., 2014). By assessing the ROC curve for the model results, a 
cut off value equal to -1.95 was selected to achieve 99.99% (exact confidence 
interval: 97.34-100%) specificity and 25.33% (exact confidence interval: 20.80-
42.24%) sensitivity (exact intervals instead of confidence intervals were calculated 
as specificity was very close to 100%). Blood samples were classified as positive or 
negative based on this cut off value. 
 
2.3. Data collation  
The two datasets, containing capture and serology data were merged (1,759 trapping 
records). Data were collated to be analysed as a Bernoulli experiment. For that 
purpose, the full dataset was organized so that each entry contained information 
regarding two subsequent trappings of a single badger (vaccinated or non-
vaccinated) that tested negative at the initial trapping. The first entry for an 
individual badger was recorded the second time that a specific badger was trapped. 
A badger that tested negative at its second trapping could then initiate a new record 
in our dataset if trapped for a third time, and so forth. Each entry line contained 
information on: infection status of the badger at the initial and current trapping, 
current and previous examination date, sweep number and zone where the badger 
was trapped each time, whether the badger had been allocated to vaccine or placebo, 
and date of treatment. Once a badger was allocated to either vaccine or placebo, it 
remained as such for the rest of the study. Prior to the analysis, three variables were 
calculated from the data recorded in the handheld computers including: delta t (Δt) 
(i.e. time in days between two subsequent trappings of an individual badger), and 
prevalence (Prev) and fraction of infected vaccinated badgers (Fi; the fraction of the 
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total number of infected badgers that became infected after vaccination) at the 
beginning of Δt in the zone where the badger was trapped. A badger allocated to the 
vaccine treatment was considered vaccinated the day after receiving the vaccine. 
Therefore, as we knew whether the badger had been allocated to the vaccine or 
placebo treatment, a new variable Vaccine status (Vs) was created that coded 0 for 
badgers allocated to the placebo treatment (also for badgers allocated to the vaccine 
treatment on the first date of treatment) and 1 for vaccinated badgers trapped at least 
one day after they received the first vaccination. 
 
2.4. Statistical analysis 
The data collation, as well as the descriptive and statistical analyses, were carried 
out using Stata® (version 14; Stata Corp., College Station, TX, USA). As part of the 
descriptive analysis, crude transmission rate parameters (beta transmission 
parameters) were calculated as the number of new cases divided by number of 
susceptibles and prevalence in each sweep, for the three zones. In order to help in 
visualizing patterns, a non-parametric regression of the beta transmission parameters 
(lowess smoothing) was conducted. 
 
The purpose of the statistical analysis was to compare new infections occurring in 
vaccinated non-infected badgers to those occurring in non-vaccinated non-infected 
ones while taking account of both the infection pressure these badgers were exposed 
to and the trial zone (A, B or C) badgers had been trapped in (Aznar et al., 2011). 
Data on 440 pairs of trappings (subsequent trappings of individual badgers) were 
used in the statistical analysis. Only badgers that tested negative at the initial trapping 
were included. Badgers were coded either 1 or 0, respectively, depending on whether 
or not they tested positive at the subsequent trapping.  
 
Assuming “separable mixing”, whereby transmission depends only on the infectivity 
of the donor and the susceptibility of the receptor (Diekmann et al., 1990), the 
expected infection status of any uninfected re-trapped badger (vaccinated or non-
vaccinated), was modelled in the total population using a generalized linear model 
(GLM). With this model we aimed to explain new infections from three explanatory 
variables: a) the vaccination status of the badger, b) the fraction of infected 
vaccinated badgers, and c) the zone where the badger was trapped. Details of the 
statistical model are elaborated below. If vaccination is effective, then we would 
expect infectivity to vary both between the three zones and also over time due to 
differences in the fraction of infected badgers that were vaccinated. It is important 
to note that the percentage of vaccinated badgers increased over the duration of the 
trial in zones B and C (Figure 2). 
The expected number of cases per unit of time E(𝐶𝐶) can be formulated as E(𝐶𝐶)=S∙(1-
e-β∙∆t∙Prevt) where S is the number of susceptible badgers and (1 − 𝑒𝑒−𝛽𝛽∗𝐼𝐼∗
∆𝑡𝑡
𝑁𝑁) is the 
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probability that any of the susceptible badgers becomes infected (supplementary 
material, Section 1). Then the complementary log-log (cloglog) link function results 
in an estimate for log (β) taking ln(Prev*Δt) as offset (Aznar et al., 2011). This model 
was run separately for vaccinated and non-vaccinated badgers, allowing separation 
of the effects of vaccination in susceptibility and in infectivity as explained in 
derivations presented in Section 1 of the supplementary material. By separating these 
two effects, estimations of VES and VEI are possible. The model used was: 
𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 𝐸𝐸(𝐶𝐶) = 𝛽𝛽0 + 𝛽𝛽1,𝐵𝐵𝑍𝑍𝐵𝐵 + 𝛽𝛽1,𝐶𝐶𝑍𝑍𝐶𝐶 + 𝛽𝛽2𝑉𝑉𝑉𝑉 + 𝛽𝛽3 𝐹𝐹𝐹𝐹 + 𝑐𝑐𝑜𝑜𝑜𝑜𝑉𝑉𝑜𝑜𝑜𝑜 
where Z codes for zone (binary dummy variable 0/1 for each of the zones, zone A 
being the reference), Vs is the vaccination status of the recipient badger, Fi is the 
fraction of vaccinated badgers among the infected badgers at the beginning of the 
time interval in that same zone, and 𝛽𝛽0, 𝛽𝛽1,𝐵𝐵, 𝛽𝛽1,𝐶𝐶, 𝛽𝛽2, 𝛽𝛽3, are the regression 
coefficients as estimated by our model. For modelling purposes, once a badger tested 
positive to the serological test, it was considered positive for the rest of the study and 
therefore subsequent trappings of this badger were not included in the analysis. As 
the number of predictors in the maximum model was small, all possible 
combinations of predictors were examined (including interaction terms). The final 
model was selected based on the lowest value for the Akaike Information Criterion 
(AIC). 
 
From this model, four transmission parameters: βvv, βvu, βuv and βuu were estimated. 
The first sub-index in these transmission parameters indicates the vaccination status 
of the badger transmitting M. bovis (whether it is from a vaccinated (v) or non-
vaccinated badger (u)), while the second sub-index refers to the vaccination status 
of the recipient badger. The two vaccine efficacies and R(p) can then be calculated 
from these four transmission parameters (see Section 1 of the supplementary 
material). Using the regression coefficients from our model, the transmission rate 
parameters, ignoring zone effects, can then be estimated as: 
𝛽𝛽𝑢𝑢𝑢𝑢 = 𝑜𝑜
𝛽𝛽0+𝛽𝛽2, 𝛽𝛽𝑢𝑢𝑢𝑢 = 𝑜𝑜
𝛽𝛽0+𝛽𝛽2+𝛽𝛽3, 𝛽𝛽𝑢𝑢𝑢𝑢 = 𝑜𝑜
𝛽𝛽0 and  𝛽𝛽𝑢𝑢𝑢𝑢 = 𝑜𝑜
𝛽𝛽0+𝛽𝛽3     
 
Vaccine efficacies were calculated as: 
𝑉𝑉𝐸𝐸𝑠𝑠 = 1 −
𝛽𝛽𝑢𝑢𝑢𝑢
𝛽𝛽𝑢𝑢𝑢𝑢
= 1 −
𝛽𝛽𝑢𝑢𝑢𝑢
𝛽𝛽𝑢𝑢𝑢𝑢
= 1 − 𝑜𝑜𝛽𝛽2 and 𝑉𝑉𝐸𝐸𝐼𝐼 = 1 −
𝛽𝛽𝑢𝑢𝑢𝑢
𝛽𝛽𝑢𝑢𝑢𝑢
=  1 −
𝛽𝛽𝑢𝑢𝑢𝑢
𝛽𝛽𝑢𝑢𝑢𝑢
= 1 −  𝑜𝑜𝛽𝛽3 , 
noting that coefficient 𝛽𝛽2 calculated for the variable (𝑉𝑉𝑉𝑉) contributes to the 
estimation of 𝑉𝑉𝐸𝐸𝑠𝑠, and the coefficient 𝛽𝛽3 calculated for the variable (𝐹𝐹𝐹𝐹) contributes 
to the estimation of 𝑉𝑉𝐸𝐸𝐼𝐼 , thus being able to estimate both vaccine efficacies. The 
reproduction ratio as a function of the proportion (p) of badgers vaccinated R(p) was 
determined as: 
𝑅𝑅(𝑝𝑝) = (1 − 𝑝𝑝) ∙ 𝑅𝑅(0) +  𝑝𝑝 ∙ 𝑅𝑅(1) 
Where R(0)= 1
1-prevalence
 and R(1)=(1-𝑉𝑉𝐸𝐸𝑆𝑆) ∙ (1-𝑉𝑉𝐸𝐸𝐼𝐼) ∙ R(0) 
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3. Results 
3.1. Vaccine field trial descriptive analysis 
Overall, 1,093 badgers were trapped over the 8 sweeps, with 435 badgers trapped in 
zone A, and 243 and 415 in zones B and C, respectively. In total, 673 badgers were 
trapped once, 253 twice, 111 three times, 38 four times, 13 five times and 5 six times. 
An initial concern over the vaccine trial design was the fact that no major physical 
boundaries existed between the three zones. A large number of badger movements 
across the three zones could have hampered the vaccination gradient between the 
zones and therefore reduced the power of the analysis. Such a large movement was 
not expected, nonetheless we can confirm that it did not occur as only in 2% (22) of 
the subsequent trapping events had badgers originally trapped in one zone been 
trapped in a different zone at a later stage.  
 
The prevalence of M. bovis infection, estimated as the overall percentage of positive 
trappings to the Enfer test at each sweep, ranged between 12.5% and 37.8% (see 
Table S1 in Section 2 of the supplementary material). At the beginning of the trial, 
the zone prevalence (the percentage of positive trappings in each zone in sweep 1) 
was higher, but not statistically different, in zone A (31.7%) compared to zones B 
(19.0%) and C (23.5%) (p-value = 0.14). During the first year of the trial (that is, 
considering sweeps 1 and 2 together to avoid the effect of seasonality on trapping 
efforts), the prevalence was also highest in zone A (26.9%) compared to zones B and 
C (20% and 25.2%, respectively) but again, these differences were not statistically 
significant (p-value = 0.49). Due to a procedural error, blood results for 70 samples 
taken from badgers during sweep 2 were not available (see Section 4 of the 
supplementary material). The incidence of M. bovis infection per sweep, defined as 
the number of newly infected badgers (captured badgers that tested positive for the 
first time in sweep n) divided by the number of susceptible badgers (badgers trapped 
in sweep n that had never tested positive or tested positive for the first time in that 
sweep), varied over time and across zones, with the lowest incidence being in sweep 
5 in zone C (see Figure S1 in Section 2 of the supplementary material). In zones B 
and C, the proportion of BCG vaccinated badgers increased from sweep 3 to 6, then 
decreased in sweeps 7 and 8 (as the last sweeps involved badger removal) (Gormley 
et al., 2017). At sweep 6, the proportion of vaccinated badgers in zones B and C were 
37.3% and 62.2% respectively (Figure 2). 
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Figure 2. Total number of badgers caught at each sweep (left vertical axis) and percentage 
of captured badgers that were vaccinated (right vertical axis), including polynomial (n=4) 
smoothing of this percentage per sweep and zone (right vertical axis). 
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Crude transmission rate parameters in each sweep, for the three zones, and a lowess 
smoothing of the transmission parameters are presented in Figure 3. During the trial, 
there was a non-significant decrease in these crude transmission rate parameters in 
zones B and C. The possible change over time in crude transmission rate was less 
clear for zone A. However, the overall initial transmission (at sweep 3) in this zone 
(i.e. even before vaccination could have had an impact) was already lower compared 
to the other two zones (Figure 3). 
 
 
Figure 3. Crude transmission rate parameters (beta, in blue) and lowess smoothing (in red) 
per sweep estimated separately for the three trial zones. 
 
3.2. Statistical analysis 
The dataset consisted of 440 records (239 originated from non-vaccinated badgers 
and 201 from vaccinated badgers). A total of 55 (23.0%) and 40 (19.9%) new 
infections occurred in non-vaccinated and vaccinated badgers, respectively. 
Vaccination status of the badger receiving the vaccine was the only statistically 
significant explanatory variable in the model. Nonetheless, all variables (except the 
interaction terms) were kept in the final model as that was the model with the lowest 
AIC (490.2). Using the coefficient obtained for recipient vaccination status, we 
calculated vaccine efficacy for susceptibility, VES, as 59% (95% CI = 6.5-82%); that 
is, a 59% reduction in susceptibility of vaccinated compared to unvaccinated badgers 
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was achieved (see Table 1), but no significant effect of vaccination on infectivity 
was observed in this trial (hence VEI = 0%). 
 
Table 1. Results of the final generalized linear model including the estimated regression 
coefficient, p-value and 95% confidence interval for all explanatory variables (fraction of 
infected vaccinated badgers, vaccination status and zone) and constant in a model fitted in 
data from all three zones of the Irish badger vaccine field trial. Only Vs, the vaccination status 
of the recipient, is significant, with the other variables retained to control for confounding. 
 
Variable    Coef   p-Value   (95% CI) 
Constant   -6.07   <0.001   -6.38 to -5.77 
Zone       
A  Reference 
B  0.55  0.083  -0.07 to 1.17 
C  0.63  0.193  -0.32 to 1.58 
Vs  -0.90  0.034  -1.73 to -0.07 
Fi  1.37  0.119  -0.35 to 3.10 
 
In addition to the main model, two more statistical analyses were conducted. As Zone 
B resembles the classic 50:50 vaccine-placebo trial design (but with a change in 
vaccination coverage over time and the availability of longitudinal data on infection), 
estimation of the direct effect of vaccination on susceptibility was possible in this 
zone only. The model showed a similar outcome for VES (54%, 95% CI = 0.0-79.9%) 
(see Table S2 in Section 3 of the supplementary material). A lower initial crude beta 
transmission parameter was observed in zone A compared to zones B and C (Figure 
3), for reasons that are not clear. Due to this lower initial transmission parameter 
observed in zone A, and as our design only required a minimum of two populations 
vaccinated at different vaccination coverages, the model was run again using data 
from zones B and C only. Similar results were obtained in terms of both the effect 
of vaccination on susceptibility and infectivity, with VES = 60% (95% CI = 8.8-
83.0%) and no significant effect of vaccination on infectivity (VEI = 0%) (see Table 
S3 in Section 3 of the supplementary material). 
 
We finalized our analyses by estimating R(p) for a range of vaccine coverages, as it 
is the impact of the combination of both vaccine efficacies that determines the 
feasibility of using vaccination as a strategy to achieve M. bovis eradication in 
badgers. The average M. bovis prevalence in badgers in Ireland declined between 
2007 to 2013, with an average prevalence from May 2007 to May 2011 equal to 
17.7%, and from June 2011 to April 2013 equal to 9.9% (Byrne et al., 2015). For 
any population where an infection is at the endemic steady state, the fraction of 
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susceptible individuals equals 1/R. Thus, for a badger prevalence equal to 18%, we 
can calculate R(0) = 1
1-prevalence
 = 1.22, and for a prevalence equal to 10%, 
R(0) = 1.11. As VES = 59% and using the higher prevalence estimate (18%), the 
reproduction ratio for a fully vaccinated population can be calculated as R(1) =  (1-
𝑉𝑉𝑉𝑉𝑆𝑆)*R(0) = 0.50. These results indicate that adding vaccination to the current 
control strategies in Ireland, eradication of M. bovis infection in badgers can be 
achieved with any vaccination coverage above 30% (Figure 4). 
 
 
Figure 4. Basic reproduction ratio for badger to badger transmission as function of 
vaccination coverage, given R(0) = 1.22 and a VES = 59%. 
 
4. Discussion 
In this manuscript, the effect of BCG vaccination on M. bovis transmission between 
badgers in the field has been quantified for the first time. Here, separate estimates on 
the effects of vaccination on both protection against infection and on the infectivity 
of badgers that become infected subsequent to vaccination are presented. The 
vaccine efficacy estimates presented in this paper contribute to a better 
understanding of the biological processes underpinning the protection against 
transmission achieved by BCG vaccination in the field. While no direct protection 
against infection following vaccination was reported in experimental trials (where 
vaccinated badgers were challenged with different doses and different strains of M. 
bovis) (Corner et al., 2008, 2010), we observed a 59% protection against infection 
of vaccinated badgers in the field. The difference between our findings and those 
obtained in laboratory trials is not surprising, as the route of infection, infection dose, 
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number of infection events to achieve this dose, etc occurring in the wild are 
unknown. Nonetheless, we cannot confirm whether or not the observed protection 
against infection is due to a lower infection dose in the wild compared to 
experimental trials (Corner et al., 2008, Lesellier et al., 2011). A reduction in the 
total infectivity of vaccinated and subsequently infected badgers in the field had been 
anticipated based on the reduction in disease progression observed in vaccinated 
compared to non-vaccinated badgers in experimental studies (Chambers et al., 2011). 
However, no reduction of infectivity was found in our study. The lack of effect of 
BCG vaccination on infectivity in the general badger population is thus at odds with 
the hypothesis that vaccination, by reducing disease progression, reduces the 
infectivity of vaccinated and subsequently infected badgers. From this study, we 
cannot determine whether a similar reduction in disease progression to that observed 
in experimental studies was found in the field as no post-mortem data were available. 
Nevertheless, if that reduction in disease progression does exist, we did not find a 
concurrent reduction in infectivity. The lack of effect of vaccination on infectivity 
has implications in terms of the effectiveness of BCG badger vaccination in Ireland 
(or how much reduction of transmission is achieved by vaccination). The 
effectiveness of a vaccination programme is the result of both the effect of 
vaccination on susceptibility and infectivity. Here, as there is no added reduction in 
transmission due to a reduction in infectivity (one type of indirect effect of 
vaccination), the total reduction in transmission or effectiveness achieved by 
vaccination is equal to VES.  
 
Once the effectiveness of BCG vaccination was calculated, in order to assess its 
impact, it was necessary to estimate the ongoing badger to badger transmission. The 
reproduction ratio for badger to badger transmission under the current control 
options in Ireland was calculated as 1.22 assuming a badger prevalence of 18%. 
Based on surveillance data collected from badgers culled as part of an interim badger 
culling regime in Ireland during 2007 to 2013, an average national prevalence of 
14.1% was estimated (Byrne et al., 2015). However, this includes two partial 
prevalence estimates (17.7% for May 2007 to May 2011, and 9.9% for June 2011 to 
April 2013), noting that differing methods were used during these periods to 
differentiate M. bovis from non-tuberculous mycobacteria (biochemical tests to May 
2011, and PCR techniques subsequently). In this paper, we used 18% as a 
conservative prevalence estimate. The formulae used for calculating R(0) is a basic 
formulae used to assess transmission in badgers assuming that there is no 
transmission between cattle and badgers. Although this is likely not the case, we can 
use this number as an approximation, and conclude that if we were to vaccinate all 
badgers in Ireland, we would be able to reduce transmission by 59%, with the 
resulting R(1) = 0.5, which is substantially below 1 indicating that eradication in 
badgers would be feasible. Further and by estimating R(p) or the reproduction ratio 
for a range of vaccine coverages (p), we were able to assess what was the minimum 
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vaccination coverage necessary to eradicate. The most relevant finding in this 
manuscript was that in Ireland, vaccination of badgers with a vaccination coverage 
equal to or higher than 30% is sufficient to eradicate M. bovis infection in badgers, 
as long as current control strategies also remain in place in both cattle and badgers. 
The outcomes of this study will have major implications for the control of M. bovis 
infection in Ireland, not only in badgers but also in cattle. It is important to note that 
if any or some of the control strategies currently in place have an effect on badger to 
badger transmission, then modifications to any strategy would have repercussions 
on the effectiveness of the badger vaccination programme (as the reproduction ratio 
for badger to badger transmission would change also). For similar reasons, it is not 
possible to predict the effectiveness of BCG vaccination in badgers in a different 
country, with different transmission characteristics between badgers. 
 
In this study the infection status of individual badgers was determined by whether or 
not these badgers tested positive to the Enfer test. Table S1 shows the prevalence of 
infection as measured by this test. Prevalence values varied between sweeps and 
zones with prevalence in sweep 2 in zone 1 being much lower (12.5%) than that 
observed in the same zone in sweep 1 (31.7%). The second lowest prevalence 
observed in the whole study was in zone C in sweep 5 (16.3%) with the rest being 
between 20.0-37.8%. We are not aware of any specific reasons why these prevalence 
values changed and we assume that these differences are due to randomness. 
Tuberculosis is a chronic disease with latent and reactivation periods and with 
serology varying through the different disease stages. If the badger population in the 
trial differed in terms of disease profile from the 215 badgers in which the test was 
optimized (i.e. a larger proportion of badgers in a chronic phase in the field trial), the 
sensitivity of the Enfer test in the trial could be higher or lower than the 25.3% 
achieved during test optimization. Indeed, prevalence estimates very much depend 
on the representativeness of the gold standard panel for the population tested as there 
is not yet a gold standard test for M. bovis infection in badgers. In a previous study 
where factors affecting study power were explored, it was shown how high test 
specificity was paramount (Aznar et al., 2013). Test sensitivity did not play an 
important role in our ability to detect an effect if BCG vaccination really worked. 
The fact that we found an effect (VES= 59%) suggests that both sensitivity and 
specificity were sufficiently large and did not affect the study power. The low 
sensitivity of the test used will also have an effect on incidence and prevalence values 
and therefore on the beta transmission parameter. We note, however, that the aim of 
this paper was not to provide true values for these parameters, but rather to use them 
to estimate VE(s) by comparing them in the vaccinated and non-vaccinated groups.  
Badger capture data from this vaccine trial has been previously analysed (Gormley 
et al., 2017). Two vaccine efficacies were reported from this earlier analysis, one for 
badgers enrolled during sweeps 1 and 2 (VE = 36%) and other for badgers enrolled 
during sweeps 3 to 6 (VE = 84%). In that study the direct effect of vaccination was 
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estimated by comparing hazard rates of badgers trapped in zone A (0% vaccination 
coverage) to that of badgers trapped in zone C (100% vaccination coverage). In 
addition to the different serological tests used in both studies (incidence in badgers 
was measured with the BrockTB Stat-Pak lateral flow serology test, (Chambers et 
al., 2008)), the methodology in which badgers were enrolled for the analysis and the 
statistical methods used to compute VE estimates were also different. Data from zone 
B were not used in the prior analysis, despite badgers from this zone being the ideal 
population for measuring the direct effect (as vaccinated and non-vaccinated badgers 
would have been exposed to the same infection pressure). 
 
In a badger vaccine field trial carried out in the UK (Carter et al., 2012), badger setts 
(rather than individual badgers) were allocated to either vaccine or placebo. From 
that field study, estimates of the direct effect of BCG vaccination on susceptibility 
in badgers have been reported with two estimates depending on the diagnostic tests 
used: VES = 54% (95% CI = 12-74%) for the more sensitive test (described as “triple 
testV”) and VES = 76% (95% CI = 48-89% for the less sensitive test (“dual test”). 
Nonetheless due to the study design of choice, separation of the effects of 
vaccination in susceptibility and infectivity was not possible in either Gormley et al. 
(2017) or Carter et al. (2012), leading to two biases in the estimate of VES. Firstly, 
the indirect effect of BCG vaccination is included in the estimate of VES (although 
this estimate should only reflect the direct effect of vaccination), and secondly, if the 
infectivity of vaccinated and non-vaccinated badgers differs, then this difference in 
infectivity has to be taken into account also when estimating VES. In hindsight, and 
based on our results, we now know that such a difference does not exist (VEI = 0 as 
the coefficient for Fi was not statistically significant). Nonetheless, it is important 
that this issue is highlighted so it can be considered in the design of future vaccine 
field trials. 
 
A reduction in M. bovis incidence in cubs from vaccinated setts compared to those 
from non-vaccinated setts was also observed in Carter et al. (2012). In that study, the 
observed reduction in incidence in cubs is reported as an indirect effect of 
vaccination. However, it is not possible to distinguish whether this reduction in 
incidence is due to the indirect effect achieved by a reduction in susceptibility or to 
a reduction in the infectivity of vaccinated infected badgers compared to non-
vaccinated infected ones. Based on our results, the reduction in incidence among 
cubs was likely due to a reduction in susceptibility of the vaccinated adult badgers 
in the sett.  
 
5. Conclusion 
In summary, we have presented a new methodology to estimate both VES and VEI 
providing further knowledge on the biological ways in which BCG vaccination 
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works in badgers. We have also presented scientific arguments that support the 
crucial role of appropriate trial design in order to obtain accurate estimates. Further, 
we have estimated the impact of vaccination in the current badger transmission 
Ireland and concluded that a minimum vaccination coverage of 30% is necessary to 
achieve eradication of M. bovis infection in badgers. As a result of this work, policy 
makers can now make informed decisions concerning the best strategy or 
combination of strategies to achieve eradication. These results could also be used to 
guide the best vaccination route to achieve the minimum vaccine coverage needed. 
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Quantification of Mycobacterium bovis transmission in a badger vaccine field 
trial 
Supplementary material 
- 1. Initial derivations and model building  
The derivations to support the estimations of the transmission parameters have 
already been published (12). In summary, and before considering vaccination, we 
showed how the number of new infections among all susceptible badgers (C) at the 
end of the time interval between two sweeps can be modelled using a binomial 
distribution with parameters S and p (where S is the number of susceptible badgers 
at the beginning of the time interval and 𝑝𝑝 = (1 − 𝑒𝑒−𝛽𝛽∗𝐼𝐼∗
∆𝑡𝑡
𝑁𝑁) is the probability that 
each of these badgers will become infected during that time interval). The expected 
number of new cases is then equal to: 
𝐸𝐸(𝐶𝐶) = 𝑆𝑆 ∗ (1 − 𝑒𝑒−𝛽𝛽∗𝐼𝐼∗
∆𝑡𝑡
𝑁𝑁 ) 
 
Then, as the number of new cases among susceptibles (C) can be obtained through 
serology, the transmission parameter β could be estimated by using a Generalized 
Linear Model (GLM) with a complementary-log-log link function, a binomial error 
function, with binomial total S and offset 𝑙𝑙𝑙𝑙 (𝐼𝐼 ∗ ∆𝑡𝑡
𝑁𝑁
). 
 
We followed then by deriving new formulae that took into account vaccination, 
showing how the number of new infections among susceptibles at the end of each 
sweep could be estimated separately for vaccinated and non-vaccinated badgers as: 
𝐸𝐸(𝐶𝐶𝑉𝑉) = 𝑆𝑆 ∗ (1 − 𝑒𝑒
−𝑒𝑒𝑘𝑘0+𝑘𝑘1∗𝐹𝐹1∗𝑃𝑃𝑃𝑃𝑒𝑒𝑃𝑃∗∆𝑡𝑡) 
(where βUV =Exp[k0] and βVV=Exp[k0+k1]) and 
𝐸𝐸(𝐶𝐶𝑈𝑈) = 𝑆𝑆 ∗ (1 − 𝑒𝑒
−𝑒𝑒𝑘𝑘0+𝑘𝑘1∗𝐹𝐹1∗𝑃𝑃𝑃𝑃𝑒𝑒𝑃𝑃∗∆𝑡𝑡) 
(where βUU=Exp[k0] and βVU=Exp[k0+k1]), respectively. 
Prev being the prevalence (I/N) and Fi the fraction of infected vaccinated badgers in 
the zone where the badger was trapped at the beginning of the time interval. Here, 
as CV and CU are known, all four betas can be calculated by using a GLM similar to 
the one described above. 
 
In this paper, by assuming separable mixing (and as the vaccination status of each 
individual badger is available), we can then modify the GLM model introducing 
vaccination status of the recipient also as one of the explanatory variables allowing 
us to estimate all the transmission rate parameters from the total population: 
𝑐𝑐𝑙𝑙𝑐𝑐𝑐𝑐𝑙𝑙𝑐𝑐𝑐𝑐 (𝐶𝐶) = 𝛽𝛽0 + 𝛽𝛽1,𝐵𝐵𝑍𝑍𝐵𝐵 + 𝛽𝛽1,𝐶𝐶𝑍𝑍𝐶𝐶 + 𝛽𝛽2𝑉𝑉𝑉𝑉 + 𝛽𝛽3𝐹𝐹𝐹𝐹  
A manual model building was carried out to select the final model; as the number of 
predictors in the maximum model was small, all possible combination of predictors 
were examined. The model including all three predictors: zone, vaccination status 
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and fraction of infected vaccinated badgers was selected based on the lowest AIC 
(AIC = 490.2). 
 
- 2. Descriptive results 
Table S1. Number and percentage of positive trappings to the Enfer 
chemiluminescent multiplex ELISA at each sweep, overall and by zone. 
 
 
 
 
Figure S1. Incidence per sweep (estimated as number of new cases divided by the 
total number of susceptible badgers per sweep) and exact confident intervals (95% 
CI) presented by trial zone. 
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3. Supporting modelling exercises 
Table S2. Generalized Linear Model results showing coefficient, p-value and 95% 
confidence interval for the explanatory variable (vaccination status) and constant 
when the model was fitted in data from zone B only. 
 
Variable   Coef   p-Value   (95% CI) 
Constant  -5.97  <0.001  -5.97 to -4.90 
Vs   -0.79   0.059   -1.60 to -0.03 
 
Table S3. Generalized Linear Model results showing coefficient, p-value and 95% 
confidence interval for all three explanatory variables (and constant): zone, 
vaccination status and the fraction of infected vaccinated badgers when the model 
was fitted in data from zones B and C only. 
 
Variable    Coef   p-Value   (95% CI) 
Constant   -5.55   <0.001   -6.09 to -5.00 
Zone       
B  Reference 
C  0.78  0.832  -0.64 to 0.79 
Vs  -0.92  0.029  -1.76 to -0.09 
Fi  1.67  0.065  -0.11 to 3.45 
 
- 4. Supplementary note on omitted data 
On reconciliation of project databases at the completion of the trial, it was noted that 
70 samples had not been tested by Enfer, due to a procedural error. These samples 
belonged to badgers that had been trapped in sweep 2 and were either trapped in 
sweep 1 or later on at subsequent sweeps. The samples were equally distributed 
between all three zones. The samples were also equally distributed in terms of 
vaccination status of the badger they belonged to. The missing samples represented 
between 9.0% and 10.7% of our entries for statistical analysis (depending on the 
infection status). The reduction in power was not considered to be a major constraint 
as the statistical analysis, in the absence of these 70 samples, showed significant 
results for VES. Additionally, even with the inclusion of these 70 samples, the 
estimates of VEI would never be significantly above zero. 
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Abstract 
 
In Ireland, in spite of a comprehensive control/eradication programme for 
Mycobacterium bovis, tuberculosis in cattle (bTB) has remained endemic in cattle at 
a low prevalence for the last 20 years. Badgers (Meles meles) are considered to be 
the main wildlife reservoir for M. bovis infection in Ireland and Great Britain. In 
order to select strategies that allow eradication of the infection in cattle, knowledge 
of the quantitative role of each of these two host species in the transmission of M. 
bovis is essential. Here, we derive algorithms that show how the Next Generation 
Matrix (NGM) and the reproduction ratio (𝑅𝑅) for the cattle-badger system can be 
calculated from prevalence data and the number of cattle herds and badgers, 
collected at the endemic steady state. By exploring the system at the endemic 
equilibrium, we can set bounds for the possible transmission scenarios between cattle 
and badgers in Ireland and demonstrate that for almost all these scenarios (except 
when all or almost all infection in cattle is solely caused by cattle), BCG vaccination 
of badgers in addition to current controls could successfully achieve eradication of 
M. bovis infection in the system. 
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1. Introduction 
 
Many animal pathogens are able to infect multiple hosts. This ability has been shown 
to be associated with a larger risk of disease emergence in humans (Haydon, 2002). 
In Ireland, Mycobacterium bovis, the infectious agent causing bovine tuberculosis 
(bTB) in cattle and other bovids, is a good example of a multi-host pathogen with at 
least one other main reservoir of infection, the Eurasian badger (Meles meles). M. 
bovis infection in humans, which are considered to be a spill-over host (Gormley and 
Corner, 2013), is uncommon in Ireland (2.5% of the culture isolates from all 
tuberculosis diagnoses) as a result of disease controls in cattle and other public health 
measures (FSAI, 2017). Most cases of M. bovis infection in humans are linked to 
infection in cattle either following consumption of unpasteurized milk and milk 
products or, less likely, following direct contact with infected animals (FSAI, 2017). 
A sound understanding of the dynamics of M. bovis in the two main reservoirs (cattle 
and badgers) is critical, to address public health concerns, and to reduce the 
economic burden on farmers and other members of society of ongoing measures to 
control and eradicate the infection in cattle. 
 
Estimating transmission parameters can help in predicting population dynamics. One 
important parameter is the basic reproduction ratio, 𝑅𝑅0, which is defined as the 
average number of new cases caused by one typical infectious individual in a totally 
susceptible population. 𝑅𝑅, or reproduction ratio when the population might not be 
fully susceptible, is a very important parameter in population dynamics of infectious 
diseases as it can be used to summarise dynamic behaviour of an infection in a host 
population with just one single value (Kermack and McKendrick, 1927; Diekmann 
et al., 1990, 2010; Fulford et al., 2002). An epidemic can only be sustained if  𝑅𝑅 > 1, 
therefore the efficacy of control measures can be assessed based on whether or not 
they are capable of reducing 𝑅𝑅 below one. 
In a single host system 𝑅𝑅  for the system can be estimated, by observing the endemic 
steady state, as the inverse of the fraction of susceptible hosts (𝑅𝑅 = N/𝑆𝑆∗) (Keeling 
and Rohani, 2008 for a textbook explanation). Note that an asterisk is used to denote 
parameters at the endemic equilibrium. In the case of a homogeneous population 
consisting of multiple hosts, 𝑅𝑅 can still be calculated by adding the number of 
susceptibles of each host type at the endemic equilibrium and dividing this number 
by the total population. However, this calculation is not applicable when some form 
of heterogeneity (either in infectivity or susceptibility) exists between the hosts. In 
such situations, 𝑅𝑅 estimations are more challenging. 
 
One way of estimating 𝑅𝑅 for the cattle-badger system would be to build a Next 
Generation Matrix (NGM), a concept explained originally by Diekmann et al. 
(1990), and further referred by other authors (Fulford et al., 2002; Heesterbeek and 
Roberts, 1995; Heesterbeek, 2000), which defines the dynamics of bTB in this 
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system. 𝑅𝑅 can then be determined mathematically as the dominant eigenvalue of this 
NGM. We could design a 2 x 2 NGM (𝑲𝑲) made of four terms: 𝑲𝑲𝑐𝑐𝑐𝑐, 𝑲𝑲𝑏𝑏𝑐𝑐, 𝑲𝑲𝑐𝑐𝑏𝑏 and 𝑲𝑲𝑏𝑏𝑏𝑏. 
Each of the four terms of this matrix being a matrix in itself that describes 
transmission between/within host species, with indices “c” and “b” referring to the 
host species cattle and badgers, respectively, and the direction of the transmission 
determined by the location of these indices; i.e. 𝑲𝑲𝑏𝑏𝑐𝑐 is the matrix that describes the 
transmission of M. bovis from badgers to cattle. Then, 𝑅𝑅  for the system is the 
dominant eigenvalue of 𝑲𝑲. 
 
A disadvantage of this approach concerns parameterization of the models that define 
each of these matrices. Estimating interspecies transmission rates between cattle and 
badgers has never been described, resulting in the introduction of uncertainty in final 
model outputs (Godfray et al., 2013). Then again, computation of the NGM for the 
endemic steady state for the two species can also be done directly if specific 
assumptions are made regarding the relative transmission between/within these two 
host types. The NGM that defines transmission in the cattle-badger system in Ireland 
can be easily estimated when assuming no interspecies transmission (to be called 
disjunct mixing). In this case, both 𝑅𝑅𝑏𝑏𝑐𝑐 (dominant eigenvalue of 𝑲𝑲𝑏𝑏𝑐𝑐) and 𝑅𝑅𝑐𝑐𝑏𝑏 
(dominant eigenvalue of 𝑲𝑲𝑐𝑐𝑏𝑏) will be equal to 0, with the intraspecies transmission 
rates being estimated independently from each of the species prevalence 
respectively. 𝑅𝑅 for the system is then equal to the largest real value of either 𝑅𝑅𝑐𝑐𝑐𝑐  
(dominant eigenvalue of 𝑲𝑲𝑐𝑐𝑐𝑐) or 𝑅𝑅𝑏𝑏𝑏𝑏 (dominant eigenvalue of 𝑲𝑲𝑏𝑏𝑏𝑏). It is more 
difficult though to estimate the NGM in a situation where cattle and badgers do 
interact to some extent. 
 
In this paper, by exploring the cattle-badger system at the endemic equilibrium, we 
have set the theoretical bounds that frame all plausible transmission scenarios in this 
system: i.e. all possible NGMs given the observed endemic steady state data for 
Ireland. Then, based on the arguments presented, we have estimated three extreme 
NGMs that are the nodes of a transmission matrix triangle that contains all possible 
transmission scenarios (NGMs) for M. bovis in Ireland. Aside, we have derived new 
equations that allow estimation of any NGM under the assumption of separable 
mixing and also showed how series of NGMs that do not follow this assumption can 
be calculated. We have illustrated this by calculating several plausible NGMs that 
assume different types of interaction between the two species. All derived equations 
only require knowledge of endemic prevalence data and total number of individuals 
in each of the species. The effect on 𝑅𝑅 achieved by BCG badger vaccination is 
estimated in all plausible transmission scenarios; a small number of unlikely 
transmission scenarios where additional badger control measures cannot achieve 
eradication of M. bovis from the system are explained. Finally, the impact of adding 
badger vaccination to the current M. bovis eradication strategy in Ireland is 
discussed.  
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2. Results and discussion 
 
Theoretical boundaries  
By observing the characteristics of matrices at the endemic steady state and taking 
into account biological properties of the cattle and badger system in Ireland, we have 
set the theoretical boundaries for all plausible Jacobian matrices (𝑀𝑀′) in the endemic 
steady state, and subsequently for all NGMs at the disease free equilibrium (𝑁𝑁𝑁𝑁𝑀𝑀), 
that could describe transmission in this system. At the endemic equilibrium, all 
plausible 𝑀𝑀′s that could describe this transmission will have a maximum eigenvalue 
equal to 1 (i.e. the reproduction ratio at the endemic equilibrium or dominant 
eigenvalue is 1) and will share a unique eigenvector (𝑒𝑒). This eigenvector e is 
observed at the endemic equilibrium as the relative frequency of cattle and badgers 
among the infected individuals. So for all 𝑀𝑀′s: 
𝑀𝑀′ ∗ 𝑒𝑒 = 𝑒𝑒 ∗ 𝟏𝟏 = 𝑒𝑒 
Because of the biological interpretation, it follows that 𝑀𝑀′ matrices can only have 
non-negative elements (E), so for a matrix: 
𝑀𝑀′ = (
𝐸𝐸𝑐𝑐𝑐𝑐
′ 𝐸𝐸𝑏𝑏𝑐𝑐
′
𝐸𝐸𝑐𝑐𝑏𝑏
′ 𝐸𝐸𝑏𝑏𝑏𝑏
′ ), then 𝐸𝐸𝑐𝑐𝑐𝑐′ , 𝐸𝐸𝑏𝑏𝑐𝑐′ , 𝐸𝐸𝑐𝑐𝑏𝑏′ , and 𝐸𝐸𝑏𝑏𝑏𝑏′   0, 
where 𝐸𝐸𝑐𝑐𝑐𝑐′  is the endemic transmission for cattle herd to cattle herd, 𝐸𝐸𝑏𝑏𝑐𝑐′  is the endemic 
transmission for badger to cattle herd, 𝐸𝐸𝑐𝑐𝑏𝑏′  is the endemic transmission for cattle herd 
to badger and 𝐸𝐸𝑏𝑏𝑏𝑏′  the endemic transmission for badger to badger.  
 
In the cattle-badger system, the prevalence of M. bovis infection in cattle herds and 
badgers are >0 indicating that at least one element on each row of the matrix that 
describes this transmission is >0. Therefore, all plausible matrices in the cattle-
badger system will be bounded by matrices with two elements equal to 0, as 0 is the 
minimum value that the other two elements can take. Although there are 6 possible 
combinations for a 2x2 matrix with two elements equal to 0, three of these 
combinations are not biologically plausible. As cattle herds are infected, the infection 
must have originated either from other cattle herds (𝐸𝐸𝑐𝑐𝑐𝑐′ > 0) or from badgers (𝐸𝐸𝑏𝑏𝑐𝑐′ >
0) implying that a matrix of the type 𝑀𝑀′ = ( 0 0
𝐸𝐸𝑐𝑐𝑏𝑏
′ 𝐸𝐸𝑏𝑏𝑏𝑏
′ ) is not plausible. Following the 
same logic for badgers, we can conclude that a matrix of the type 𝑀𝑀′ = (𝐸𝐸𝑐𝑐𝑐𝑐
′ 𝐸𝐸𝑏𝑏𝑐𝑐
′
0 0
) is 
not plausible either. Further the possibility that cattle herds do not infect other cattle 
herds and badgers do not infect other badgers is not considered biologically valid: 
i.e.  𝑀𝑀′ = ( 0 𝐸𝐸𝑏𝑏𝑐𝑐
′
𝐸𝐸𝑐𝑐𝑏𝑏
′ 0
) is not a valid matrix. Thus, there are three possible 𝑀𝑀′s that 
bound all plausible transmission scenarios for the cattle-badger system: 𝑀𝑀′ =
(
𝐸𝐸𝑐𝑐𝑐𝑐
′ 0
0 𝐸𝐸𝑏𝑏𝑏𝑏
′ ) , 𝑀𝑀
′ = (
𝐸𝐸𝑐𝑐𝑐𝑐
′ 0
𝐸𝐸𝑐𝑐𝑏𝑏
′ 0
), and 𝑀𝑀′ = (0 𝐸𝐸𝑏𝑏𝑐𝑐
′
0 𝐸𝐸𝑏𝑏𝑏𝑏
′ ). As 𝑀𝑀′ ∗ 𝑒𝑒 = 𝑒𝑒, given two known 
matrix elements, the other two elements can be ascertained (as this relationship 
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yields two equations and only two unknowns). To move from these Jacobian 
matrices 𝑀𝑀′s estimated at the endemic equilibrium to the NGMs estimated at disease 
free equilibrium, these three matrices need to be adjusted to account for the fact that 
at the disease free equilibrium the total population is susceptible. The elements of 
these matrices, when divided by the fraction of susceptible, will become the partial 
reproduction ratios estimated at the endemic equilibrium: 𝑅𝑅𝑐𝑐𝑐𝑐′ , 𝑅𝑅𝑐𝑐𝑐𝑐′ , 𝑅𝑅𝑐𝑐𝑐𝑐′  𝑎𝑎𝑎𝑎𝑎𝑎 𝑅𝑅𝑐𝑐𝑐𝑐′ . 
These matrices will also have to be adjusted to reflect the right distribution of the 
different host types, with the resultant matrices being made of the partial 
reproduction ratios estimated at the disease free equilibrium: 𝑅𝑅𝑐𝑐𝑐𝑐, 𝑅𝑅𝑐𝑐𝑐𝑐, 𝑅𝑅𝑐𝑐𝑐𝑐 and 𝑅𝑅𝑐𝑐𝑐𝑐. 
The methodology to do these corrections is presented in section 3.2.2. 
 
The three resultant NGMs calculated in this way can be represented then as the 
vertices of a triangle placed on a plane, with these three vertices, the lines connecting 
these vertices and the area within the triangle representing all possible NGMs in the 
cattle-badger system in Ireland (Figure 1).  
 
In this triangle, the NGM obtained when no interspecies interaction is assumed 
(disjunct mixing) or 𝑁𝑁𝑁𝑁𝑀𝑀 = (𝑅𝑅𝑐𝑐𝑐𝑐 0
0 𝑅𝑅𝑐𝑐𝑐𝑐
), bounds inter-species transmission at the 
lower end with 𝑅𝑅𝑐𝑐𝑐𝑐 = 𝑅𝑅𝑐𝑐𝑐𝑐 = 0 and is presented as node 1 in the transmission triangle 
(Figure 1). The other two matrices represent transmission scenarios where the 
infection is solely originated from either cattle (𝑁𝑁𝑁𝑁𝑀𝑀 = (𝑅𝑅𝑐𝑐𝑐𝑐 0
𝑅𝑅𝑐𝑐𝑐𝑐 0
)) or badgers 
(𝑁𝑁𝑁𝑁𝑀𝑀 = (
0 𝑅𝑅𝑐𝑐𝑐𝑐
0 𝑅𝑅𝑐𝑐𝑐𝑐
)) and are shown as nodes 2 and 3, respectively, in the transmission 
triangle. From node 1, two lines, one towards node 2 and one towards node 3 can be 
drawn. These two connecting lines between the three nodes will consist of NGMs 
that have one element equal to 0, i.e. the NGMs on the line between node 1 and node 
2 will be of the form (𝑅𝑅𝑐𝑐𝑐𝑐 0
𝑅𝑅𝑐𝑐𝑐𝑐 𝑅𝑅𝑐𝑐𝑐𝑐
) while the NGMs on the line between node 1 and 3 
will be of the form (𝑅𝑅𝑐𝑐𝑐𝑐 𝑅𝑅𝑐𝑐𝑐𝑐
0 𝑅𝑅𝑐𝑐𝑐𝑐
). These two lines bound the space of possible NGMs 
as the 0 element would become negative beyond these lines (see Figure 1). 
 
If we assume that infectivity and susceptibility intraspecies is always larger than the 
infectivity and susceptibility interspecies, we can define the third line of the triangle 
(line that joins nodes 2 and 3) as a line made of NGMs under the separable mixing 
scenario. In this line, many combinations of susceptibility and infectivity are 
possible, with nodes 2 and 3 representing transmission scenarios with maximum 
infectivity of cattle and badgers respectively. It is important to note that although the 
interspecies susceptibility and infectivity at this line will never be larger than that of 
the intraspecies, some of the susceptibility-infectivity combinations could result in 
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NGMs where the interspecies transmission parameter is larger than the intraspecies 
equivalent.  
 
The two axes of the plane where the transmission triangle lies are therefore: 
y-axis: a vertical axis measuring the relative contribution of cattle to the total number 
of infections in the system. This axis has a scale from 0 to 1 based on the formula: 
𝑅𝑅𝑐𝑐𝑐𝑐/(𝑅𝑅𝑐𝑐𝑐𝑐 + 𝑅𝑅𝑏𝑏𝑏𝑏), and x-axis: a horizontal axis that indicates the level of interaction 
between the two species. This axis is also measured from 0 to 1, with 0 indicating 
maximal interaction (separable mixing) and 1 none. The level of interaction will be 
measured by x. In order to scale the axis from 0 to 1, the interspecies endemic 
transmission parameters will be multiplied by (1-x) as shown in the following matrix: 
𝑀𝑀′ = (
𝐸𝐸𝑐𝑐𝑐𝑐
′ (1 − 𝑥𝑥)𝐸𝐸𝑏𝑏𝑏𝑏
′
(1 − 𝑥𝑥)𝐸𝐸𝑐𝑐𝑐𝑐
′ 𝐸𝐸𝑏𝑏𝑏𝑏
′ ). For this 𝑀𝑀′ series as well as for other series types, 
the matrices will be resolved following the methodology shown in section 3.2.2. For 
that, the two interspecies endemic transmission parameters will be formulated as a 
function of their intraspecies equivalent. 
 
Derivations to estimate any of the NGMs along the y-axis (separable mixing) are 
covered in section 3.2.1 while derivations to estimate any of the NGMs within the 
triangle as well as those on the lines joining nodes 1 and 2 and nodes 1 and 3 are 
shown in 3.2.2. 
 
Figure 1. Theoretical transmission triangle delimited by nodes 1, 2 and 3. 
 
NGMs results 
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Here the results for the three NGMs that form the nodes in the theoretical 
transmission triangle are presented. Further, we present the results for two other 
NGMs contained within this triangle, NGM A and NGM B. 
Under the assumption of disjunct mixing (no interspecies transmission), the 
reproduction ratio for M. bovis infection in cattle herds, badgers and the system, 
respectively, were estimated as: 
𝑅𝑅𝑐𝑐𝑐𝑐 =
1
1 − 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑝𝑝 ℎ𝑝𝑝𝑝𝑝𝑒𝑒𝑒𝑒
=
1
1 − 0.063
= 1.07 
𝑅𝑅𝑏𝑏𝑏𝑏 =
1
1 − 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝑏𝑏𝑐𝑐𝑒𝑒𝑏𝑏𝑝𝑝𝑝𝑝𝑒𝑒
=
1
1 − 0.14
= 1.16 
with 𝑅𝑅 = max (𝑅𝑅𝑐𝑐𝑐𝑐, 𝑅𝑅𝑏𝑏𝑏𝑏) = 1.16 
The NGM resulting from these results represents node 1 in the transmission triangle 
shown in Figure 1 and 2 (𝑅𝑅𝑏𝑏𝑐𝑐 = 𝑅𝑅𝑐𝑐𝑏𝑏 = 0 as there is no interspecies transmission). To 
estimate the partial reproduction ratios, we used a prevalence of M. bovis infection 
in cattle herds and badgers of 6.3% and 14%, respectively, and a total number of 
72,228 cattle herds and 63,000 badgers (see Material and Methods, 3.1). 
 
Under the assumption of separable mixing and using the combined prevalence in 
both species, the reproduction ratio for the cattle-badger system was estimated from 
endemic equilibrium data as 1
𝑓𝑓𝑆𝑆
𝑇𝑇𝑂𝑂𝑇𝑇 (3.2.1, section a.). Here, 𝑓𝑓𝑆𝑆𝑇𝑇𝑇𝑇𝑇𝑇 represents the 
fraction of susceptible cattle herds and badgers out of the total population (cattle 
herds and badgers) at the endemic equilibrium. The “reproduction ratio” of the 
system from the endemic equilibrium (as opposite to the real reproduction ratio) was 
then calculated using equation (4) as 𝑅𝑅 = 1.11.  
 
Assuming separable mixing, we also estimated the Jacobian matrix for the cattle and 
badger system at the endemic equilibrium (3.2.1, section b1)). Using equations (5) 
and (6), and as the susceptibility of badgers can be estimated as 𝑦𝑦𝑏𝑏 =
𝛾𝛾𝑏𝑏
𝛾𝛾𝑡𝑡
=
 𝑓𝑓𝑏𝑏
𝐼𝐼
𝑓𝑓𝑏𝑏
𝑆𝑆 (3.2.1, 
section c.), we estimated 𝑅𝑅𝑐𝑐𝑐𝑐′ = 0.38 and 𝑅𝑅𝑏𝑏𝑏𝑏′ = 0.73 for a scenario where the relative 
infectivity of cattle and badgers are the same (𝑥𝑥𝑐𝑐 = 𝑥𝑥𝑏𝑏 = 1). Similarly, both partial 
reproduction ratios were estimated for two extreme scenarios, one where all the 
infectivity came from cattle herds (𝑅𝑅𝑐𝑐𝑐𝑐′ = 1.11 and 𝑅𝑅𝑏𝑏𝑏𝑏′ = 0) and one where all the 
infectivity came from badgers (𝑅𝑅𝑐𝑐𝑐𝑐′ = 0 and 𝑅𝑅𝑏𝑏𝑏𝑏′ = 1.11) (3.2.1, section b1)). In all 
three scenarios ′ = 𝑅𝑅𝑐𝑐𝑐𝑐′ + 𝑅𝑅𝑏𝑏𝑏𝑏′ = 1.11 , as a result of the separable mixing assumption. 
 
For a homogeneous population, the 𝑅𝑅′ estimated at the endemic steady state is indeed 
a correct estimate of the real 𝑅𝑅. However, for a system such as the cattle-badger 
system where there is potential heterogeneity between cattle herds and badgers in 
terms of their susceptibility to M. bovis infection, this 𝑅𝑅′ is no longer a correct 
estimate for the real reproduction ratio (Biemans et al., 2017). When an infectious 
agent is introduced into an infection free population with more than one host type 
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(such as the cattle-badger system), if the susceptibility of the host types involved is 
the same, the depletion of susceptible individuals would occur at the same rate in the 
different host types (i.e. cattle and badgers). If susceptibility of the cattle herds and 
badgers differ, then the depletion of individuals of the most susceptible type would 
occur more quickly than that of the less susceptible type. Thus the relative attack rate 
(a combination of frequency of occurrence and susceptibility) of the more 
susceptible type will decrease as we approach the endemic equilibrium. Below, we 
present the results obtained when the NGM at the disease free equilibrium and 𝑅𝑅0 
are estimated as an extrapolation from the Jacobian matrix at the endemic 
equilibrium, taking into account the difference between the rate of depletion among 
cattle herds and among badgers (due to differences in terms of their susceptibility). 
Two extreme NGMs assuming separable mixing were calculated. If we assume all 
infectivity comes from cattle herds (Material and Methods 3.2.1, section b2), then 
𝑅𝑅 = 𝑅𝑅𝑐𝑐𝑐𝑐 = 1.07, 𝑅𝑅𝑐𝑐𝑐𝑐 = 2.25, 𝑅𝑅𝑐𝑐𝑐𝑐 = 0 and 𝑅𝑅𝑐𝑐𝑐𝑐 = 0 (NGM presented in node 2 in Figure 
1 and 2). Assuming all infectivity originates from badgers 𝑅𝑅 = 𝑅𝑅𝑐𝑐𝑐𝑐 = 1.16, 𝑅𝑅𝑐𝑐𝑐𝑐 =
0.55, 𝑅𝑅𝑐𝑐𝑐𝑐 = 0 and 𝑅𝑅𝑐𝑐𝑐𝑐 = 0  (NGM shown in node 3 in Figure 1 and 2). Another NGM 
assuming separable mixing and equal infectivity of cattle herds and badgers was 
estimated using equations (7), and (8) respectively as 𝑅𝑅𝑐𝑐𝑐𝑐 = 𝑅𝑅𝑐𝑐𝑐𝑐 = 0.77  and 𝑅𝑅𝑐𝑐𝑐𝑐 =
𝑅𝑅𝑐𝑐𝑐𝑐 = 0.36 (NGM A in Figure 2), and its reproduction ratio was also estimated using 
equation (9) as 𝑅𝑅 = 0.77 + 0.36 = 1.13. 
 
In the derivations presented in section 3.2.2, we show how all possible NGMs within 
the transmission triangle can be estimated. The general formula based on the Irish 
data for calculating the NGM at the disease free equilibrium 𝑀𝑀 from  𝑀𝑀′ is: 
𝑀𝑀 =
1
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇  
(
 
 
 
 
 
𝐼𝐼𝑐𝑐 + 𝑆𝑆𝑐𝑐
𝑁𝑁
𝑆𝑆𝑐𝑐
𝑆𝑆𝑐𝑐 + 𝑆𝑆𝑐𝑐
(𝐸𝐸𝑐𝑐𝑐𝑐
′ 𝐸𝐸𝑐𝑐𝑐𝑐
′ )
𝐼𝐼𝑐𝑐 + 𝑆𝑆𝑐𝑐
𝑁𝑁
𝑆𝑆𝑐𝑐
𝑆𝑆𝑐𝑐 + 𝑆𝑆𝑐𝑐
(𝐸𝐸𝑐𝑐𝑐𝑐
′ 𝐸𝐸𝑐𝑐𝑐𝑐
′ )
)
 
 
 
 
 
= (
1.07 (𝐸𝐸𝑐𝑐𝑐𝑐
′ 𝐸𝐸𝑐𝑐𝑐𝑐
′ )
1.16 (𝐸𝐸𝑐𝑐𝑐𝑐
′ 𝐸𝐸𝑐𝑐𝑐𝑐
′ )
) 
Note that as  𝑀𝑀′ has dominant eigenvalue 1, the dominant eigenvalue of the NGM 
matrix 𝑀𝑀 has to be between 1.07 and 1.16. The eigenvector in the endemic 
equilibrium is (c,b)=( 0.340332, 0.659668). 
 
To illustrate, we can look at node 2 (as an example of a separable mixing matrix); 
here, the matrix obtained by solving the two equations system as indicated in 3.2.2 
would be 𝑀𝑀′ = (
1 0
𝐼𝐼𝑏𝑏
𝐼𝐼𝑇𝑇𝑇𝑇𝑇𝑇
𝐼𝐼𝑐𝑐
𝐼𝐼𝑇𝑇𝑇𝑇𝑇𝑇
0
) = (
1 0
0.659668
0.340332
0), with 𝑀𝑀 = (
1.07 (1 0)
1.16 (
0.659668
0.340332
0)
) =
(
1.07 0
2.25 0
) with 𝑅𝑅 = 1.07. These are the same values we obtained above when using 
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the methodology described in 3.2.1. In a similar way, other NGMs that do not assume 
separable mixing can also be calculated. Here, we estimated the NGM for a matrix 
𝑀𝑀′ = (
𝐸𝐸𝑐𝑐𝑐𝑐
′ 𝑥𝑥𝐸𝐸𝑏𝑏𝑏𝑏
′
𝑥𝑥𝐸𝐸𝑐𝑐𝑐𝑐
′ 𝐸𝐸𝑏𝑏𝑏𝑏
′
) that assumes very low interspecies transmission (0.06 times that 
of the intra-species transmission, i.e. x = 0.06) as an example of a matrix opposed to 
the maximum interspecies transmission observed in the case of separable mixing. 
The results obtained were: 𝑅𝑅𝑏𝑏𝑏𝑏 = 0.07, 𝑅𝑅𝑏𝑏𝑏𝑏 = 0.06, 𝑅𝑅𝑏𝑏𝑏𝑏 = 0.95  and 𝑅𝑅𝑏𝑏𝑏𝑏 = 1.13 with 
𝑅𝑅 = 1.15 (NGM B in Figure 2). 
 
Figure 2 below presents the results for three extreme NGMs and 𝑅𝑅s that frame all 
possible matrices that can describe transmission in cattle herds and badgers in 
Ireland. Also NGMs A and B, are shown as an example of NGMs contained within 
the triangle. The transmission triangle is presented on a plane with the y-axis 
indicating the origin of the infectivity (cattle herds and/or badgers), and the x-axis 
indicating the level of interaction between the two species. Matrix A is the NGM 
obtained when assuming separable mixing and equal infectivity of cattle herds and 
badgers. In this triangle, as we move up from this matrix, the infectivity of cattle 
herds increases while the infectivity of badgers decreases, and the opposite occurs 
as we move down. This matrix also assumes maximum interaction between the two 
species, with this interaction decreasing as we move towards the right hand side of 
the triangle. Matrix B is also presented within the transmission triangle and has been 
located close to node 1, as very small interspecies transmission is assumed. Note that 
this NGM is similar to the matrix assumed by Brooks-Pollock & Danon (2017) based 
on model assumptions in Brooks-Pollock & Wood (2015), apart from the essential 
asymmetry in transmission between badgers and cattle that we base on the 
differences in prevalence. 
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Figure 2. Range of NGMs and 𝑅𝑅s for the cattle-badger system in Ireland, with and without 
interaction between the two species, and for a number of relative infectivities of cattle and 
badgers. 
 
Summarizing, the methodology presented in this manuscript allows estimation of all 
plausible matrices that could describe M. bovis transmission in Ireland. We have 
shown the results for some of these NGMs, with a focus on transmission scenarios 
with very different biological interpretations. After calculating all plausible NGMs 
within this triangle, our results indicate that 𝑅𝑅 for the cattle-badger system in Ireland 
has to be contained within the range determined by the three extreme NGMs 
presented in the nodes of the triangle, i.e. 1.07 < 𝑅𝑅 < 1.16; indeed NGMs A and B 
show values within this interval. The reproduction ratio for the system is therefore 
above 1, and indicates that with current control strategies eradication of M. bovis 
from the system will not occur. These results also indicate that the maximum value 
the reproduction ratio for cattle to cattle transmission can take is 1.07, above 1 but 
not far from it. Indeed, for most of the plausible NGMs, this value is below 1. This 
result is not surprising as with the current test and remove controls in cattle, the 
within-herd transmission is likely to be low, and this will also apply to the between-
herd transmission. The fact that 𝑅𝑅𝑐𝑐𝑐𝑐 < 1 in most of the NGMs has large implications 
in terms of selecting appropriate eradication strategies, suggesting that additional 
intervention strategies applied to badgers (if successful), could lead to eradication. 
 
Impact of BCG vaccination in badgers on the cattle-badger system 
Following on from the results presented above, here we explore the impact of badger 
vaccination on the badger-cattle system. As BCG badger vaccination at 100% 
 121 
 
vaccine coverage can reduce 𝑅𝑅𝑏𝑏𝑏𝑏 by 59% (Aznar et al., 2017), then the reproduction 
ratio for the system after BCG badger vaccination (𝑅𝑅𝑏𝑏𝑏𝑏(1)) for the maximum 
plausible value of 𝑅𝑅𝑏𝑏𝑏𝑏 = 1.16 is 𝑅𝑅𝑏𝑏𝑏𝑏(1) = (1 − 0.59) ∗ 1.16 = 0.48. This suggests that 
badger vaccination can achieve 𝑅𝑅𝑏𝑏𝑏𝑏 < 1 in all transmission scenarios. Nonetheless, 
there are a small number of plausible scenarios where transmission from badgers to 
cattle (𝑅𝑅𝑏𝑏𝑏𝑏) is so small, that adding control strategies in badgers (such as vaccination) 
would have very little impact on 𝑅𝑅0 because in those cases 𝑅𝑅𝑏𝑏𝑏𝑏 is above 1. To delimit 
the area where BCG vaccination cannot achieve eradication of M. bovis from the 
system we looked at areas in the triangle where 𝑅𝑅𝑏𝑏𝑏𝑏 ≥ 1. There are two nodes where 
𝑅𝑅𝑏𝑏𝑏𝑏 ≥ 1 (nodes 1 and 2), this is also the case for the NGMs on the line connecting 
both nodes (as 𝑅𝑅𝑏𝑏𝑏𝑏 = 0 in this line and 𝑅𝑅𝑏𝑏𝑏𝑏 = 1.07 as in nodes 1 and 2). This indicates 
that the area where 𝑅𝑅𝑏𝑏𝑏𝑏 ≥ 1 is close to this line. To delimit this area further, we 
assessed a number of 𝑀𝑀′ series to obtain the x values for which 𝑅𝑅𝑏𝑏𝑏𝑏 = 1. For that, 
similarly to the derivations presented in Material and Methods 3.2.2, were two 
elements of a matrix 𝑀𝑀′ were obtained from a 2 equation system, the values of x for 
which 𝑅𝑅𝑏𝑏𝑏𝑏 = 1 from these four matrices series: 𝑀𝑀′ = (
𝐸𝐸𝑐𝑐𝑐𝑐
′ 𝑥𝑥𝐸𝐸𝑏𝑏𝑏𝑏
′
𝑥𝑥𝐸𝐸𝑐𝑐𝑐𝑐
′ 𝐸𝐸𝑏𝑏𝑏𝑏
′
), 𝑀𝑀′ =
(
𝐸𝐸𝑐𝑐𝑐𝑐
′ 𝑥𝑥𝐸𝐸𝑐𝑐𝑐𝑐
′
𝑥𝑥𝐸𝐸𝑏𝑏𝑏𝑏
′ 𝐸𝐸𝑏𝑏𝑏𝑏
′
), 𝑀𝑀′ = (𝐸𝐸𝑐𝑐𝑐𝑐
′ 𝑥𝑥𝐸𝐸𝑏𝑏𝑐𝑐
′
𝐸𝐸𝑏𝑏𝑐𝑐
′ 𝑥𝑥𝐸𝐸𝑐𝑐𝑐𝑐
′
), and 𝑀𝑀′ = (𝐸𝐸𝑐𝑐𝑐𝑐
′ 𝑥𝑥𝐸𝐸𝑐𝑐𝑐𝑐
′
𝐸𝐸𝑏𝑏𝑐𝑐
′ 𝑥𝑥𝐸𝐸𝑏𝑏𝑐𝑐
′
) were estimated. These 
matrices series are shown in Figure 3 as blue lines (except for the last matrix series 
which represents the series of matrices based on the separable mixing assumption 
and are shown below the red line that goes from nodes 2 to 3), with the NGMs at 
which 𝑅𝑅𝑏𝑏𝑏𝑏 becomes 1 shown as black dots. An approximation of the area where 𝑅𝑅𝑏𝑏𝑏𝑏 ≥
1 and eradication is not feasible is then shown in yellow and is the result of joining 
these black dots using straight lines. 
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Figure 3. Transmission triangle showing the area (yellow) where eradication (by adding BCG 
badger vaccination to current control strategies) would not be feasible. The NGMs at the 
nodes of the triangle and NGMs A and B are shown as red dots. Four series of NGMs are 
shown as blue lines (a vertical blue line cannot be seen as coincides with the triangle 
boundary) with four black dots (one in each line) showing the NGMs at which 𝑅𝑅𝑐𝑐𝑐𝑐 = 1. A 
magnified view of the area surrounding node 1 is also presented 
 
This analysis helps to visualize in a simple way the magnitude of the scenarios for 
which eradication, by adding BCG badger vaccination (yellow area), would not be 
feasible. Aside, by examining the location of this area within the triangle, we can 
extrapolate some biological interpretations of the matrices contained in this area. All 
the matrices along this triangle’s boundary represent a biological scenario where 
badgers do not transmit any infection to cattle (𝑅𝑅𝑏𝑏𝑐𝑐 = 0). Similarly, the area close to 
this boundary, is made of scenarios where transmission from badgers to cattle is very 
small, with the edges indicating that either there is no transmission between cattle 
and badgers or all or most of it is originated from cattle. Based on literature available, 
we can be confident that the transmission scenarios that fall within this yellow area 
are not very likely to reflect field transmission between cattle and badgers in Ireland. 
For example, large scale experimental field trials in Ireland (O’Mairtin et al. 1998; 
Griffin et al. 2005) have determined that the removal of badgers is associated with 
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reduced bTB risk to cattle in the removal areas compared to that in matched reference 
areas.  
 
Sensitivity analysis 
As there was some uncertainty in terms of the total number of badgers in contact 
with cattle herds and the prevalence of M. bovis infection in this species, 𝑅𝑅𝑐𝑐𝑐𝑐, 𝑅𝑅𝑏𝑏𝑏𝑏 
and 𝑅𝑅 (under the assumption of separable mixing and equal infectivity of badgers 
and cattle herds) were estimated for a range of prevalence and number of badgers 
values, as presented in Table 1. 𝑅𝑅𝑏𝑏𝑏𝑏 and 𝑅𝑅 were also assessed assuming 40% and 
100% vaccine coverage. 
 
Table 1. 𝑅𝑅𝑐𝑐𝑐𝑐, 𝑅𝑅𝑏𝑏𝑏𝑏 and 𝑅𝑅 estimated under the assumption of separable mixing and equal 
infectivity of badgers and cattle herds for a range of prevalence and badger numbers, in the 
absence of vaccination. 𝑅𝑅𝑏𝑏𝑏𝑏 and 𝑅𝑅 are also calculated assuming badger vaccination at 40% 
and 100% vaccine coverage , and are presented as 𝑅𝑅𝑏𝑏𝑏𝑏(0.4) and 𝑅𝑅𝑏𝑏𝑏𝑏(1) and 𝑅𝑅0.4 and 𝑅𝑅1, 
respectively 
 
  
 
In Table 1, we present the partial and system reproduction ratios when assuming 
separable mixing and equal infectivity of cattle and badgers while varying badger 
prevalence and total number of badgers for 0%, 40% and 100% vaccination 
coverage. A minimum badger prevalence of 10% and a maximum of 30% were 
explored; likewise we explored changes in the number of total badgers (min=40,000, 
max=90,000). Badger vaccination with 100% coverage was able to achieve 
eradication of M. bovis from the system in all the scenarios presented. That was also 
the case when vaccination was used with 40% rather than 100% coverage, except for 
the scenario assuming 30% prevalence in badgers. Here the reproduction ratio was 
above but close to 1 (𝑅𝑅0.4 = 1.09). 
 
Conclusion 
BCG vaccination of badgers has the potential to achieve eradication of M. bovis 
infection in the cattle-badger system in Ireland, unless there is limited transmission 
from badgers to cattle (implying that almost all infection in cattle originates from 
No. Badgers Prev Badgers Rcc Rbb R Rbb(0.4) R0.4 Rbb(1) R1
63,000 14% 0.36 0.77 1.13 0.59 0.95 0.32 0.68
90,000 14% 0.28 0.85 1.14 0.65 0.93 0.35 0.63
63,000 14% 0.36 0.77 1.13 0.59 0.95 0.32 0.68
40,000 14% 0.48 0.64 1.12 0.49 0.97 0.26 0.74
63,000 30% 0.21 1.15 1.36 0.88 1.09 0.47 0.68
63,000 14% 0.36 0.77 1.13 0.59 0.95 0.32 0.68
63,000 10% 0.45 0.64 1.09 0.49 0.94 0.26 0.71
100% coverage40% coverage0% coverage
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cattle). The transmission scenarios, where 𝑅𝑅𝑐𝑐𝑐𝑐 > 1 and therefore eradication by 
adding BCG vaccination would not be feasible, represent a very small proportion of 
all possible transmission scenarios that can explain the observed data (yellow area 
in Figure 3); also, these scenarios would be highly unlikely to represent transmission 
in the field. In all other scenarios vaccination in badgers together with the current 
interventions in cattle lead to eradication of bTB from the system.  
 
Achieving 100% BCG badger vaccination coverage in the field, regardless of 
deployment methodology, will not be possible. Nonetheless, the results obtained 
when vaccination coverage of 40% is assumed are still quite promising, with 
eradication of M. bovis being feasible in most scenarios. 
 
We have arrived at these conclusions by deriving equations that allow calculation of 
𝑅𝑅 and the NGM at the disease free equilibrium based on the observed endemic 
equilibrium data. The straightforwardness of the data required will make this 
methodology very appealing in many scenarios where multiple hosts are involved. 
By using this methodology we have been also able to reduce the uncertainty 
introduced by the lack of reliable transmission parameters between cattle and 
badgers. 
 
3. Material and Methods 
 
3.1 Data 
To define the M. bovis cattle-badger system in Ireland, we first looked at the 
landscape where these two populations overlap and where interspecies transmission 
is feasible. In this paper, cattle to cattle transmission (𝑅𝑅𝑐𝑐𝑐𝑐) represents the transmission 
of M. bovis between cattle belonging to different herds caused by nose to nose 
contact, environmental contamination, or cattle movements. To estimate the number 
of cattle herds in contact with the badger population, and using the Department of 
Agriculture, Food and the Marine (DAFM) Wildlife Unit (WU) database, a file was 
extracted of badger setts (n=36,095) assigned for capture linked to farms that had 
triggered badger culling between 2004 and 2015. This file was merged with a 
geodatabase containing badger sett locations using ArcGIS (ESRI, ArcGIS Desktop: 
Release 10.3 Redlands, CA: Environmental Systems Research Institute). A buffer 
with a 500 m radius was generated around each of these setts. This distance was 
selected to represent the average distance from a main sett to the edge of a badger 
social group territory and is the distance used by DAFM in their interim badger 
culling program to calculate ‘treated’ land. Where buffers overlapped, their 
intersecting boundaries were dissolved. Using the DAFM Land Parcel Identification 
System (LPIS) for 2015, all cattle herds intersecting the 500 metre buffer area were 
identified (n=72,288). The estimated bTB prevalence at cattle herd level for 2015 in 
the buffer area was 6.3%. The prevalence was calculated using the Animal Health 
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Computer System (AHCS) database from DAFM as the percentage of the herds in 
the buffer area that were restricted in 2015 with 1 or more animals identified as skin 
reactors or lesions as calculated by Gallagher et al. (2013). 
 
The pre-culled badger population in Ireland was estimated at 84,000 (Sleeman et 
al., 2009). These badgers reside in approximately 19,000 social groups (Byrne et 
al. 2014) with a higher proportion of social groups occurring within higher bTB 
risk areas. To derive a badger population estimate for the present simulations, we 
assumed that 40% of the badger population was culled (based on social groups; 
Byrne et al. 2014) at a conservative culling efficacy of 64% (Byrne et al. 2013; 
n=63,000). A minimum number of 40,000 and a maximum of 90,000 badgers were 
also selected for the sensitivity analysis. In Byrne et al. (2015), two partial badger 
apparent prevalence estimates were reported: 17.7% for the period from May 2007 
to May 2011, and 9.9% for the period from June 2011 to April 2013 when PCR 
techniques were introduced (biochemical tests were used until May 2011). 
Although an average badger prevalence of 14% was used in the current analysis, a 
maximum prevalence of 30% and a minimum of 10% (based on expert opinion) 
were also explored. The effects of BCG vaccination with 100% and 40% coverage 
in 𝑅𝑅𝑏𝑏𝑏𝑏 and subsequently in 𝑅𝑅 were estimated using estimates for vaccine efficacy 
for susceptibility VES=59% and vaccine efficacy for infectiousness VEI=0%, as 
previously described by Aznar et al. (2017). 
 
3.2 Derivations 
Equations to estimate 𝑅𝑅  and the NGM under the assumption of disjunct mixing (node 
1) are described in the introduction. As no interaction is assumed between species 
(𝑅𝑅𝑐𝑐𝑏𝑏 = 𝑅𝑅𝑏𝑏𝑐𝑐 = 0), each of the intra-species reproduction ratios (𝑅𝑅𝑐𝑐𝑐𝑐 and 𝑅𝑅𝑏𝑏𝑏𝑏) can be 
calculated as 1
1−𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 
, with the system 𝑅𝑅 being the largest of either 𝑅𝑅𝑐𝑐𝑐𝑐 or 𝑅𝑅𝑏𝑏𝑏𝑏. 
Below, we first present the derivations to estimate any plausible NGM and 𝑅𝑅 under 
the assumption of separable mixing, including the two extreme NGMs that form 
nodes 2 and 3 (section 3.2.1). Secondly, we show the derivations to estimate a 
number of series of matrices that do not necessarily assume separable mixing (but 
could) within the transmission triangle, including the NGMs that form the lines 
joining nodes 1 and 2 and nodes 1 and 3 (section 3.2.2). Although any NGM within 
the triangle can be estimated using the later derivations, derivations presented in 
section 3.2.1 are needed to confirm whether or not all NGMs under the assumption 
of separable mixing fall on the line between nodes 2 and 3. Note that all plausible 
NGMs in this triangle will have a standardized eigenvector equal to the ratio of the 
prevalence of M. bovis infection in cattle herds to that in badgers. 
 
3.2.1. Derivations to estimate any NGM and 𝑅𝑅  under the assumption of separable 
mixing 
 126 
 
Assuming separable mixing, we first show the derivations to estimate 𝑅𝑅′ 
(reproduction ratio at the endemic equilibrium) from data observed at the endemic 
equilibrium (section a.). In section b., the derivations to estimate the Jacobian matrix 
at the endemic and at the disease free equilibrium (NGM) are shown. To be able to 
estimate these NGMs, it was necessary to estimate the susceptibility of cattle herds 
and badgers; the derivations to estimate the susceptibility of the two hosts are 
presented in section c.  
 
a. Derivations to estimate 𝑅𝑅′ in the cattle-badger system from the endemic 
equilibrium assuming separable mixing 
  
If we assume that there is separable mixing between both species (cattle and 
badgers), then, the force of infection in each of the species will come from both cattle 
and badgers and the model equations for a SIR (Susceptible-Infectious-Recovered) 
model can be written as: 
𝑑𝑑𝑑𝑑𝑐𝑐
𝑑𝑑𝑑𝑑
= 𝛽𝛽𝑐𝑐𝑐𝑐
𝑑𝑑𝑐𝑐𝑆𝑆𝑐𝑐
𝑁𝑁
+ 𝛽𝛽𝑏𝑏𝑐𝑐
𝑑𝑑𝑏𝑏𝑆𝑆𝑐𝑐
𝑁𝑁
− 𝛼𝛼𝑑𝑑𝑐𝑐  
𝑑𝑑𝑑𝑑𝑏𝑏
𝑑𝑑𝑑𝑑
= 𝛽𝛽𝑐𝑐𝑏𝑏
𝑑𝑑𝑐𝑐𝑆𝑆𝑏𝑏
𝑁𝑁
+ 𝛽𝛽𝑏𝑏𝑏𝑏
𝑑𝑑𝑏𝑏𝑆𝑆𝑏𝑏
𝑁𝑁
− 𝛼𝛼𝑑𝑑𝑏𝑏 
where 𝛼𝛼 is the recovery rate, and 𝛽𝛽 the transmission rate parameter with indices “c” 
and “b” referring to the hosts, cattle (farms) and badgers (individuals) respectively, 
and the direction of the transmission determined by the location of these indices, i.e. 
𝛽𝛽𝑏𝑏𝑐𝑐 is the transmission rate from badgers to cattle herds. 
Under the assumption of separable mixing, we can then define the transmission rate 
from cattle herds to badgers or βcb as the product of the contact rate (c), the 
susceptibility of badgers (γb) and the infectivity of cattle (φc), or βcb= cγb φc; likewise 
we can define βcc= cγc φc, βbc= cγc φb and βbb= cγb φb. 
By substitution, the model equations can then be written as: 
𝑑𝑑𝑑𝑑𝑐𝑐
𝑑𝑑𝑑𝑑
= 𝑐𝑐𝛾𝛾
𝑐𝑐
𝑆𝑆𝑐𝑐𝑑𝑑𝑇𝑇𝑇𝑇𝑇𝑇
𝑁𝑁
(𝜑𝜑
𝑐𝑐
𝑑𝑑𝑐𝑐
𝑑𝑑𝑇𝑇𝑇𝑇𝑇𝑇
+ 𝜑𝜑
𝑏𝑏 
𝑑𝑑𝑏𝑏
𝑑𝑑𝑇𝑇𝑇𝑇𝑇𝑇
) − 𝛼𝛼𝑑𝑑𝑐𝑐 =  𝑐𝑐𝛾𝛾𝑐𝑐𝜑𝜑𝑑𝑑
𝑆𝑆𝑐𝑐𝑑𝑑𝑇𝑇𝑇𝑇𝑇𝑇
𝑁𝑁
− 𝛼𝛼𝑑𝑑𝑐𝑐  (1) 
𝑑𝑑𝑑𝑑𝑏𝑏
𝑑𝑑𝑑𝑑
= 𝑐𝑐𝛾𝛾
𝑏𝑏
𝑆𝑆𝑏𝑏𝑑𝑑𝑇𝑇𝑇𝑇𝑇𝑇
𝑁𝑁
(𝜑𝜑
𝑐𝑐
𝑑𝑑𝑐𝑐
𝑑𝑑𝑇𝑇𝑇𝑇𝑇𝑇
+ 𝜑𝜑
𝑏𝑏 
𝑑𝑑𝑏𝑏
𝑑𝑑𝑇𝑇𝑇𝑇𝑇𝑇
) − 𝛼𝛼𝑑𝑑𝑏𝑏 =  𝑐𝑐𝛾𝛾𝑏𝑏𝜑𝜑𝑑𝑑
𝑆𝑆𝑏𝑏𝑑𝑑𝑇𝑇𝑇𝑇𝑇𝑇
𝑁𝑁
− 𝛼𝛼𝑑𝑑𝑏𝑏  (2) 
Where 𝜑𝜑
𝑑𝑑
 is the total average infectivity at time t. 
Then, by adding both equations: 
𝑑𝑑𝑑𝑑𝑇𝑇𝑇𝑇𝑇𝑇
𝑑𝑑𝑑𝑑
= 𝑐𝑐𝜑𝜑
𝑑𝑑
𝑆𝑆𝑇𝑇𝑇𝑇𝑇𝑇𝑑𝑑𝑇𝑇𝑇𝑇𝑇𝑇
𝑁𝑁
(𝛾𝛾
𝑐𝑐
𝑆𝑆𝑐𝑐
𝑆𝑆𝑇𝑇𝑇𝑇𝑇𝑇
+ 𝛾𝛾
𝑏𝑏 
𝑆𝑆𝑏𝑏
𝑆𝑆𝑇𝑇𝑇𝑇𝑇𝑇
) − 𝛼𝛼𝑑𝑑𝑇𝑇𝑇𝑇𝑇𝑇 = 𝑐𝑐 𝛾𝛾𝑑𝑑 𝜑𝜑𝑑𝑑
𝑆𝑆𝑇𝑇𝑇𝑇𝑇𝑇𝑑𝑑𝑇𝑇𝑇𝑇𝑇𝑇
𝑁𝑁
− 𝛼𝛼𝑑𝑑𝑇𝑇𝑇𝑇𝑇𝑇  (3) 
𝑑𝑑𝑑𝑑𝑇𝑇𝑇𝑇𝑇𝑇
𝑑𝑑𝑑𝑑
= 𝛼𝛼𝑑𝑑𝑇𝑇𝑇𝑇𝑇𝑇 (
𝑐𝑐 𝛾𝛾
𝑑𝑑
 𝜑𝜑
𝑑𝑑
𝛼𝛼
∙
𝑆𝑆𝑇𝑇𝑇𝑇𝑇𝑇
𝑁𝑁
− 1)  where 
𝑐𝑐 𝛾𝛾
𝑑𝑑
 𝜑𝜑
𝑑𝑑
𝛼𝛼
= 𝑅𝑅𝑑𝑑 
with  𝛾𝛾𝑡𝑡 being the total average susceptibility and 𝑅𝑅𝑑𝑑 being the reproduction ratio at 
time t, respectively. 
 
As the system is at the endemic equilibrium, then 𝑑𝑑𝑑𝑑𝑇𝑇𝑇𝑇𝑇𝑇
𝑑𝑑𝑑𝑑
= 0, and this is satisfied if  
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 𝐼𝐼𝑇𝑇𝑇𝑇𝑇𝑇
∗ = 0 (disease free equilibrium) or 𝑅𝑅𝑡𝑡
𝑆𝑆𝑇𝑇𝑇𝑇𝑇𝑇
∗
𝑁𝑁
− 1 = 0 (endemic equilibrium) and 
therefore: 
𝑅𝑅𝑡𝑡 =
𝑁𝑁
𝑆𝑆𝑇𝑇𝑇𝑇𝑇𝑇
∗ =
1
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇   or 
𝑅𝑅′ =
1
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇 (4) 
Were 𝑓𝑓𝑆𝑆𝑇𝑇𝑇𝑇𝑇𝑇 is the fraction of susceptible cattle herds and badgers out of the total 
population of cattle herds and badgers. Note that this R is based on the average 
susceptibility at the endemic equilibrium and this average susceptibility is different 
to that calculated at the disease free equilibrium. 
 
b. Estimation of the Jacobian matrix for cattle and badgers at the endemic and the 
disease free equilibrium (NGM)  
 
Here, we present how the Jacobian matrix at the endemic equilibrium for cattle herds 
and badgers can be calculated. Then, we demonstrate how the NGM at the disease 
free equilibrium and the real 𝑅𝑅 can be extrapolated from the endemic equilibrium 
matrix by taking into account the relative increase in the average susceptibility of the 
most susceptible type. 
b1) Endemic equilibrium 
Under the assumption of separable mixing, each of the components of the NGM for 
the cattle-badger system near the endemic equilibrium can be calculated as a function 
of the relative susceptibility and relative infectivity of cattle and badgers (    𝛾𝛾𝑐𝑐   
𝛾𝛾𝑡𝑡
, 
   𝛾𝛾𝑏𝑏   
𝛾𝛾𝑡𝑡
,
   𝜑𝜑𝑐𝑐   
𝜑𝜑𝑡𝑡
, 
   𝜑𝜑𝑏𝑏   
𝜑𝜑𝑡𝑡
), the contact rate (c), and the fractions of susceptible cattle and badgers 
(𝑓𝑓𝑐𝑐𝑆𝑆, 𝑓𝑓𝑏𝑏𝑆𝑆) (Diekmann et al., 2010). The Jacobian matrix in the endemic equilibrium for 
cattle and badgers can then be written as a 2x2 matrix with the relative infectivity of 
cattle and badgers presented as columns (𝑥𝑥𝑐𝑐 =
   𝜑𝜑𝑐𝑐   
𝜑𝜑𝑡𝑡
 and 𝑥𝑥𝑏𝑏 =
   𝜑𝜑𝑏𝑏   
𝜑𝜑𝑡𝑡
) and their relative 
susceptibility as rows (𝑦𝑦𝑐𝑐 =
   𝛾𝛾𝑐𝑐   
𝛾𝛾𝑡𝑡
 and 𝑦𝑦𝑏𝑏 =
   𝛾𝛾𝑏𝑏   
𝛾𝛾𝑡𝑡
): 
 
 
𝒙𝒙𝒄𝒄 𝒙𝒙𝒃𝒃 
𝒇𝒇𝒄𝒄
𝑺𝑺𝒚𝒚𝒄𝒄  𝑐𝑐 𝑥𝑥𝑐𝑐𝑦𝑦𝑐𝑐𝑓𝑓𝑐𝑐
𝑆𝑆 𝑐𝑐 𝑥𝑥𝑏𝑏𝑦𝑦𝑐𝑐𝑓𝑓𝑐𝑐𝑆𝑆 
𝒇𝒇𝒃𝒃
𝑺𝑺𝒚𝒚𝒃𝒃  𝑐𝑐 𝑥𝑥𝑐𝑐𝑦𝑦𝑏𝑏𝑓𝑓𝑏𝑏
𝑆𝑆 𝑐𝑐 𝑥𝑥𝑏𝑏𝑦𝑦𝑏𝑏𝑓𝑓𝑏𝑏𝑆𝑆 
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with 𝑅𝑅𝑐𝑐𝑐𝑐′ = 𝑐𝑐 𝑥𝑥𝑐𝑐𝑦𝑦𝑐𝑐𝑓𝑓𝑐𝑐𝑆𝑆 and 𝑅𝑅𝑏𝑏𝑏𝑏′ = 𝑐𝑐 𝑥𝑥𝑏𝑏𝑦𝑦𝑏𝑏𝑓𝑓𝑏𝑏𝑆𝑆 being the partial reproduction ratios at the 
endemic equilibrium for cattle herd to cattle herd transmission and badger to badger 
transmission, respectively. 
 
At the endemic equilibrium, the fractions of infected cattle herds and infected 
badgers are connected to the fraction of cattle and badgers among the susceptibles 
as: (𝑓𝑓𝑐𝑐
𝐼𝐼
𝑓𝑓𝑏𝑏
𝐼𝐼 ) =  (
𝑦𝑦𝑐𝑐𝑓𝑓𝑐𝑐
𝑆𝑆
𝑦𝑦𝑏𝑏𝑓𝑓𝑏𝑏
𝑆𝑆), and the addition of these two fractions is equal to 1. Therefore if 
we take  𝑦𝑦
𝑐𝑐
𝑓𝑓
𝑐𝑐
𝑆𝑆 = 𝑎𝑎, it follows that 𝑦𝑦𝑏𝑏𝑓𝑓 𝑏𝑏𝑆𝑆 = 1 − 𝑎𝑎. 
As the contact rate is equal to 𝑐𝑐 = 1
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇, by substitution in the NGM above, we can 
derive that: 
𝑅𝑅𝑐𝑐𝑐𝑐
′ =
1
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇  𝑥𝑥𝑐𝑐𝑎𝑎 
𝑅𝑅𝑏𝑏𝑏𝑏
′ =
1
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇  𝑥𝑥𝑏𝑏(1 − 𝑎𝑎) 
If we assume separable mixing, then we can calculate the reproduction ratio of the 
system at the endemic equilibrium as:  𝑅𝑅𝑡𝑡 = 𝑅𝑅′ = 𝑅𝑅𝑐𝑐𝑐𝑐′ +  𝑅𝑅𝑏𝑏𝑏𝑏′  and rearranging the 
equations above: 
 𝑅𝑅𝑡𝑡 =
1
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇  (𝑎𝑎𝑥𝑥𝑐𝑐 + (1 − 𝑎𝑎)𝑥𝑥𝑏𝑏) 
As we showed in section a) that 𝑅𝑅𝑡𝑡 =
1
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇 then  
(𝑎𝑎𝑥𝑥𝑐𝑐 + (1 − 𝑎𝑎)𝑥𝑥𝑏𝑏) = 1 
Hence, 𝑥𝑥𝑏𝑏 =
1
(1−𝑎𝑎)
−
𝑎𝑎
(1−𝑎𝑎)
𝑥𝑥𝑐𝑐 with one possible solution being that the relative 
infectivity of cattle herds is 𝑥𝑥𝑐𝑐 = 1 and the relative infectivity of badgers 𝑥𝑥𝑏𝑏 =
(1−𝑎𝑎)
(1−𝑎𝑎)
=
1. 
For 𝑥𝑥𝑏𝑏 = 1 and 𝑥𝑥𝑐𝑐 = 1 then  
𝑅𝑅𝑏𝑏𝑏𝑏
′ =
1
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇 (1 − 𝑎𝑎) (5) 
𝑅𝑅𝑐𝑐𝑐𝑐
′ =
𝑎𝑎
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇 (6) 
If we assume that all the infectivity comes from cattle, and badgers do not play any 
role (i.e. 𝑥𝑥𝑏𝑏 = 0), then the infectivity of cattle is 𝑥𝑥𝑐𝑐 = 1/𝑎𝑎 and 𝑅𝑅𝑏𝑏𝑏𝑏′ = 0 and 𝑅𝑅𝑐𝑐𝑐𝑐′ =
1
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇. 
If, we assume that all the infectivity comes from badgers (i.e. 𝑥𝑥𝑐𝑐 = 0), then 𝑥𝑥𝑏𝑏 =
1
(1−𝑎𝑎)
 
and 𝑅𝑅𝑏𝑏𝑏𝑏′ =
1
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇 and 𝑅𝑅𝑐𝑐𝑐𝑐′ = 0. 
 
Note that these are solutions for the partial reproduction ratios at the endemic 
equilibrium but to estimate the system NGM we need to estimate the partial 
reproduction ratios at the disease free equilibrium. 
 
b2) Disease free equilibrium  
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We can now extrapolate the NGM at the disease free equilibrium from the matrix at 
the endemic equilibrium presented in section b1). Here, and for demonstration 
purposes, we first assume that heterogeneity between cattle and badgers is 
exclusively due to differences in their susceptibility, i.e. the infectivity of both 
species being equal. 
 
If susceptibility differs between species, we can define a new contact rate 𝑐𝑐′ =
1
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇  
   𝛾𝛾0   
𝛾𝛾𝑡𝑡
  , where    𝛾𝛾0   
𝛾𝛾𝑡𝑡
 reflects the relative increase in the average susceptibility of the 
most susceptible species at the endemic equilibrium rather than at the disease free 
equilibrium (𝛾𝛾0 represents the average susceptibility at the disease free equilibrium). 
At the disease free equilibrium, all individuals, cattle and badgers, are susceptible so 
their relative susceptibility can be expressed as 𝑦𝑦′𝑐𝑐 =
   𝛾𝛾𝑐𝑐   
𝛾𝛾0
 and 𝑦𝑦′𝑏𝑏 =
   𝛾𝛾𝑏𝑏   
𝛾𝛾0
; likewise the 
fractions of susceptible cattle and susceptible badgers can be written as 𝑓𝑓𝑐𝑐𝑇𝑇𝑇𝑇𝑇𝑇 and 
𝑓𝑓𝑏𝑏
𝑇𝑇𝑇𝑇𝑇𝑇 respectively.  
 
The NGM at the disease free equilibrium is presented below: 
 
 
 𝒙𝒙𝒄𝒄
′   𝒙𝒙𝒃𝒃
′  
𝒇𝒇𝒄𝒄
𝒕𝒕𝒕𝒕𝒕𝒕𝒚𝒚𝒄𝒄
′   𝑐𝑐′𝑥𝑥𝑐𝑐
′ 𝑦𝑦𝑐𝑐
′𝑓𝑓𝑐𝑐
𝑇𝑇𝑇𝑇𝑇𝑇  𝑐𝑐′𝑥𝑥𝑏𝑏′ 𝑦𝑦𝑐𝑐′𝑓𝑓𝑐𝑐𝑇𝑇𝑇𝑇𝑇𝑇 
𝒇𝒇𝒃𝒃
𝒕𝒕𝒕𝒕𝒕𝒕𝒚𝒚𝒃𝒃
′   𝑐𝑐′𝑥𝑥𝑐𝑐
′ 𝑦𝑦𝑏𝑏
′ 𝑓𝑓𝑏𝑏
𝑇𝑇𝑇𝑇𝑇𝑇  𝑐𝑐′𝑥𝑥𝑏𝑏′ 𝑦𝑦𝑏𝑏′ 𝑓𝑓𝑏𝑏𝑇𝑇𝑇𝑇𝑇𝑇 
 
As we did previously in section b., we can now make 𝑦𝑦𝑐𝑐′𝑓𝑓𝑐𝑐𝑇𝑇𝑇𝑇𝑇𝑇 = 𝑎𝑎′ and 𝑦𝑦𝑏𝑏′ 𝑓𝑓𝑏𝑏𝑇𝑇𝑇𝑇𝑇𝑇 = (1 −
𝑎𝑎′). By substituting in 𝑅𝑅𝑐𝑐𝑐𝑐 and 𝑅𝑅𝑏𝑏𝑏𝑏 (reproduction ratios for cattle to cattle transmission 
and badger to badger transmission at the disease free equilibrium): 
𝑅𝑅𝑐𝑐𝑐𝑐 =  𝑐𝑐
′𝑥𝑥𝑐𝑐
′𝑎𝑎′ (7) 
𝑅𝑅𝑏𝑏𝑏𝑏 =  𝑐𝑐
′𝑥𝑥𝑏𝑏
′ (1 − 𝑎𝑎′) (8) 
with 
𝑅𝑅 =  𝑐𝑐′𝑥𝑥𝑐𝑐
′ 𝑎𝑎′ + 𝑐𝑐′𝑥𝑥𝑏𝑏
′ (1 − 𝑎𝑎′) (9) 
As cattle herds and badgers have the same infectivity (𝑥𝑥′𝑐𝑐 = 𝑥𝑥′𝑏𝑏 = 1), then: 
𝑅𝑅 = 𝑐𝑐′(𝑎𝑎′ + (1 − 𝑎𝑎′)) = 𝑐𝑐′ =
1
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇  
   𝛾𝛾0   
𝛾𝛾𝑡𝑡
 
Similar to the calculations done at the endemic equilibrium, we can also calculate 𝑅𝑅  
and the two extreme NGMs that form nodes 2 and 3 in Figure 1, by assuming all 
In
fe
ct 
Susc
ept 
 130 
 
infectivity is coming from cattle (the infectivity of badgers is null (𝑥𝑥𝑏𝑏′ = 0)), or all 
infectivity is coming from badgers (𝑥𝑥𝑐𝑐′ = 0) respectively. 
If we assume that badgers do not play any role in transmission (𝑥𝑥𝑏𝑏′ = 0), then from 
the endemic equilibrium derivations 𝑥𝑥𝑐𝑐′ =
1
𝑎𝑎
 and: 
𝑅𝑅 = 𝑅𝑅𝑐𝑐𝑐𝑐 = 𝑐𝑐
′𝑎𝑎′
1
𝑎𝑎
= 𝑐𝑐′
𝑎𝑎′
𝑎𝑎
=
 𝑓𝑓𝑐𝑐
𝑇𝑇𝑇𝑇𝑇𝑇
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇𝑓𝑓𝑐𝑐𝑆𝑆
=
1
1 − 𝑃𝑃𝑅𝑅𝑃𝑃𝑃𝑃𝑐𝑐
 
with 𝑅𝑅𝑐𝑐𝑏𝑏 =
   𝛾𝛾𝑐𝑐   
𝛾𝛾𝑡𝑡
   𝛾𝛾𝑏𝑏   
𝛾𝛾𝑡𝑡
𝑅𝑅𝑐𝑐𝑐𝑐 
The resultant NGM will correspond to node 2 in the transmission triangle in Figure 
1. 
 
If transmission only originates from badgers, then from the endemic equilibrium 
derivations we can see that 𝑥𝑥𝑏𝑏′ =
1
1−𝑎𝑎
 and:  
𝑅𝑅 = 𝑅𝑅𝑏𝑏𝑏𝑏 =  𝑐𝑐
′𝑥𝑥𝑏𝑏
′ (1 − 𝑎𝑎′) =
1
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇  
   𝛾𝛾0   
𝛾𝛾𝑡𝑡
(1 − 𝑎𝑎′)
1 − 𝑎𝑎
=
1
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇  
   𝛾𝛾0   
𝛾𝛾𝑡𝑡
𝑦𝑦𝑏𝑏
′ 𝑓𝑓𝑏𝑏
𝑇𝑇𝑇𝑇𝑇𝑇
𝑦𝑦𝑏𝑏𝑓𝑓𝑏𝑏
𝑆𝑆
=
1
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇  
   𝛾𝛾0   
𝛾𝛾𝑡𝑡
 
   𝛾𝛾𝑏𝑏   
𝛾𝛾0
𝑓𝑓𝑏𝑏
𝑇𝑇𝑇𝑇𝑇𝑇
   𝛾𝛾𝑏𝑏   
𝛾𝛾𝑡𝑡
𝑓𝑓𝑏𝑏
𝑆𝑆
 
𝑅𝑅 = 𝑅𝑅𝑏𝑏𝑏𝑏 =
 𝑓𝑓𝑏𝑏
𝑇𝑇𝑇𝑇𝑇𝑇
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇𝑓𝑓𝑏𝑏
𝑆𝑆 =
1
1 − 𝑃𝑃𝑅𝑅𝑃𝑃𝑃𝑃𝑏𝑏
 
and 𝑅𝑅𝑏𝑏𝑐𝑐 =
   𝛾𝛾𝑏𝑏   
𝛾𝛾𝑡𝑡
   𝛾𝛾𝑐𝑐   
𝛾𝛾𝑡𝑡
𝑅𝑅𝑏𝑏𝑏𝑏   
𝑃𝑃𝑅𝑅𝑃𝑃𝑃𝑃𝑏𝑏 and 𝑃𝑃𝑅𝑅𝑃𝑃𝑃𝑃𝑐𝑐  represent the prevalence of M. bovis infection in badgers and cattle 
herds, respectively. The resultant NGM will be node 3 in the transmission triangle 
(Figure 1). 
 
c. Derivations to estimate the relative susceptibility of cattle and badgers 
 
If we assume a SIR model under the endemic equilibrium, the differential equation 
that describes the fraction of infected cattle (𝑓𝑓𝑐𝑐𝐼𝐼) can be written as: 
𝑑𝑑𝑓𝑓𝑐𝑐
𝐼𝐼
𝑑𝑑𝑑𝑑
=
𝑑𝑑
𝐼𝐼𝑐𝑐
𝐼𝐼𝑇𝑇𝑇𝑇𝑇𝑇
𝑑𝑑𝑑𝑑
=
𝑑𝑑𝐼𝐼𝑐𝑐
𝑑𝑑𝑑𝑑 𝐼𝐼𝑇𝑇𝑇𝑇𝑇𝑇 −
𝑑𝑑𝐼𝐼𝑇𝑇𝑇𝑇𝑇𝑇
𝑑𝑑𝑑𝑑 𝐼𝐼𝑐𝑐
𝐼𝐼𝑇𝑇𝑇𝑇𝑇𝑇
2 =
1
𝐼𝐼𝑇𝑇𝑇𝑇𝑇𝑇
𝑑𝑑𝐼𝐼𝑐𝑐
𝑑𝑑𝑑𝑑
 
because at the endemic equilibrium 𝑑𝑑𝐼𝐼𝑇𝑇𝑇𝑇𝑇𝑇
𝑑𝑑𝑑𝑑
= 0. 
If we substitute 𝑑𝑑𝐼𝐼𝑐𝑐
𝑑𝑑𝑑𝑑
 for equation (1), shown in 3.2.1 section a., then: 
𝑑𝑑𝑓𝑓𝑐𝑐
𝐼𝐼
𝑑𝑑𝑑𝑑
= 𝑐𝑐𝛾𝛾𝑐𝑐𝜑𝜑𝑡𝑡
𝑆𝑆𝑐𝑐
𝑁𝑁
− 𝛼𝛼
𝐼𝐼𝑐𝑐
𝐼𝐼𝑇𝑇𝑇𝑇𝑇𝑇
= 𝑐𝑐𝛾𝛾𝑐𝑐𝜑𝜑𝑡𝑡
𝑆𝑆𝑐𝑐
𝑁𝑁
− 𝛼𝛼𝑓𝑓𝑐𝑐
𝐼𝐼  
As the fraction of infected cattle remains constant in the endemic equilibrium (𝑑𝑑𝑑𝑑𝑐𝑐
𝐼𝐼
𝑑𝑑𝑡𝑡
=
0), then  
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𝛼𝛼𝑓𝑓𝑐𝑐
𝐼𝐼 = 𝑐𝑐𝑐𝑐𝑐𝑐𝜑𝜑𝑡𝑡
𝑆𝑆𝑐𝑐
𝑁𝑁
 
Similarly, we can write the differential equation that describes the fraction of 
infected badgers (𝑓𝑓𝑏𝑏𝐼𝐼) and substituting 
𝑑𝑑𝑑𝑑𝑏𝑏
𝑑𝑑𝑑𝑑
 for equation (2): 
𝛼𝛼𝑓𝑓𝑏𝑏
𝐼𝐼 = 𝑐𝑐𝑐𝑐𝑏𝑏𝜑𝜑𝑡𝑡
𝑆𝑆𝑏𝑏
𝑁𝑁
 
Then  
𝑓𝑓𝑐𝑐
𝐼𝐼
𝑓𝑓𝑏𝑏
𝐼𝐼 =
𝑐𝑐𝑐𝑐𝑆𝑆𝑐𝑐
𝑐𝑐𝑏𝑏𝑆𝑆𝑏𝑏
 
And as 𝑓𝑓𝑐𝑐𝐼𝐼 + 𝑓𝑓𝑏𝑏𝐼𝐼 = 1: 
 
𝑓𝑓𝑐𝑐
𝐼𝐼
1 − 𝑓𝑓𝑐𝑐𝐼𝐼
=
𝑐𝑐𝑐𝑐𝑆𝑆𝑐𝑐
𝑐𝑐𝑏𝑏𝑆𝑆𝑏𝑏
 
 
𝑓𝑓𝑐𝑐
𝐼𝐼 =
𝑐𝑐𝑐𝑐𝑆𝑆𝑐𝑐
𝑐𝑐𝑐𝑐𝑆𝑆𝑐𝑐 + 𝑐𝑐𝑏𝑏𝑆𝑆𝑏𝑏
=
𝑐𝑐𝑐𝑐𝑓𝑓𝑐𝑐
𝑆𝑆
𝑐𝑐𝑐𝑐𝑓𝑓𝑐𝑐𝑆𝑆 + 𝑐𝑐𝑏𝑏𝑓𝑓𝑏𝑏
𝑆𝑆 =
   𝑐𝑐𝑐𝑐   
𝑐𝑐𝑡𝑡
𝑓𝑓𝑐𝑐
𝑆𝑆 
Therefore the susceptibility of cattle can be calculated as: 
   𝑐𝑐𝑐𝑐   
𝑐𝑐𝑡𝑡
=
𝑓𝑓𝑐𝑐
𝐼𝐼
𝑓𝑓𝑐𝑐𝑆𝑆
 
Following a similar derivation for badgers, the susceptibility of badgers can be 
written as: 
   𝑐𝑐𝑏𝑏   
𝑐𝑐𝑡𝑡
=
𝑓𝑓𝑏𝑏
𝐼𝐼
𝑓𝑓𝑏𝑏
𝑆𝑆 
with the relative susceptibility of cattle herds compared to badgers resulting from 
dividing these two fractions. As all the possible solutions for NGMs assuming 
separable mixing share susceptibility estimates, these derivations indicate that all 
these NGMs will fall on the same line of the plane. Thus, showing that indeed the 
NGMs triangle can be closed. 
 
3.2.2. Estimation of any NGM and 𝑅𝑅 that is part of the triangle 
All Jacobian matrices that follow from the prevalence and number of cattle herds 
and badgers observed in Ireland at the endemic equilibrium share the same 
eigenvector e, including the three extreme 𝑀𝑀′s from which the NGMs that form the 
nodes of the triangle presented in Figure 1 are calculated. For all 𝑀𝑀′s: 
𝑒𝑒 = (𝑒𝑒𝑐𝑐
𝑒𝑒𝑏𝑏
)=(
𝐼𝐼𝑐𝑐
𝐼𝐼𝑇𝑇𝑇𝑇𝑇𝑇
𝐼𝐼𝑏𝑏
𝐼𝐼𝑇𝑇𝑇𝑇𝑇𝑇
) 
For all these matrices also: 𝑀𝑀′ ∗ 𝑒𝑒 = 𝑒𝑒 
To solve the matrices that form the nodes of the triangle, and as in these matrices 
two elements are equal to 0, we can express the relationship above as a system of 
two equations with two unknowns. Using as an example the 𝑀𝑀′ that defines node 1 
in Figure 1, 𝐸𝐸𝑐𝑐𝑐𝑐′  and 𝐸𝐸𝑏𝑏𝑏𝑏′  would be the unknowns and: 
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(
𝐸𝐸𝑐𝑐𝑐𝑐
′ 0
0 𝐸𝐸𝑏𝑏𝑏𝑏
′ ) ∗  (
𝐼𝐼𝑐𝑐
𝐼𝐼𝑇𝑇𝑇𝑇𝑇𝑇
𝐼𝐼𝑏𝑏
𝐼𝐼𝑇𝑇𝑇𝑇𝑇𝑇
) = (
𝐼𝐼𝑐𝑐
𝐼𝐼𝑇𝑇𝑇𝑇𝑇𝑇
𝐼𝐼𝑏𝑏
𝐼𝐼𝑇𝑇𝑇𝑇𝑇𝑇
), 
and the two resultant equations would be:  
𝐸𝐸𝑐𝑐𝑐𝑐
′ ∗  
𝐼𝐼𝑐𝑐
𝐼𝐼𝑇𝑇𝑇𝑇𝑇𝑇
=
𝐼𝐼𝑐𝑐
𝐼𝐼𝑇𝑇𝑇𝑇𝑇𝑇
 
𝐸𝐸𝑏𝑏𝑏𝑏
′ ∗
𝐼𝐼𝑏𝑏
𝐼𝐼𝑇𝑇𝑇𝑇𝑇𝑇
=
𝐼𝐼𝑏𝑏
𝐼𝐼𝑇𝑇𝑇𝑇𝑇𝑇
 
By solving the equations, then 𝐸𝐸𝑐𝑐𝑐𝑐′ = 𝐸𝐸𝑏𝑏𝑏𝑏′ = 1 and 𝑀𝑀′ = (
1 0
0 1
). 
To calculate the NGM (𝑀𝑀) for this specific matrix, then: 
𝑁𝑁𝑁𝑁𝑀𝑀 =
1
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇  
(
 
 
𝐼𝐼𝑐𝑐+𝑆𝑆𝑐𝑐
𝑁𝑁
𝑆𝑆𝑐𝑐
𝑆𝑆𝑐𝑐+𝑆𝑆𝑏𝑏
(1 0)
𝐼𝐼𝑏𝑏+𝑆𝑆𝑏𝑏
𝑁𝑁
𝑆𝑆𝑏𝑏
𝑆𝑆𝑐𝑐+𝑆𝑆𝑏𝑏
(0 1)
)
 
 
 with 
𝑁𝑁𝑁𝑁𝑀𝑀 =
1
𝑓𝑓𝑆𝑆
𝑇𝑇𝑇𝑇𝑇𝑇  
(
 
 
𝐼𝐼𝑐𝑐+𝑆𝑆𝑐𝑐
𝑁𝑁
𝑆𝑆𝑐𝑐
𝑆𝑆𝑐𝑐+𝑆𝑆𝑏𝑏
(𝐸𝐸𝑐𝑐𝑐𝑐
′ 𝐸𝐸𝑏𝑏𝑐𝑐
′ )
𝐼𝐼𝑏𝑏+𝑆𝑆𝑏𝑏
𝑁𝑁
𝑆𝑆𝑏𝑏
𝑆𝑆𝑐𝑐+𝑆𝑆𝑏𝑏
(𝐸𝐸𝑐𝑐𝑏𝑏
′ 𝐸𝐸𝑏𝑏𝑏𝑏
′ )
)
 
 
 being the general solution. 
Other NGMs within the triangle can also be estimated as above by fixing one of the 
elements at a time of a matrix type 𝑀𝑀′ = (𝐸𝐸𝑐𝑐𝑐𝑐
′ 𝐸𝐸𝑏𝑏𝑐𝑐
′
𝐸𝐸𝑐𝑐𝑏𝑏
′ 𝐸𝐸𝑏𝑏𝑏𝑏
′ ) and estimating the solution for 
small increments of a second element. This will result in a number of series of 
matrices that starting from each of the nodes of the triangle might or might not reach 
one of the triangle boundaries.  
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Introduction 
 
Ireland commenced a control/eradication programme for Mycobacterium bovis 
infection in cattle in 1954 (More and Good, 2006). Prevalence of infection was very 
high, with about 80% of cattle herds being infected. Some success was achieved over 
the first 10 years of the control programme (animal incidence was reduced from 17% 
to 0.5% by 1965), suggesting that eradication of the infection in cattle was feasible. 
However, following this early success, and despite an overtime increase in cattle 
controls, incidence in cattle remained relatively stable (Figure 1 Chapter 1). 
Meanwhile, badgers (Meles meles) were confirmed as a reservoir of the infection 
and were suspected as the main reason for the failure to eradicate the infection in 
cattle (Costello et al., 1999; Griffin et al., 2005). As a result, starting in Ireland in the 
early 1990s, cattle farms with severe bTB outbreaks were subjected to an 
epidemiological investigation. Where all other possible sources of infection were 
ruled out and badgers were implicated, targeted removals of badgers were carried 
out around these farms (Olea-Popelka et al., 2009). These badger removal operations 
were gradually intensified and became more systematic with about 4,700 badger 
removal licences being issued in 2000 (O’Boyle, I., 2000). 
 
Within this context, the main objective of this thesis was to quantitatively assess the 
contribution of each of the species, cattle and badgers, to infection maintenance. It 
also sought to answer the specific question of whether or not BCG badger 
vaccination should be added to the current control strategies to help in the eradication 
of bTB in cattle. Ultimately, the main goal was to gain enough scientific knowledge 
so that new policy on bovine tuberculosis (bTB), leading to eradication, could be 
formulated. Chapters 2 to 5 were strategically designed to assess the impact of BCG 
vaccination on M. bovis transmission in the badger population. The biological ways 
in which BCG vaccination worked to achieve a reduction on the M. bovis 
transmission in a badger population were also disentangled. In Chapter 6, by 
estimating all the plausible Next Generation Matrices (NGMs) for the cattle-badger 
system in Ireland, we were able to assess not only the effectiveness of vaccination in 
the badger population but also in the cattle-badger system. 
 
Based on the results from this thesis as well as on other parallel research (Gormley 
et al., 2017), the Irish government signalled the intention to include BCG badger 
vaccination in the eradication programme for M. bovis in Ireland (DAFM, 2017). In 
this final chapter, the main findings from this thesis are discussed. The two main sets 
of results, one related to the confirmation of bTB working hypothesis and another to 
the potential of BCG vaccination to achieve M. bovis eradication, both of them 
critical to the future of the bTB strategy policy are examined. Also, a number of 
questions in relation to adding badger vaccination to the eradication programme that 
could arise from policymakers and other stakeholders are pre-empted and answered. 
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A section on the challenges posed by the introduction of BCG vaccination and how 
these challenges can be overcome follows. Finally, suggestions for further scientific 
work are made. 
 
Main results 
 
a) Confirmation of working hypotheses 
In this thesis, two working hypotheses fundamental to the design of a path to bTB 
eradication have been confirmed. Firstly, it has been confirmed that eradication of 
M. bovis infection in the cattle-badger system would not be feasible without the 
addition of new control strategies, as shown by the basic reproduction ratio estimated 
under current controls (1.07 𝑅𝑅0 1.16 ) (Chapter 6). Secondly, it was shown that the 
reproduction ratio for cattle to cattle transmission was below 1 (𝑅𝑅𝑐𝑐𝑐𝑐 < 1) for almost 
all plausible transmission scenarios, indicating that eradication of the infection in the 
system can be achieved by the addition of interventions in badgers alone. Although 
these are some of the general conclusions from this thesis, it is important that we 
further analyse these outcomes so that policy makers have a full understanding of 
their significance and limitations. 
 
In relation to the first statement that current controls will not result in eradication, an 
important disclaimer has to be made. In our analysis. we made an inherent 
assumption that the cattle-badger system is at the endemic equilibrium. In this way, 
data observed in the field can then be extrapolated to obtain 𝑅𝑅0 at the disease free 
equilibrium (where all the individuals are susceptible). In Figure 1 of the thesis 
introduction, it was shown that a slight decrease in bTB incidence in cattle had been 
observed since the introduction of badger culling. Based on that, it is possible then 
that the system is not at the endemic equilibrium and that if badger culling were to 
be continued at a similar rate, the infection could die out in the system (assuming 
badger culling is responsible for the decrease in incidence). In this way, the statement 
that eradication would not occur with current strategies would be incorrect. 
Nonetheless, if the observed reduction in cattle bTB incidence is real (rather than an 
artefact) and if this reduction is truly due to the introduction of badger removal, the 
statement could still be relevant as badger culling is anticipated not to be continued 
at the current rate (6,000 badger/year) (O’Keeffe, DAFM, personal communication).  
 
Secondly, we have confirmed that in the majority of the plausible transmission 
scenarios, badgers (as opposed to cattle herds) contribute the most to the overall 
transmission (based on the observed prevalence of M. bovis infection in both species 
and the number of cattle herds and badgers). For example, assuming separable 
mixing and equal relative infectivity of the two species, the partial reproduction 
ratios, 𝑅𝑅𝑐𝑐𝑐𝑐 and 𝑅𝑅𝑏𝑏𝑏𝑏, were estimated, confirming the hypothesis that the contribution 
from badgers to 𝑅𝑅0 is higher than that from cattle herds (𝑅𝑅𝑏𝑏𝑏𝑏 = 0.77, 𝑅𝑅𝑐𝑐𝑐𝑐 = 0.36). The 
 141 
 
significance of this statement, is that it confirms the working hypothesis that a greater 
leverage (in terms of impact on 𝑅𝑅0) can be achieved if additional control options were 
to be focussed on the species that contributes the most to 𝑅𝑅0, in this case badgers 
(assuming equal effectiveness, feasibility and availability of control options in the 
two species and assuming that resources are scarce and their optimization is 
imperative). Nonetheless, the statements above should not be interpreted lightly as 
in no case should our conclusions preclude the addition of new control strategies in 
cattle. Quite the opposite, not only current controls in cattle will have to be 
maintained for our results to be true, but adding additional or more stringent control 
strategies in cattle might be necessary to compensate for the fact that culling in 
badgers will not be maintained at the current rate. Aside, these added controls can 
help accelerating the rate of decrease in 𝑅𝑅0 and therefore time to eradication. Further 
details about time to eradication will be discussed later in this chapter. 
 
b) BCG vaccination in badgers has the potential to achieve eradication of M. bovis 
infection in the cattle-badger system in Ireland 
In Chapter 5, BCG vaccine efficacy in badgers was estimated as VES=59% and 
VEI=0%. Here, it was shown how vaccination if added to current controls, was able 
to achieve eradication of the infection in the badger population. Nonetheless, it was 
in Chapter 6 where the possibility of achieving eradication of the infection from the 
system (in the majority of the plausible transmission scenarios) was confirmed. A 
biological and mathematical description of the small number of transmission 
scenarios where eradication would not be feasible is also presented. By looking at 
extreme scenarios in terms of M. bovis transmission in the system, all matrices that 
could describe transmission in cattle and badgers in Ireland were framed within a 
NGM triangle (with the vertices of this triangle representing the most extreme 
transmission scenarios) (Figures 1 and 2 in Chapter 6). Further, the approximate area 
within this triangle where eradication of the infection in the system (by adding BCG 
badger vaccination at 100% coverage) was not feasible was estimated (Figure 3 
Chapter 6). This area is shown in yellow and lies parallel to the line that joins nodes 
1 and 2 in the NGMs transmission triangle. Nodes 1 and 2 represent transmission 
scenarios where either: 1) no interaction between the two species is present (node 1), 
or 2) there is maximal interaction between species with all the infection originated 
from cattle (node 2). In both scenarios 𝑅𝑅𝑐𝑐𝑐𝑐 = 1.07 and both would result in a 
reproduction ratio after adding badger vaccination (at 100% coverage) to current 
controls above 1 (𝑅𝑅1 = 1.07). Further, the area where eradication is not possible is 
characterized by 𝑅𝑅𝑐𝑐𝑐𝑐 > 1 and 𝑅𝑅1 > 1. In this area, transmission from badgers to cattle 
is so small (or non-existent), that any control measures focused on badger 
transmission exclusively will not have a sufficient effect on the reproduction ratio of 
the system to bring it below 1. Nonetheless, as it can be observed in Figure 3, the 
number of transmission scenarios where 𝑅𝑅𝑐𝑐𝑐𝑐 > 1 and therefore 𝑅𝑅1 > 1 is very small. 
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This leads to the conclusion that eradication by adding badger vaccination would be 
feasible in a large proportion of all the plausible transmission scenarios. 
Very few parameters were needed to estimate the plausible NGMs that could 
describe the transmission between badgers and cattle herds: number of cattle herds 
and badgers and prevalence in both species. As cattle data are quite reliable, the 
sensitivity analysis focused on badger numbers and prevalence. In all the scenarios 
explored  𝑅𝑅1 < 1 (more precisely, 𝑅𝑅1 < 0.74). 𝑅𝑅0 was also calculated when only 40% 
of the badger population was vaccinated and assuming larger /lower number of 
badgers and their prevalence than those used for the main analysis. The 40% 
vaccination coverage selected aimed to reflect badger trapping capabilities (as 
observed in previous vaccine trials) (Byrne et al., 2012). At this coverage, 
eradication was also feasible except when the badger prevalence would have 
exceeded 30% (𝑅𝑅0.4 = 1.09). Therefore in this thesis and as a difference from other 
modelling exercises, the uncertainty in the success of adding vaccination to the 
current control strategies does not depend on inaccurate parameterization but rather 
on the logistics of achieving sufficient vaccination coverage. 
 
c) Further insights 
One difficulty when translating the results from this thesis into policy arises from the 
fact that our calculations assume that current controls in cattle and badgers are going 
to remain in place; because badger culling rates will most likely not be maintained 
(O’Keeffe, DAFM, personal communication), this assumption does not stand. If we 
assume that the observed recent reduction in cattle incidence is due to badger culling, 
then, the key question is: how long will the observed NGM remain stable subsequent 
to reducing/abolishing badger culling? Badger culling can potentially affect 
transmission to cattle in two ways: by reducing badger density, and by reducing the 
prevalence in badgers (if culling of badgers is focused on infected badgers), both 
resulting in a reduction of transmission opportunities (Byrne et al., 2015). 
Nonetheless, there is no research yet available on the time that it would take for a 
badger population to recover in numbers subsequent to targeted culling, or the time 
that it would take for infection prevalence to raise. As a result, our recommendation 
would be that badger vaccination should be carried out in a manner that assures the 
minimum vaccination coverage is achieved before badger densities can recover. 
Also, and as mentioned before, this should be seen as another argument supporting 
that stringent controls in the cattle population are put in place along with the addition 
of BCG vaccination. 
 
Until now, the use of BCG vaccination in cattle has not been possible as there are no 
vaccine-compatible diagnostic assays capable of distinguishing vaccinated from 
infected cattle (Vordermeier 2016). Some research is being carried out in this field 
with expectations that a test with these specifications will be available in the near 
future. This issue has been thoroughly considered in an EFSA report (EFSA, 2013). 
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Nonetheless, and apart from all regulatory and trial design issues highlighted in this 
report, the main question to be answered is whether or not a strategy based on testing 
of cattle followed by either vaccination or removal (TVR) can achieve an 
equal/higher impact on 𝑅𝑅𝑐𝑐𝑐𝑐 (and subsequently on 𝑅𝑅0) than that obtained with the 
removal of SICCT positive cattle. If the impact of TVR is higher than the impact 
from current controls in cattle, then a question that policy makers could pose is 
whether or not vaccinating cattle would be a better option than vaccinating badgers. 
Assuming that the vaccine efficacy of BCG in cattle would be similar to that 
observed in badgers (VES=59% and VEI=0%) and based on the NGM assuming 
equal infectivity of cattle herds and badgers (NGM A in Chapter 6, i.e. 𝑅𝑅𝑏𝑏𝑏𝑏 = 𝑅𝑅𝑏𝑏𝑐𝑐 =
0.77  and 𝑅𝑅𝑐𝑐𝑐𝑐 = 𝑅𝑅𝑐𝑐𝑏𝑏 = 0.36), a larger reduction in 𝑅𝑅0 would be achieved by 
vaccinating only badgers (𝑅𝑅1 = 0.68) compared to vaccinating only cattle (𝑅𝑅1 =
0.92) in Ireland (in each case, assuming 100% coverage). Nonetheless, the 
comparison should take into account the fact that the effort/logistics and economics 
of vaccinating badgers are much larger than those required for vaccinating cattle. It 
is estimated that vaccinating 40% of the badgers would achieve a similar reduction 
of 𝑅𝑅0 compared to vaccinating the entire cattle population (𝑅𝑅0.4 = 0.95) (further 
calculations based on results from Chapter 6). The question that could follow is 
whether it would be a better strategy to wait until BCG cattle vaccination becomes 
available? There are still too many uncertainties on whether a TVR strategy in cattle 
will work/be available. As badger culling is going to be gradually reduced, awaiting 
for certainty in relation to this strategy (without adding badger vaccination) will 
result in changes to the NGM that could compromise the ability to eradicate the 
infection in cattle. 
 
Another question that may arise from the results of this thesis is how long it will take 
to achieve eradication. There is a simple formula that can give us an approximate 
estimate of time to eradication based on 𝑅𝑅0: 
𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 = ln (
1
10
) /ln (𝑅𝑅0) 
In the sensitivity analysis carried out in Chapter 6 (Table 1), it is shown how 𝑅𝑅0 is 
close to 1 in all but one of the scenarios (when vaccination coverage is equal to 40%); 
in most scenarios 0.9 < 𝑅𝑅0.4 < 1.0. Using the formula above, the time to eradication 
for a value of 𝑅𝑅0 = 0.97 was estimated at approximately 76 years and for 𝑅𝑅0 = 0.9 
was estimated at 22 years. The time is greatly reduced to 4.5 years if 𝑅𝑅0 = 0.6. 
Although our results show that eradication can be achieved by exclusively adding 
BCG badger vaccination, introducing added controls in cattle that can further reduce 
𝑅𝑅𝑐𝑐𝑐𝑐 and subsequently 𝑅𝑅0, can also play a decisive role in the eradication programme 
as it will help to reduce the time to eradication; further, it could become a “deal 
breaker” for achieving it. To elucidate, as mentioned previously that badger culling 
is going to be reduced over time in Ireland, if badger culling is reduced, 𝑅𝑅0 will 
increase over a number of years. Therefore, achieving a fast reduction of 𝑅𝑅0 before 
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seeing the effects of reduced/no culling in the NGM might be necessary to achieve 
eradication. Critical assessment of current controls as well as the introduction of new 
measures, such as risk based trading, a national policy on better management of 
infected herds and addressing residual infection, should be considered to assure the 
needed fast decline in 𝑅𝑅0. 
Finally, an important concept to communicate to policy makers is that 𝑅𝑅0 is not a 
static parameter; as new control options are introduced, the NGM of the system will 
change, hence the need to re-assess this matrix over time. The relative simplicity in 
which the NGM was estimated in this thesis (not so much the way in which it was 
derived) will make this task easy and greatly recommended. For that, data on 
prevalence in both species as well as number of cattle herds and badgers should be 
collected on an ongoing basis during the eradication programme.  
 
Challenges ahead and suggestions for further work 
 
a) Defining the role of badger culling into the future 
In Ireland, badger and cattle prevalence are not homogeneous throughout the country 
when measured in single cross sectional. Whether that implies that the NGMs 
described in this thesis for the country as a whole, will not apply depends on the long 
term average for these smaller areas. The conclusions from this thesis then might or 
might not be valid in these areas with larger/smaller badger and/or cattle prevalence. 
In order to decide the best eradication strategies in these areas, first it would be 
necessary to establish whether or not the system (in these areas) is at the endemic 
equilibrium and what the magnitude of this endemic equilibrium is. Defining the 
plausible NGMs for these areas will also provide information on the most adequate 
eradication strategies. Calculations based on the results from Chapter 6 show that M. 
bovis eradication would not be feasible with badger vaccination coverage equal to 
40% if badger prevalence exceeds 23%. A possible solution here would be to use 
focused/targeted badger culling (instead of vaccination), together with added cattle 
controls as an aid to bring badger density and prevalence down prior to the 
introduction of badger vaccination (assuming that the system here is at the endemic 
equilibrium and the conclusions from this thesis still apply). 
 
In Ireland, some badger culling will remain in place once BCG badger vaccination 
is incorporated to the eradication programme (O’Keeffe, DAFM, personal 
communication). Also, it is important to clarify that the deployment of BCG vaccine 
in badgers in Ireland will be done intramuscularly as there is as yet no oral vaccine 
available (personal communication). If an oral vaccine was available, then 
deployment of the vaccine could be done in a timely manner assuring large 
vaccination coverage given adequate uptake levels. As the logistic efforts to deploy 
BCG vaccine intramuscularly will be lengthy and very similar to those required for 
badger culling, and as resources will be scarce, some policy will have to be written 
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on when badger culling will occur instead of vaccination. Further work on population 
recovery and estimations of the effect of badger density on 𝑅𝑅0 are recommended. 
 
b) Logistics of the transition from culling to vaccination 
Operational and policy changes will be needed to move to a new eradication 
programme that encompasses vaccination. Some of the logistical changes will 
include: the development of appropriate software to run the programme, staff 
training, etc. More importantly, if culling and vaccination are going to be used 
concurrently, specific criteria will have to be laid out as to when either of the two 
options are applied. Consistency in the criteria used will help in the assessment of 
programme progress. 
 
c) Maintaining a robust programme in the face of political pressure 
BCG vaccine efficacy in the field was estimated in Chapter 5. In this chapter, it was 
shown that during the four years the Kilkenny vaccine trial lasted, bTB prevalence 
in badgers did not decrease in any of the trial zones, including zones B and C where 
vaccination had been applied at 50 and 100% vaccination coverage. Although the 
real coverage achieved in these zones was lower than that quoted, and not sustained 
over time (see Figure 2 in Chapter 5), it is expected that a similar lack of decrease in 
prevalence will be observed in the years shortly after the introduction of a badger 
vaccination programme; this will result in disquiet among interested observers about 
the efficiency of the applied controls and will put considerable pressure on policy 
makers. Notwithstanding the lack of effect of vaccination on bTB prevalence in 
badgers in the short term, in Chapter 5 it was possible to demonstrate that during the 
study period, a reduction of badger to badger transmission occurred in the zones 
where vaccination had been applied (zones B and C), indicating that badger 
vaccination was working. Therefore, it is critical that adequate systems for 
measuring ongoing badger to badger transmission are designed, especially in the first 
few years after the introduction of badger vaccination. Also, in order to provide 
confidence that the added control options in cattle and badgers are working, data that 
allows estimation of changes in the cattle-badger system should be collected, and the 
NGM of the system assessed over time.  
 
Conclusion 
 
In Ireland, BCG badger vaccination has the potential to eradicate M. bovis infection 
not only from the badger population but also from the cattle-badger system. 
Although BCG vaccine efficacy in badgers is not high (VES=59% and VEI=0%), we 
have demonstrated that the values the reproduction ratio for the system can take are 
not far from 1 (1.07 𝑅𝑅0 1.16 ) and in most cases can be brought below 1 if BCG 
vaccination is added to the current controls in the country. Nonetheless, for the 
reasons explained in this chapter, we recommend that new, more stringent, and/or 
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revised control options in cattle are adopted (along with badger vaccination) as a 
reassurance and as a way to speed up the eradication programme. Finally, it is greatly 
encouraged that policy makers understand the importance, and allow for adequate 
systems to measure progress to be put in place if/when additional control options are 
added. Also, it is important for all stakeholders to have realistic expectations from 
the badger vaccination programme, expectations which should always be based on 
science. The inability of achieving eradication of M. bovis in cattle in Ireland and 
other countries with a wildlife reservoir has generated large controversy. Now, and 
in view of the results in this thesis, it is possible to explain why, in countries without 
a wildlife reservoir, bTB has been eradicated quite efficiently using similar control 
strategies to the ongoing controls in cattle in Ireland. 
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Bovine tuberculosis (bTB) is a chronic inflammatory disease of cattle caused by 
infection with Mycobacterium bovis. Apart from the respiratory and other general 
symptoms similar to those observed in human tuberculosis, cattle infected with M. 
bovis can show some specific symptoms such as mastitis. When tuberculous lesions 
develop in the udder, shedding of the mycobacteria via milk is possible. In the past, 
consumption of unpasteurized milk contaminated with this agent was a common 
cause of infection in humans. Although the number of human M. bovis infections 
has been greatly reduced in developed countries, contaminated milk and milk 
products still remain the main vehicle of transmission. The large decrease achieved 
in the number of human tuberculosis cases due to M. bovis, was mainly the result of 
control and eradication programmes in cattle, largely based (although not 
exclusively) on the testing and removal of infected animals. Some countries were 
successful in the eradication of the infection in cattle; however, Ireland and the UK 
are two countries where infection is still present despite ongoing control/eradication 
programmes over many years. Ireland commenced a control/eradication programme 
in 1954, and by 1965, cattle incidence had been reduced by more than 95% (from 
17% to 0.5%). Following scientific advice, the control programme was intensified 
over subsequent years yet cattle incidence remained relatively stable. The fact that 
some countries were able to eradicate the infection, while others struggled to 
maintain it at a low prevalence generated much controversy around the efficacy of 
the control strategies used in the latter group. In Ireland and the UK, further 
controversy was sparked by the discovery of a second host for M. bovis, the Eurasian 
badger (Meles meles). Based on subsequent research, badgers were identified as the 
main wildlife reservoir for infection in both countries. Although the exact role of 
badgers in transmission was (at the beginning of this thesis) still not known, several 
studies had confirmed a significant association between badger removal and a 
decrease in cattle bTB outbreaks. In Ireland, some targeted badger culling 
commenced in the early 1990s, and became part of the eradication programme some 
years later. Badger culling was considered a short-medium term strategy that would 
allow for research to be carried out on other plausible control strategies in the 
meantime. A number of laboratory studies where badgers were vaccinated with 
Bacillus Calmette-Guerin (BCG) vaccine, reported a reduction in disease 
progression in vaccinated compared to non-vaccinated badgers subsequent to being 
experimentally challenged with M. bovis. In Ireland, there were expectations that 
BCG vaccination of badgers in the field would help to reduce M. bovis transmission 
not only within the badger population but also between cattle and badgers. This PhD 
was designed to determine whether or not these expectations had a scientific base. 
 
As a first step, assessing the impact of BCG vaccination in the field, rather than in 
an experimental context, was necessary. Although all badgers challenged with M. 
bovis in these trials became infected, some protection against infection could 
potentially be attained under natural conditions. The infective dose that badgers are 
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exposed to in the field, the number of infection events to achieve this dose and the 
route of infection are all unknown. All these parameters, among others, could have 
an impact on the degree of BCG protection that is achieved in the field. In addition, 
the indirect effects of BCG vaccination in badgers had been never investigated; this 
indirect effect could potentially help in reducing transmission. 
 
In the second chapter of this thesis, a badger BCG vaccine field trial was designed 
in a manner that allowed for the effects of BCG vaccination on badger to badger 
transmission to be assessed. For that, two types of vaccine efficacy had to be 
estimated, vaccine efficacy for susceptibility (VES) and vaccine efficacy for 
infectiousness (VEI). VES measures the direct effect of vaccination achieved as a 
reduction in the susceptibility of badgers to M. bovis infection. On the contrary, VEI 
is a measure of a type of indirect effect, resulting from a reduction in the 
infectiousness of vaccinated and subsequently infected badgers. A double blind 
(50/50) vaccine/placebo randomized control trial is regularly used to assess the direct 
effects of vaccination; however, this type of design does not allow for estimations of 
VEI. The design of choice was therefore a compromise whereby both effects could 
be obtained. More importantly, by estimating the effects of vaccination on both 
susceptibility and infectivity, it was possible to assess the effects of the vaccine on 
badger to badger transmission. The study area (located in County Kilkenny in 
Ireland) of approximately 750 square km was divided from North to South into three 
zones (A, B and C) with similar characteristics in terms of size, number of main 
badger setts, cattle herds, cattle and land classification type. Vaccination was applied 
at 0, 50 and 100% coverage with badgers in the middle zone being randomly 
allocated to the vaccine/placebo, and all badgers in zone A receiving the placebo. In 
this chapter the methodology for analysing the trial data collected was also 
explained.  
 
The third chapter of this thesis was dedicated to assess the power of the study design. 
Here, the effects on study power of sample size, prevalence in badgers at the 
beginning of the trial, sensitivity and specificity of the diagnostic test, transmission 
rate between unvaccinated badgers, VES and VEI were determined. The main finding 
from this study was that the specificity of the diagnostic test used in the trial had a 
very large effect on the study power, while test sensitivity did not play a large role. 
Specificity values below 99.4% resulted in study power below 50% as even a small 
proportion of false positives, randomly occurring in the many negative samples from 
both vaccinated and unvaccinated animals masked the effects of vaccination. It was 
concluded then that the diagnostic test to be used in the badger vaccine trial had to 
be optimized to maximize test specificity. 
In the fourth chapter the characteristics of a multiplex chemiluminescent assay 
(Enfer test) for detection of M. bovis infection in badgers were optimized in order to 
maximise specificity, and therefore statistical power. The Relative Light Units 
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(RLU) obtained from testing blood samples from badgers captured by the national 
Department of Agriculture, Food and the Marine (DAFM) were analysed. A stepwise 
logistic regression with analytical weights was used for the analysis. Optimisation 
resulted in a test with 30.77% sensitivity and 99.99% specificity. In addition, and 
significant for the analysis, the characteristics of this test did not vary greatly 
between vaccinated and non-vaccinated badgers. 
 
The results from the BCG badger vaccine trial were presented in the fifth chapter. 
Badgers in the three zones of the vaccine trial area were tattooed and microchipped 
at the first trapping, with trappings occurring over four years. Blood samples were 
collected at first capture and every subsequent recapture. Data obtained from the 
three zones of the vaccine trial, as well as blood test results, were analysed with the 
aim to compare new infections occurring in non-infected non-vaccinated badgers to 
those in non-infected vaccinated ones. A Generalized Linear Model (GLM) with a 
cloglog link function was used for the analysis. Vaccine efficacy for susceptibility 
was estimated as VES=59% (95% CI =6.5%-82%) whereas vaccine efficacy for 
infectivity (VEI) was 0%, implying that there was a complete lack of effect from 
BCG vaccination on the infectivity of vaccinated and subsequently infected badgers. 
In this chapter, the impact of badger vaccination on badger transmission was also 
assessed for the first time. For that, the reproduction ratio for badger to badger 
transmission (R0) under current controls was estimated using a simple formula as 
1.22 assuming a prevalence in badgers of 18%. Therefore, and as BCG vaccination 
was shown to be able to reduce transmission by 59%, the reproduction ratio for a 
badger population vaccinated with 100% vaccine coverage (or R1) was estimated to 
be 0.5. These results suggested that eradication in badgers by adding BCG 
vaccination to the current controls in cattle and badgers would be feasible. The 
formula used for estimating R0 assumes that there is no transmission between cattle 
and badgers. Based on available research, this was unlikely to be the case which 
suggests that these last results could only be taken as an approximation. 
Consequently, the transmission between the two species was explored in the final 
chapter.  
 
In Chapter 6, and as the culmination of the previous chapters, the quantitative role 
of each of the two host species, cattle and badgers, in the transmission of M. bovis in 
Ireland was assessed. Algorithms to estimate the Next Generation Matrix (NGM) 
and the basic reproduction ratio for the cattle-badger system were developed and all 
plausible NGMs describing the transmission between the two species were 
calculated from prevalence data and the number of cattle herds and badgers, 
collected at the endemic steady state. By exploring the system at the endemic 
equilibrium, it was possible to demonstrate that for almost all these plausible 
transmission scenarios, BCG vaccination of badgers in addition to current controls 
could successfully achieve eradication of M. bovis infection in the system. All 
 154 
 
transmission scenarios were represented within a NGM triangle, with the vertices of 
this triangle representing extreme transmission possibilities. The small number of 
transmission scenarios where eradication of M. bovis from the system by adding 
BCG badger vaccination to the current controls was not feasible were shown as an 
area within the triangle. These scenarios were characterized by small/non-existent 
transmission from badgers to cattle, with all or almost all of the infections in cattle 
and badgers being caused by cattle. These scenarios would be highly unlikely to 
represent transmission in the field, and only represent a small proportion of the total. 
Similar results were obtained when the effects of a smaller badger vaccination 
coverage (40%) was investigated. It was concluded therefore, that BCG vaccination 
of badgers has the potential, if added to current controls, to achieve eradication of 
M. bovis infection in the cattle-badger system in Ireland. Nonetheless, for reasons 
explained in the general discussion (Chapter 7) of this thesis, it is highly 
recommended that additional/more stringent controls are applied in cattle along with 
BCG badger vaccination in order to ensure and/or accelerate the eradication process. 
In this final chapter, some answers to potential queries in relation to adding BCG 
vaccination to the current eradication programme, and some further 
recommendations for policy makers and other stakeholders are presented. As stated 
in the final paragraph in Chapter 7: “Now, and in view of the results in this thesis, it 
is possible to explain why, in countries without a wildlife reservoir, bTB has been 
eradicated quite efficiently using similar control strategies to the ongoing controls in 
cattle in Ireland.”.  
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